gene_name	query	indication_meshId	indication_meshName	clinical_success
ABAT	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
ABAT	[MASK] is a promising drug target for the treatment of infantile spasms.	D013036	Spasms, Infantile	1
ABCA4	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
ABCC8	[MASK] is a promising drug target for the treatment of traumatic brain injuries.	D000070642	Brain Injuries, Traumatic	0
ABCC8	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
ABCC8	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	1
ABCC8	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
ABCC8	[MASK] is a promising drug target for the treatment of spinal cord injuries.	D013119	Spinal Cord Injuries	0
ABCD1	[MASK] is a promising drug target for the treatment of adrenoleukodystrophy.	D000326	Adrenoleukodystrophy	1
ABL1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
ABL1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
ABL1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
ABL1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
ABL1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ABL1	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
ABL1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
ABL1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
ABL1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
ABL1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
ABL1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ABL1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ABL1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
ABL1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
ABL1	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
ABL1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
ABL1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
ACACA	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
ACACA	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
ACACB	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
ACE	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
ACE	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
ACE	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	1
ACE2	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
ACE2	[MASK] is a promising drug target for the treatment of acute lung injury.	D055371	Acute Lung Injury	0
ACHE	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	1
ACHE	[MASK] is a promising drug target for the treatment of anesthesia recovery period.	D000762	Anesthesia Recovery Period	1
ACHE	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
ACHE	[MASK] is a promising drug target for the treatment of dementia.	D003704	Dementia	1
ACHE	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
ACHE	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
ACHE	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
ACHE	[MASK] is a promising drug target for the treatment of trichomonas infections.	D014245	Trichomonas Infections	1
ACHE	[MASK] is a promising drug target for the treatment of xerostomia.	D014987	Xerostomia	0
ACHE	[MASK] is a promising drug target for the treatment of lewy body disease.	D020961	Lewy Body Disease	1
ACHE	[MASK] is a promising drug target for the treatment of reproductive tract infections.	D060737	Reproductive Tract Infections	1
ACLY	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	1
ACLY	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type ii.	D006938	Hyperlipoproteinemia Type II	1
ACLY	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	1
ACLY	[MASK] is a promising drug target for the treatment of dyslipidemias.	D050171	Dyslipidemias	1
ACLY	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	1
ACVR1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
ACVR2A	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
ACVR2A	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
ACVR2A	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
ACVR2A	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	0
ACVR2A	[MASK] is a promising drug target for the treatment of pure red-cell aplasia.	D012010	Red-Cell Aplasia, Pure	0
ACVR2A	[MASK] is a promising drug target for the treatment of thalassemia.	D013789	Thalassemia	0
ACVR2B	[MASK] is a promising drug target for the treatment of cachexia.	D002100	Cachexia	0
ACVR2B	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
ACVR2B	[MASK] is a promising drug target for the treatment of muscular atrophy.	D009133	Muscular Atrophy	0
ACVR2B	[MASK] is a promising drug target for the treatment of inclusion body myositis.	D018979	Myositis, Inclusion Body	0
ACVR2B	[MASK] is a promising drug target for the treatment of sarcopenia.	D055948	Sarcopenia	0
ACVRL1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
ACVRL1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of charcot-marie-tooth disease.	D002607	Charcot-Marie-Tooth Disease	0
ACVRL1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
ACVRL1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
ACVRL1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
ACVRL1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
ACVRL1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	1
ACVRL1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of thalassemia.	D013789	Thalassemia	1
ACVRL1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
ACVRL1	[MASK] is a promising drug target for the treatment of facioscapulohumeral muscular dystrophy.	D020391	Muscular Dystrophy, Facioscapulohumeral	0
ADA	[MASK] is a promising drug target for the treatment of severe combined immunodeficiency due to adenosine deaminase deficiency.	C531816	Severe combined immunodeficiency due to adenosine deaminase deficiency	1
ADAMTS4	[MASK] is a promising drug target for the treatment of edema.	D004487	Edema	0
ADAMTS5	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
ADCY6	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
ADCYAP1R1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
ADH5	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
ADM	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
ADNP	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
ADNP	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
ADNP	[MASK] is a promising drug target for the treatment of cognition disorders.	D003072	Cognition Disorders	0
ADORA1	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
ADORA1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	1
ADORA1	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
ADORA1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
ADORA1	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
ADORA2A	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
ADORA2A	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
ADORA2A	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
ADORA2A	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
ADORA2A	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
ADORA2A	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
ADORA2A	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
ADORA3	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
ADRA1A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
ADRA1A	[MASK] is a promising drug target for the treatment of blepharoptosis.	D001763	Blepharoptosis	1
ADRA1A	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
ADRA1A	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
ADRA1A	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	0
ADRA1A	[MASK] is a promising drug target for the treatment of hypotension.	D007022	Hypotension	1
ADRA1A	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
ADRA1A	[MASK] is a promising drug target for the treatment of prostatic hyperplasia.	D011470	Prostatic Hyperplasia	1
ADRA1A	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
ADRA1A	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
ADRA1A	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
ADRA1A	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	0
ADRA1A	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
ADRA1B	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
ADRA1B	[MASK] is a promising drug target for the treatment of hypotension.	D007022	Hypotension	1
ADRA1B	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	0
ADRA1B	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
ADRA1D	[MASK] is a promising drug target for the treatment of hypotension.	D007022	Hypotension	1
ADRA1D	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
ADRA1D	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	0
ADRA1D	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
ADRA2A	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	1
ADRA2A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
ADRA2A	[MASK] is a promising drug target for the treatment of blepharoptosis.	D001763	Blepharoptosis	1
ADRA2A	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
ADRA2A	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
ADRA2A	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
ADRA2A	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
ADRA2A	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
ADRA2A	[MASK] is a promising drug target for the treatment of hypotension.	D007022	Hypotension	0
ADRA2A	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	0
ADRA2A	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
ADRA2A	[MASK] is a promising drug target for the treatment of rosacea.	D012393	Rosacea	1
ADRA2A	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
ADRA2A	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
ADRA2A	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
ADRA2A	[MASK] is a promising drug target for the treatment of geographic atrophy.	D057092	Geographic Atrophy	0
ADRA2B	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	1
ADRA2B	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
ADRA2B	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
ADRA2B	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	0
ADRA2B	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
ADRA2B	[MASK] is a promising drug target for the treatment of traumatic shock.	D012774	Shock, Traumatic	1
ADRA2B	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
ADRA2B	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
ADRA2C	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
ADRA2C	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	1
ADRA2C	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
ADRA2C	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
ADRA2C	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
ADRA2C	[MASK] is a promising drug target for the treatment of raynaud disease.	D011928	Raynaud Disease	0
ADRA2C	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
ADRA2C	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
ADRB1	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	1
ADRB1	[MASK] is a promising drug target for the treatment of cardiac arrhythmias.	D001145	Arrhythmias, Cardiac	1
ADRB1	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	1
ADRB1	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
ADRB1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
ADRB1	[MASK] is a promising drug target for the treatment of hemangioma.	D006391	Hemangioma	1
ADRB1	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
ADRB1	[MASK] is a promising drug target for the treatment of hypotension.	D007022	Hypotension	0
ADRB1	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
ADRB1	[MASK] is a promising drug target for the treatment of retinopathy of prematurity.	D012178	Retinopathy of Prematurity	0
ADRB1	[MASK] is a promising drug target for the treatment of post-traumatic stress disorders.	D013313	Stress Disorders, Post-Traumatic	0
ADRB1	[MASK] is a promising drug target for the treatment of supraventricular tachycardia.	D013617	Tachycardia, Supraventricular	1
ADRB1	[MASK] is a promising drug target for the treatment of ventricular fibrillation.	D014693	Ventricular Fibrillation	1
ADRB1	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
ADRB2	[MASK] is a promising drug target for the treatment of cardiac arrhythmias.	D001145	Arrhythmias, Cardiac	1
ADRB2	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	1
ADRB2	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	1
ADRB2	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	0
ADRB2	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
ADRB2	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
ADRB2	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
ADRB2	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
ADRB2	[MASK] is a promising drug target for the treatment of hypoglycemia.	D007003	Hypoglycemia	0
ADRB2	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
ADRB2	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
ADRB2	[MASK] is a promising drug target for the treatment of retinopathy of prematurity.	D012178	Retinopathy of Prematurity	0
ADRB2	[MASK] is a promising drug target for the treatment of post-traumatic stress disorders.	D013313	Stress Disorders, Post-Traumatic	0
ADRB2	[MASK] is a promising drug target for the treatment of ventricular fibrillation.	D014693	Ventricular Fibrillation	1
ADRB2	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	1
ADRB3	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
ADRB3	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
AGER	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
AGER	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
AGT	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
AGT	[MASK] is a promising drug target for the treatment of hepatorenal syndrome.	D006530	Hepatorenal Syndrome	0
AGT	[MASK] is a promising drug target for the treatment of hypotension.	D007022	Hypotension	1
AGT	[MASK] is a promising drug target for the treatment of sepsis.	D018805	Sepsis	1
AGTR1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
AGTR1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
AGTR1	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
AGTR1	[MASK] is a promising drug target for the treatment of pneumonia.	D011014	Pneumonia	0
AGTR2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
AGTR2	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
AGTR2	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
AGTR2	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
AGTR2	[MASK] is a promising drug target for the treatment of peripheral nervous system diseases.	D010523	Peripheral Nervous System Diseases	0
AGTR2	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
AGTR2	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
AGTR2	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
AGTR2	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
AIFM1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
AIFM1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
AKR1B1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
AKR1C3	[MASK] is a promising drug target for the treatment of endometriosis.	D004715	Endometriosis	0
AKT1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
AKT1	[MASK] is a promising drug target for the treatment of langerhans-cell histiocytosis.	D006646	Histiocytosis, Langerhans-Cell	0
AKT1	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
AKT1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
AKT1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
AKT1	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
AKT1	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
AKT1	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
AKT1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
AKT1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
AKT1	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
AKT1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
AKT1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
AKT1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
AKT1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
AKT1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
AKT1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
ALAS1	[MASK] is a promising drug target for the treatment of porphyrias.	D011164	Porphyrias	1
ALB	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ALCAM	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
ALCAM	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
ALDH1A1	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	1
ALDH2	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	0
ALDH2	[MASK] is a promising drug target for the treatment of alcohol-related disorders.	D019973	Alcohol-Related Disorders	0
ALK	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
ALK	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
ALK	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
ALK	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
ALK	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
ALK	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ALK	[MASK] is a promising drug target for the treatment of leiomyosarcoma.	D007890	Leiomyosarcoma	0
ALK	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
ALK	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
ALK	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
ALK	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
ALK	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
ALK	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ALK	[MASK] is a promising drug target for the treatment of anaplastic large-cell lymphoma.	D017728	Lymphoma, Large-Cell, Anaplastic	1
ALK	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
ALK	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
ALOX15	[MASK] is a promising drug target for the treatment of vlcad deficiency.	C536353	VLCAD deficiency	0
ALOX15	[MASK] is a promising drug target for the treatment of pontocerebellar hypoplasia.	C580383	Pontocerebellar Hypoplasia	0
ALOX15	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
ALOX15	[MASK] is a promising drug target for the treatment of rett syndrome.	D015518	Rett Syndrome	0
ALOX15	[MASK] is a promising drug target for the treatment of mitochondrial diseases.	D028361	Mitochondrial Diseases	0
ALOX15	[MASK] is a promising drug target for the treatment of hearing loss.	D034381	Hearing Loss	0
ALOX5	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
ALOX5	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
ALOX5	[MASK] is a promising drug target for the treatment of renal insufficiency.	D051437	Renal Insufficiency	0
ALOX5	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
ALOX5	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
ALOX5AP	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
ALOX5AP	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	0
ALOX5AP	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
ALPL	[MASK] is a promising drug target for the treatment of hypophosphatasia.	D007014	Hypophosphatasia	1
AMY2A	[MASK] is a promising drug target for the treatment of pancreatic diseases.	D010182	Pancreatic Diseases	0
AMY2A	[MASK] is a promising drug target for the treatment of exocrine pancreatic insufficiency.	D010188	Exocrine Pancreatic Insufficiency	1
ANGPT1	[MASK] is a promising drug target for the treatment of intermittent claudication.	D007383	Intermittent Claudication	0
ANGPT1	[MASK] is a promising drug target for the treatment of ischemia.	D007511	Ischemia	0
ANGPT2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
ANGPT2	[MASK] is a promising drug target for the treatment of anus neoplasms.	D001005	Anus Neoplasms	0
ANGPT2	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
ANGPT2	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
ANGPT2	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ANGPT2	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	1
ANGPT2	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
ANGPT2	[MASK] is a promising drug target for the treatment of pneumonia.	D011014	Pneumonia	0
ANGPT2	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
ANGPT2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ANGPT2	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	1
ANGPTL3	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
ANGPTL3	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type ii.	D006938	Hyperlipoproteinemia Type II	1
ANGPTL3	[MASK] is a promising drug target for the treatment of lipodystrophy.	D008060	Lipodystrophy	0
ANGPTL3	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type i.	D008072	Hyperlipoproteinemia Type I	0
ANGPTL3	[MASK] is a promising drug target for the treatment of dyslipidemias.	D050171	Dyslipidemias	0
ANGPTL3	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
ANPEP	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
ANPEP	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
ANPEP	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
ANPEP	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
ANPEP	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	1
ANPEP	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	1
ANPEP	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	1
ANPEP	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
ANPEP	[MASK] is a promising drug target for the treatment of wilms tumor.	D009396	Wilms Tumor	1
ANPEP	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
ANPEP	[MASK] is a promising drug target for the treatment of neuroblastoma.	D009447	Neuroblastoma	1
ANPEP	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	1
ANPEP	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
ANPEP	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
ANPEP	[MASK] is a promising drug target for the treatment of rhabdomyosarcoma.	D012208	Rhabdomyosarcoma	1
ANPEP	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
ANPEP	[MASK] is a promising drug target for the treatment of ewing sarcoma.	D012512	Sarcoma, Ewing	1
ANPEP	[MASK] is a promising drug target for the treatment of osteosarcoma.	D012516	Osteosarcoma	1
ANPEP	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
ANPEP	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
ANPEP	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	1
ANPEP	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
ANPEP	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	1
ANPEP	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
ANXA5	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	0
ANXA5	[MASK] is a promising drug target for the treatment of cardiovascular diagnostic techniques.	D003935	Diagnostic Techniques, Cardiovascular	0
AOC3	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
AOC3	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
AOC3	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
AOC3	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
AOC3	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
AOC3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
AOC3	[MASK] is a promising drug target for the treatment of proteinuria.	D011507	Proteinuria	0
AOC3	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
AOC3	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
AOC3	[MASK] is a promising drug target for the treatment of sclerosing cholangitis.	D015209	Cholangitis, Sclerosing	0
AOC3	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	0
AOC3	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
AOC3	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
AOC3	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
AOC3	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
APCS	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
APCS	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	0
APOA1	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type ii.	D006938	Hyperlipoproteinemia Type II	0
APOA1	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
APOA1	[MASK] is a promising drug target for the treatment of hypoalphalipoproteinemias.	D052456	Hypoalphalipoproteinemias	0
APOA1	[MASK] is a promising drug target for the treatment of acute coronary syndrome.	D054058	Acute Coronary Syndrome	0
APOBEC3G	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
APOBEC3G	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	0
APOC3	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
APOC3	[MASK] is a promising drug target for the treatment of lipodystrophy.	D008060	Lipodystrophy	1
APOC3	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type i.	D008072	Hyperlipoproteinemia Type I	1
APOC3	[MASK] is a promising drug target for the treatment of hypertriglyceridemia.	D015228	Hypertriglyceridemia	1
APOE	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type ii.	D006938	Hyperlipoproteinemia Type II	0
APP	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	1
APP	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
APP	[MASK] is a promising drug target for the treatment of neurological diagnostic techniques.	D003943	Diagnostic Techniques, Neurological	1
APP	[MASK] is a promising drug target for the treatment of geographic atrophy.	D057092	Geographic Atrophy	0
AR	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
AR	[MASK] is a promising drug target for the treatment of cachexia.	D002100	Cachexia	0
AR	[MASK] is a promising drug target for the treatment of dyspareunia.	D004414	Dyspareunia	1
AR	[MASK] is a promising drug target for the treatment of eye diseases.	D005128	Eye Diseases	0
AR	[MASK] is a promising drug target for the treatment of hypogonadism.	D007006	Hypogonadism	1
AR	[MASK] is a promising drug target for the treatment of induced labor.	D007751	Labor, Induced	1
AR	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
AR	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	1
AR	[MASK] is a promising drug target for the treatment of muscular atrophy.	D009133	Muscular Atrophy	0
AR	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	0
AR	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
AR	[MASK] is a promising drug target for the treatment of physiological sexual dysfunction.	D012735	Sexual Dysfunction, Physiological	1
AR	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
AR	[MASK] is a promising drug target for the treatment of psychological sexual dysfunctions.	D020018	Sexual Dysfunctions, Psychological	1
AR	[MASK] is a promising drug target for the treatment of hormone replacement therapy.	D020249	Hormone Replacement Therapy	1
AR	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
AR	[MASK] is a promising drug target for the treatment of atrophic vaginitis.	D059268	Atrophic Vaginitis	1
ARG1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
ARG1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
ARG1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
ARG1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ARG1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ARG1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
ARG1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
ARG1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
ARG1	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
ARG1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ARG1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
ARG2	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
ARG2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
ARG2	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
ARG2	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ARG2	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ARG2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
ARG2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
ARG2	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
ARG2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ASPH	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ASPH	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
ATP1A1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
ATP1A1	[MASK] is a promising drug target for the treatment of peptic esophagitis.	D004942	Esophagitis, Peptic	0
ATP1A1	[MASK] is a promising drug target for the treatment of gastroesophageal reflux.	D005764	Gastroesophageal Reflux	1
ATP1A1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
ATP1A1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ATP1A1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
ATP1A1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
ATP1A1	[MASK] is a promising drug target for the treatment of peptic ulcer.	D010437	Peptic Ulcer	0
ATP4A	[MASK] is a promising drug target for the treatment of duodenal ulcer.	D004381	Duodenal Ulcer	1
ATP4A	[MASK] is a promising drug target for the treatment of peptic esophagitis.	D004942	Esophagitis, Peptic	1
ATP4A	[MASK] is a promising drug target for the treatment of gastritis.	D005756	Gastritis	1
ATP4A	[MASK] is a promising drug target for the treatment of gastroesophageal reflux.	D005764	Gastroesophageal Reflux	1
ATP4A	[MASK] is a promising drug target for the treatment of stomach ulcer.	D013276	Stomach Ulcer	1
ATP4A	[MASK] is a promising drug target for the treatment of ulcer.	D014456	Ulcer	1
ATP4A	[MASK] is a promising drug target for the treatment of zollinger-ellison syndrome.	D015043	Zollinger-Ellison Syndrome	1
ATP4A	[MASK] is a promising drug target for the treatment of helicobacter infections.	D016481	Helicobacter Infections	1
ATR	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
AURKA	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
AURKA	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
AURKA	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
AURKA	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
AURKA	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
AURKA	[MASK] is a promising drug target for the treatment of neuroblastoma.	D009447	Neuroblastoma	0
AURKA	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
AURKA	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
AURKA	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
AURKA	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
AURKA	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
AURKA	[MASK] is a promising drug target for the treatment of t-cell lymphoma.	D016399	Lymphoma, T-Cell	0
AURKA	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
AURKA	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
AURKB	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
AURKB	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
AURKB	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
AURKB	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
AURKB	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
AURKB	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
AURKB	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
AURKB	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
AURKB	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
AURKB	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
AURKB	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
AURKB	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
AURKB	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
AURKB	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
AURKC	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
AURKC	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
AURKC	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
AURKC	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
AURKC	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
AURKC	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
AURKC	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
AURKC	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
AURKC	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
AURKC	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
AURKC	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
AVPR1A	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
AVPR1A	[MASK] is a promising drug target for the treatment of dysmenorrhea.	D004412	Dysmenorrhea	0
AVPR1A	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
AVPR1A	[MASK] is a promising drug target for the treatment of huntington disease.	D006816	Huntington Disease	0
AVPR1A	[MASK] is a promising drug target for the treatment of hyponatremia.	D007010	Hyponatremia	0
AVPR1A	[MASK] is a promising drug target for the treatment of hypotension.	D007022	Hypotension	0
AVPR1A	[MASK] is a promising drug target for the treatment of and conduct disorders impulse control disruptive.	D007174	Disruptive, Impulse Control, and Conduct Disorders	0
AVPR1A	[MASK] is a promising drug target for the treatment of sepsis.	D018805	Sepsis	0
AVPR1B	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	0
AVPR1B	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
AVPR1B	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
AVPR2	[MASK] is a promising drug target for the treatment of cardiac edema.	D004489	Edema, Cardiac	1
AVPR2	[MASK] is a promising drug target for the treatment of hyponatremia.	D007010	Hyponatremia	0
AVPR2	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
AVPR2	[MASK] is a promising drug target for the treatment of liver diseases.	D008107	Liver Diseases	0
AVPR2	[MASK] is a promising drug target for the treatment of polyuria.	D011141	Polyuria	1
AXL	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
AXL	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
AXL	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
AXL	[MASK] is a promising drug target for the treatment of iga glomerulonephritis.	D005922	Glomerulonephritis, IGA	0
AXL	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
AXL	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
AXL	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
AXL	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
BACE1	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
BCHE	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	1
BCHE	[MASK] is a promising drug target for the treatment of dementia.	D003704	Dementia	1
BCHE	[MASK] is a promising drug target for the treatment of cocaine-related disorders.	D019970	Cocaine-Related Disorders	0
BCHE	[MASK] is a promising drug target for the treatment of drug-related side effects and adverse reactions.	D064420	Drug-Related Side Effects and Adverse Reactions	0
BCKDK	[MASK] is a promising drug target for the treatment of inborn urea cycle disorders.	D056806	Urea Cycle Disorders, Inborn	1
BCL2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
BCL2	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
BCL2	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
BCL2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
BCL2	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	1
BCL2	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
BCL2	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
BCL2	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	0
BCL2	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
BCL2L1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
BCL2L1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
BCL2L1	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
BCL2L1	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	0
BCL2L1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
BCL2L1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
BCL2L1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
BCL2L1	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
BCL2L1	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
BCL2L1	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	0
BCL2L1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
BCL2L1	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
BCR	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
BCR	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
BCR	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
BCR	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
BCR	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
BCR	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
BCR	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
BCR	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
BCR	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
BCR	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
BCR	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
BCR	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
BCR	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
BCR	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
BCR	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
BCR	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
BDKRB1	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
BDKRB1	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
BDKRB1	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
BDKRB1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
BDKRB1	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
BDKRB2	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
BDKRB2	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
BDKRB2	[MASK] is a promising drug target for the treatment of rhinitis.	D012220	Rhinitis	0
BDKRB2	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
BDKRB2	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
BIRC2	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
BIRC2	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
BIRC2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
BIRC2	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
BIRC2	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
BIRC2	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
BIRC2	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
BIRC3	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
BIRC3	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
BIRC3	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
BIRC3	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
BIRC3	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
BIRC3	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
BIRC3	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
BIRC5	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
BIRC5	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
BIRC5	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
BIRC5	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
BIRC5	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
BMP10	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
BMP10	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
BMP10	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
BMP10	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
BMP10	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
BMP10	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
BMP2	[MASK] is a promising drug target for the treatment of bone diseases.	D001847	Bone Diseases	0
BMP2	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
BMP2	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	0
BMP6	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	0
BMPR1A	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	0
BRAF	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	1
BRAF	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
BRAF	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
BRAF	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	1
BRAF	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
BRAF	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
BRAF	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
BRAF	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
BRAF	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	1
BRAF	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
BRAF	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
BRAF	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
BRAF	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
BRAF	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
BRAF	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
BRAF	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
BRAF	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
BRAF	[MASK] is a promising drug target for the treatment of erdheim-chester disease.	D031249	Erdheim-Chester Disease	1
BRAF	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	1
BRD2	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
BRD2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
BRD2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
BRD2	[MASK] is a promising drug target for the treatment of squamous cell carcinoma.	D002294	Carcinoma, Squamous Cell	0
BRD2	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
BRD2	[MASK] is a promising drug target for the treatment of female infertility.	D007247	Infertility, Female	0
BRD2	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
BRD2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
BRD2	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
BRD2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
BRD3	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
BRD3	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
BRD3	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
BRD3	[MASK] is a promising drug target for the treatment of squamous cell carcinoma.	D002294	Carcinoma, Squamous Cell	0
BRD3	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
BRD3	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
BRD3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
BRD3	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
BRD3	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
BRD4	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
BRD4	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
BRD4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
BRD4	[MASK] is a promising drug target for the treatment of squamous cell carcinoma.	D002294	Carcinoma, Squamous Cell	0
BRD4	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
BRD4	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	0
BRD4	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
BRD4	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
BRD4	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
BRD4	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
BRD4	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
BRD4	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
BRD4	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
BRD4	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
BSG	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
BTK	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
BTK	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
BTK	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	1
BTK	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
BTK	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	1
BTK	[MASK] is a promising drug target for the treatment of waldenstrom macroglobulinemia.	D008258	Waldenstrom Macroglobulinemia	1
BTK	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
BTK	[MASK] is a promising drug target for the treatment of myasthenia gravis.	D009157	Myasthenia Gravis	0
BTK	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
BTK	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
BTK	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	1
BTK	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	1
BTK	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	1
BTK	[MASK] is a promising drug target for the treatment of central nervous system neoplasms.	D016543	Central Nervous System Neoplasms	0
BTK	[MASK] is a promising drug target for the treatment of marginal zone b-cell lymphoma.	D018442	Lymphoma, B-Cell, Marginal Zone	1
BTK	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	1
BTK	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
BTK	[MASK] is a promising drug target for the treatment of b-cell prolymphocytic leukemia.	D054403	Leukemia, Prolymphocytic, B-Cell	0
C1S	[MASK] is a promising drug target for the treatment of autoimmune hemolytic anemia.	D000744	Anemia, Hemolytic, Autoimmune	1
C1S	[MASK] is a promising drug target for the treatment of idiopathic thrombocytopenic purpura.	D016553	Purpura, Thrombocytopenic, Idiopathic	0
C3	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
C3	[MASK] is a promising drug target for the treatment of autoimmune hemolytic anemia.	D000744	Anemia, Hemolytic, Autoimmune	1
C3	[MASK] is a promising drug target for the treatment of paroxysmal hemoglobinuria.	D006457	Hemoglobinuria, Paroxysmal	1
C3	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
C3	[MASK] is a promising drug target for the treatment of geographic atrophy.	D057092	Geographic Atrophy	1
C5	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
C5	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
C5	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
C5	[MASK] is a promising drug target for the treatment of eye diseases.	D005128	Eye Diseases	0
C5	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
C5	[MASK] is a promising drug target for the treatment of paroxysmal hemoglobinuria.	D006457	Hemoglobinuria, Paroxysmal	1
C5	[MASK] is a promising drug target for the treatment of hemolytic-uremic syndrome.	D006463	Hemolytic-Uremic Syndrome	1
C5	[MASK] is a promising drug target for the treatment of myasthenia gravis.	D009157	Myasthenia Gravis	1
C5	[MASK] is a promising drug target for the treatment of myositis.	D009220	Myositis	0
C5	[MASK] is a promising drug target for the treatment of neuromyelitis optica.	D009471	Neuromyelitis Optica	1
C5	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
C5	[MASK] is a promising drug target for the treatment of granulomatosis with polyangiitis.	D014890	Granulomatosis with Polyangiitis	0
C5	[MASK] is a promising drug target for the treatment of antiphospholipid syndrome.	D016736	Antiphospholipid Syndrome	0
C5	[MASK] is a promising drug target for the treatment of sepsis.	D018805	Sepsis	0
C5	[MASK] is a promising drug target for the treatment of guillain-barre syndrome.	D020275	Guillain-Barre Syndrome	0
C5	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
C5	[MASK] is a promising drug target for the treatment of microscopic polyangiitis.	D055953	Microscopic Polyangiitis	0
C5	[MASK] is a promising drug target for the treatment of geographic atrophy.	D057092	Geographic Atrophy	1
C5AR1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
C5AR1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
C5AR1	[MASK] is a promising drug target for the treatment of iga glomerulonephritis.	D005922	Glomerulonephritis, IGA	0
C5AR1	[MASK] is a promising drug target for the treatment of hemolytic-uremic syndrome.	D006463	Hemolytic-Uremic Syndrome	0
C5AR1	[MASK] is a promising drug target for the treatment of bullous pemphigoid.	D010391	Pemphigoid, Bullous	0
C5AR1	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
C5AR1	[MASK] is a promising drug target for the treatment of urticaria.	D014581	Urticaria	0
C5AR1	[MASK] is a promising drug target for the treatment of vasculitis.	D014657	Vasculitis	1
C5AR1	[MASK] is a promising drug target for the treatment of granulomatosis with polyangiitis.	D014890	Granulomatosis with Polyangiitis	1
C5AR1	[MASK] is a promising drug target for the treatment of microscopic polyangiitis.	D055953	Microscopic Polyangiitis	1
C9orf72	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
C9orf72	[MASK] is a promising drug target for the treatment of frontotemporal dementia.	D057180	Frontotemporal Dementia	0
CA2	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
CA2	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	1
CACNA1A	[MASK] is a promising drug target for the treatment of absence epilepsy.	D004832	Epilepsy, absence	0
CACNA1B	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
CACNA1B	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CACNA1B	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
CACNA1C	[MASK] is a promising drug target for the treatment of traumatic brain injuries.	D000070642	Brain Injuries, Traumatic	0
CACNA1C	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
CACNA1C	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	1
CACNA1C	[MASK] is a promising drug target for the treatment of unstable angina.	D000789	Angina, Unstable	1
CACNA1C	[MASK] is a promising drug target for the treatment of cardiac arrhythmias.	D001145	Arrhythmias, Cardiac	0
CACNA1C	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	1
CACNA1C	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
CACNA1C	[MASK] is a promising drug target for the treatment of fissure in ano.	D005401	Fissure in Ano	0
CACNA1C	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
CACNA1C	[MASK] is a promising drug target for the treatment of cardiomyopathies.	D009202	Cardiomyopathies	1
CACNA1C	[MASK] is a promising drug target for the treatment of subarachnoid hemorrhage.	D013345	Subarachnoid Hemorrhage	1
CACNA1C	[MASK] is a promising drug target for the treatment of supraventricular tachycardia.	D013617	Tachycardia, Supraventricular	1
CACNA1C	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
CACNA1G	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
CACNA1G	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
CACNA1G	[MASK] is a promising drug target for the treatment of absence epilepsy.	D004832	Epilepsy, absence	0
CACNA1G	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	0
CACNA1G	[MASK] is a promising drug target for the treatment of essential tremor.	D020329	Essential Tremor	0
CACNA1H	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
CACNA1H	[MASK] is a promising drug target for the treatment of absence epilepsy.	D004832	Epilepsy, absence	0
CACNA1H	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CACNA1I	[MASK] is a promising drug target for the treatment of absence epilepsy.	D004832	Epilepsy, absence	0
CACNA1I	[MASK] is a promising drug target for the treatment of essential tremor.	D020329	Essential Tremor	0
CACNA2D1	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
CACNA2D1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	1
CACNA2D1	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	1
CACNA2D1	[MASK] is a promising drug target for the treatment of fibromyalgia.	D005356	Fibromyalgia	1
CACNA2D1	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	0
CACNA2D1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	1
CACNA2D1	[MASK] is a promising drug target for the treatment of prostatic hyperplasia.	D011470	Prostatic Hyperplasia	0
CACNA2D1	[MASK] is a promising drug target for the treatment of physiological sexual dysfunction.	D012735	Sexual Dysfunction, Physiological	0
CACNA2D1	[MASK] is a promising drug target for the treatment of urethritis.	D014526	Urethritis	0
CACNA2D1	[MASK] is a promising drug target for the treatment of psychological sexual dysfunctions.	D020018	Sexual Dysfunctions, Psychological	0
CACNA2D1	[MASK] is a promising drug target for the treatment of complex regional pain syndromes.	D020918	Complex Regional Pain Syndromes	0
CACNA2D1	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
CACNA2D1	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	1
CACNA2D1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
CACNA2D1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
CALCA	[MASK] is a promising drug target for the treatment of hyperostosis corticalis deformans juvenilis.	C537701	Hyperostosis corticalis deformans juvenilis	1
CALCA	[MASK] is a promising drug target for the treatment of cluster headache.	D003027	Cluster Headache	1
CALCA	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
CALCA	[MASK] is a promising drug target for the treatment of hypercalcemia.	D006934	Hypercalcemia	1
CALCA	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
CALCA	[MASK] is a promising drug target for the treatment of osteitis deformans.	D010001	Osteitis Deformans	1
CALCA	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	1
CALCA	[MASK] is a promising drug target for the treatment of mammary paget's disease.	D010144	Paget's Disease, Mammary	1
CALCA	[MASK] is a promising drug target for the treatment of extramammary paget disease.	D010145	Paget Disease, Extramammary	1
CALCA	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
CALCB	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
CALCR	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	0
CALCR	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
CALCR	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	1
CALCRL	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CALCRL	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
CALCRL	[MASK] is a promising drug target for the treatment of pneumonia.	D011014	Pneumonia	0
CALCRL	[MASK] is a promising drug target for the treatment of trigeminal neuralgia.	D014277	Trigeminal Neuralgia	0
CAPN1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CAPN2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CAPN9	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CASP3	[MASK] is a promising drug target for the treatment of actinic keratosis.	D055623	Keratosis, Actinic	0
CASP9	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
CASP9	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CASP9	[MASK] is a promising drug target for the treatment of urogenital neoplasms.	D014565	Urogenital Neoplasms	0
CASR	[MASK] is a promising drug target for the treatment of hypercalcemia.	D006934	Hypercalcemia	1
CASR	[MASK] is a promising drug target for the treatment of secondary hyperparathyroidism.	D006962	Hyperparathyroidism, Secondary	1
CASR	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	0
CASR	[MASK] is a promising drug target for the treatment of primary hyperparathyroidism.	D049950	Hyperparathyroidism, Primary	1
CCKAR	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
CCKAR	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
CCL11	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
CCL2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CCL2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CCL2	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
CCL2	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
CCL2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
CCL2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CCL2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CCL2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CCL2	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
CCL2	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
CCL2	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
CCL2	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
CCN2	[MASK] is a promising drug target for the treatment of fibrosis.	D005355	Fibrosis	0
CCN2	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
CCN2	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
CCNA2	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
CCNA2	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CCR1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
CCR1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CCR1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CCR1	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
CCR2	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
CCR2	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
CCR2	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
CCR2	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
CCR2	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
CCR2	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
CCR2	[MASK] is a promising drug target for the treatment of liver diseases.	D008107	Liver Diseases	0
CCR2	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
CCR2	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
CCR2	[MASK] is a promising drug target for the treatment of nephrotic syndrome.	D009404	Nephrotic Syndrome	0
CCR2	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CCR2	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CCR2	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
CCR2	[MASK] is a promising drug target for the treatment of diabetes complications.	D048909	Diabetes Complications	0
CCR2	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
CCR2	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
CCR3	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
CCR3	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
CCR3	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
CCR3	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
CCR4	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CCR5	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
CCR5	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
CCR5	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
CCR5	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
CCR5	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
CD19	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
CD19	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
CD19	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	1
CD19	[MASK] is a promising drug target for the treatment of neuromyelitis optica.	D009471	Neuromyelitis Optica	1
CD19	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	1
CD19	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	1
CD19	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	1
CD19	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
CD19	[MASK] is a promising drug target for the treatment of b-cell prolymphocytic leukemia.	D054403	Leukemia, Prolymphocytic, B-Cell	0
CD1D	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CD1D	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CD1D	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CD200R1	[MASK] is a promising drug target for the treatment of urticaria.	D014581	Urticaria	0
CD22	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
CD22	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
CD22	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CD24	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CD24	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
CD24	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	0
CD24	[MASK] is a promising drug target for the treatment of pneumonia.	D011014	Pneumonia	0
CD27	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
CD27	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
CD27	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CD27	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
CD27	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
CD27	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
CD27	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CD27	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CD27	[MASK] is a promising drug target for the treatment of urogenital neoplasms.	D014565	Urogenital Neoplasms	0
CD274	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
CD274	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
CD274	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
CD274	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	0
CD274	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
CD274	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
CD274	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	1
CD274	[MASK] is a promising drug target for the treatment of mouth neoplasms.	D009062	Mouth Neoplasms	0
CD274	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
CD274	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
CD274	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	1
CD274	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
CD274	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
CD274	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
CD28	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
CD28	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
CD28	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
CD28	[MASK] is a promising drug target for the treatment of infectious skin diseases.	D012874	Skin Diseases, Infectious	1
CD28	[MASK] is a promising drug target for the treatment of sepsis.	D018805	Sepsis	0
CD28	[MASK] is a promising drug target for the treatment of acute kidney injury.	D058186	Acute Kidney Injury	0
CD33	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
CD33	[MASK] is a promising drug target for the treatment of mastocytosis.	D008415	Mastocytosis	0
CD33	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
CD33	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CD37	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	0
CD37	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CD38	[MASK] is a promising drug target for the treatment of immunoglobulin light-chain amyloidosis.	D000075363	Immunoglobulin Light-chain Amyloidosis	1
CD38	[MASK] is a promising drug target for the treatment of autoimmune hemolytic anemia.	D000744	Anemia, Hemolytic, Autoimmune	0
CD38	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CD38	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
CD38	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
CD38	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CD38	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	0
CD3E	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
CD3E	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CD3E	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	1
CD3E	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
CD3E	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
CD3E	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
CD3E	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
CD3E	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
CD3E	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
CD3E	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
CD3E	[MASK] is a promising drug target for the treatment of neuroblastoma.	D009447	Neuroblastoma	0
CD3E	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
CD3E	[MASK] is a promising drug target for the treatment of osteosarcoma.	D012516	Osteosarcoma	0
CD3E	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
CD3E	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
CD3E	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	0
CD3E	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	1
CD3E	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	1
CD3E	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
CD3E	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
CD4	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
CD4	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
CD4	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
CD40	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
CD40	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
CD40	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
CD40	[MASK] is a promising drug target for the treatment of myasthenia gravis.	D009157	Myasthenia Gravis	0
CD40	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CD40	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
CD40	[MASK] is a promising drug target for the treatment of idiopathic thrombocytopenic purpura.	D016553	Purpura, Thrombocytopenic, Idiopathic	0
CD40LG	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	0
CD44	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CD44	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
CD44	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CD44	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CD44	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
CD47	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CD52	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CD52	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
CD6	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
CD6	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
CD6	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
CD7	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
CD7	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	0
CD79B	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	0
CD79B	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CD79B	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	1
CD80	[MASK] is a promising drug target for the treatment of juvenile arthritis.	D001171	Arthritis, Juvenile	1
CD80	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
CD80	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CD86	[MASK] is a promising drug target for the treatment of juvenile arthritis.	D001171	Arthritis, Juvenile	1
CD86	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
CD8A	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
CDC7	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CDC7	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
CDC7	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CDC7	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CDC7	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
CDC7	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
CDH3	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CDH3	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CDK1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CDK1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
CDK1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CDK1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CDK1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CDK1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CDK1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CDK1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CDK1	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
CDK1	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
CDK2	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
CDK2	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
CDK2	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
CDK2	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
CDK2	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
CDK2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CDK2	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
CDK2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CDK2	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CDK4	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
CDK4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CDK4	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
CDK4	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
CDK4	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
CDK4	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CDK4	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CDK4	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CDK4	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CDK4	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
CDK4	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
CDK4	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
CDK4	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
CDK5	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CDK5	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CDK5	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CDK5	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CDK6	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
CDK6	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CDK6	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
CDK6	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CDK6	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CDK6	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CDK6	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
CDK6	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
CDK7	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
CDK9	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
CDK9	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
CDK9	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CDK9	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CDK9	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CDK9	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	0
CDK9	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
CDKN2A	[MASK] is a promising drug target for the treatment of anus neoplasms.	D001005	Anus Neoplasms	0
CDKN2A	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
CDKN2A	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
CDKN2A	[MASK] is a promising drug target for the treatment of vaginal neoplasms.	D014625	Vaginal Neoplasms	0
CEACAM5	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CEACAM5	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
CEACAM5	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	0
CEACAM5	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CEACAM5	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
CEACAM5	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
CETP	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	0
CETP	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
CFD	[MASK] is a promising drug target for the treatment of glomerulonephritis.	D005921	Glomerulonephritis	0
CFD	[MASK] is a promising drug target for the treatment of geographic atrophy.	D057092	Geographic Atrophy	0
CFTR	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
CFTR	[MASK] is a promising drug target for the treatment of cystinosis.	D003554	Cystinosis	0
CFTR	[MASK] is a promising drug target for the treatment of polycystic kidney diseases.	D007690	Polycystic Kidney Diseases	0
CHAT	[MASK] is a promising drug target for the treatment of human influenza.	D007251	Influenza, Human	0
CHEK1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CHEK1	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
CHEK1	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
CHEK1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
CHEK1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CHEK1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CHEK1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
CHEK1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CHEK1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
CHEK2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CHEK2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CHEK2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CHEK2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
CHEK2	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
CHM	[MASK] is a promising drug target for the treatment of choroideremia.	D015794	Choroideremia	0
CHRM1	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
CHRM1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
CHRM1	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
CHRM1	[MASK] is a promising drug target for the treatment of gastrointestinal diseases.	D005767	Gastrointestinal Diseases	1
CHRM1	[MASK] is a promising drug target for the treatment of peptic ulcer.	D010437	Peptic Ulcer	0
CHRM1	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
CHRM1	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
CHRM1	[MASK] is a promising drug target for the treatment of sialorrhea.	D012798	Sialorrhea	1
CHRM1	[MASK] is a promising drug target for the treatment of xerostomia.	D014987	Xerostomia	0
CHRM1	[MASK] is a promising drug target for the treatment of lewy body disease.	D020961	Lewy Body Disease	0
CHRM1	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	1
CHRM1	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	1
CHRM1	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	1
CHRM2	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
CHRM2	[MASK] is a promising drug target for the treatment of gastrointestinal diseases.	D005767	Gastrointestinal Diseases	1
CHRM2	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
CHRM2	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
CHRM2	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	1
CHRM3	[MASK] is a promising drug target for the treatment of underactive urinary bladder.	D000077295	Urinary Bladder, Underactive	0
CHRM3	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
CHRM3	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
CHRM3	[MASK] is a promising drug target for the treatment of neurogenic urinary bladder.	D001750	Urinary Bladder, Neurogenic	1
CHRM3	[MASK] is a promising drug target for the treatment of gastrointestinal diseases.	D005767	Gastrointestinal Diseases	1
CHRM3	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
CHRM3	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
CHRM3	[MASK] is a promising drug target for the treatment of sialorrhea.	D012798	Sialorrhea	1
CHRM3	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	1
CHRM3	[MASK] is a promising drug target for the treatment of xerostomia.	D014987	Xerostomia	0
CHRM3	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	1
CHRM3	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	1
CHRM3	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	1
CHRM3	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	1
CHRM4	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
CHRM4	[MASK] is a promising drug target for the treatment of gastrointestinal diseases.	D005767	Gastrointestinal Diseases	1
CHRM4	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
CHRM4	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
CHRM4	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	1
CHRM4	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
CHRNA3	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CHRNA3	[MASK] is a promising drug target for the treatment of gastroparesis.	D018589	Gastroparesis	0
CHRNA3	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
CHRNA4	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
CHRNA4	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
CHRNA4	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
CHRNA4	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CHRNA4	[MASK] is a promising drug target for the treatment of gastroparesis.	D018589	Gastroparesis	0
CHRNA4	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
CHRNA7	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
CHRNA7	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
CHRNA7	[MASK] is a promising drug target for the treatment of cognition disorders.	D003072	Cognition Disorders	0
CHRNA7	[MASK] is a promising drug target for the treatment of cough.	D003371	Cough	0
CHRNA7	[MASK] is a promising drug target for the treatment of drug-induced dyskinesia.	D004409	Dyskinesia, Drug-Induced	0
CHRNA7	[MASK] is a promising drug target for the treatment of nervous system diseases.	D009422	Nervous System Diseases	0
CHRNA7	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
CHRNA7	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
CHRNA7	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	1
CHRNB2	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
CHRNB2	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
CHRNB2	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
CHRNB2	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CHRNB2	[MASK] is a promising drug target for the treatment of gastroparesis.	D018589	Gastroparesis	0
CHRNB2	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
CHRNB4	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CHRNB4	[MASK] is a promising drug target for the treatment of gastroparesis.	D018589	Gastroparesis	0
CHRNB4	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
CLCN2	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
CLCN2	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
CLCN2	[MASK] is a promising drug target for the treatment of spinal stenosis.	D013130	Spinal Stenosis	0
CLCN2	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
CLDN6	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
CLDN6	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CLDN6	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
CLDN6	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
CLN6	[MASK] is a promising drug target for the treatment of neuronal ceroid-lipofuscinoses.	D009472	Neuronal Ceroid-Lipofuscinoses	0
CLPP	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CLPP	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CLPP	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
CLPP	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CLPP	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CMA1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
CMA1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
CMA1	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
CMA1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
CMA1	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
CNDP1	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	0
CNR1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CNR1	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
CNR1	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	0
CNR1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
CNR1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
CNR1	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
CNR1	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	0
CNR1	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	0
CNR1	[MASK] is a promising drug target for the treatment of absence epilepsy.	D004832	Epilepsy, absence	0
CNR1	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
CNR1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
CNR1	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
CNR1	[MASK] is a promising drug target for the treatment of nausea.	D009325	Nausea	1
CNR1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CNR1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
CNR1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
CNR1	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
CNR1	[MASK] is a promising drug target for the treatment of prader-willi syndrome.	D011218	Prader-Willi Syndrome	0
CNR1	[MASK] is a promising drug target for the treatment of infantile spasms.	D013036	Spasms, Infantile	0
CNR1	[MASK] is a promising drug target for the treatment of tobacco use disorder.	D014029	Tobacco Use Disorder	1
CNR1	[MASK] is a promising drug target for the treatment of vomiting.	D014839	Vomiting	1
CNR1	[MASK] is a promising drug target for the treatment of gastroparesis.	D018589	Gastroparesis	0
CNR1	[MASK] is a promising drug target for the treatment of hiv wasting syndrome.	D019247	HIV Wasting Syndrome	1
CNR1	[MASK] is a promising drug target for the treatment of cocaine-related disorders.	D019970	Cocaine-Related Disorders	0
CNR1	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
CNR1	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	0
CNR2	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
CNR2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CNR2	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
CNR2	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
CNR2	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
CNR2	[MASK] is a promising drug target for the treatment of nausea.	D009325	Nausea	1
CNR2	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
CNR2	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
CNR2	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
CNR2	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
CNR2	[MASK] is a promising drug target for the treatment of vomiting.	D014839	Vomiting	1
CNR2	[MASK] is a promising drug target for the treatment of hiv wasting syndrome.	D019247	HIV Wasting Syndrome	1
CNR2	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
CNR2	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
CNR2	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
CNR2	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
CNR2	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
COL18A1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
COL18A1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
COL18A1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
COL1A1	[MASK] is a promising drug target for the treatment of tissue adhesions.	D000267	Tissue Adhesions	0
COL1A1	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
COL1A1	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	0
COL1A1	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
COL1A1	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
COL7A1	[MASK] is a promising drug target for the treatment of epidermolysis bullosa.	D004820	Epidermolysis Bullosa	1
COMT	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	1
COQ7	[MASK] is a promising drug target for the treatment of cognition disorders.	D003072	Cognition Disorders	0
CPB2	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
CPB2	[MASK] is a promising drug target for the treatment of pulmonary embolism.	D011655	Pulmonary Embolism	0
CPS1	[MASK] is a promising drug target for the treatment of hyperammonemia.	D022124	Hyperammonemia	1
CPT1A	[MASK] is a promising drug target for the treatment of hypertrophic cardiomyopathy.	D002312	Cardiomyopathy, Hypertrophic	0
CPT2	[MASK] is a promising drug target for the treatment of hypertrophic cardiomyopathy.	D002312	Cardiomyopathy, Hypertrophic	0
CRBN	[MASK] is a promising drug target for the treatment of leprosy.	D007918	Leprosy	1
CRBN	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
CRHR1	[MASK] is a promising drug target for the treatment of social phobia.	D000072861	Phobia, Social	0
CRHR1	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
CRHR1	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	0
CRHR1	[MASK] is a promising drug target for the treatment of depression.	D003863	Depression	0
CRHR1	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
CRHR1	[MASK] is a promising drug target for the treatment of post-traumatic stress disorders.	D013313	Stress Disorders, Post-Traumatic	0
CRHR1	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
CRHR2	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
CRHR2	[MASK] is a promising drug target for the treatment of depression.	D003863	Depression	0
CRHR2	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
CRHR2	[MASK] is a promising drug target for the treatment of chronic fatigue syndrome.	D015673	Fatigue Syndrome, Chronic	0
CRP	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
CRP	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
CRP	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
CRP	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
CRP	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CRP	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
CSF1	[MASK] is a promising drug target for the treatment of bone neoplasms.	D001859	Bone Neoplasms	0
CSF1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CSF1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CSF1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CSF1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CSF1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CSF1	[MASK] is a promising drug target for the treatment of sarcoidosis.	D012507	Sarcoidosis	0
CSF1	[MASK] is a promising drug target for the treatment of pigmented villonodular synovitis.	D013586	Synovitis, Pigmented Villonodular	0
CSF1R	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
CSF1R	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CSF1R	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
CSF1R	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CSF1R	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CSF1R	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
CSF1R	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
CSF1R	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
CSF1R	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
CSF1R	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
CSF1R	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
CSF1R	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CSF1R	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CSF1R	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
CSF1R	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CSF1R	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	1
CSF1R	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
CSF1R	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
CSF1R	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
CSF1R	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CSF1R	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
CSF1R	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CSF1R	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	1
CSF1R	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
CSF2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CSF2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
CSF2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
CSF2	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	0
CSF2	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
CSF2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
CSF2	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
CSF2	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
CSF2RA	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
CSF2RA	[MASK] is a promising drug target for the treatment of nontuberculous mycobacterium infections.	D009165	Mycobacterium Infections, Nontuberculous	0
CSF2RA	[MASK] is a promising drug target for the treatment of neutropenia.	D009503	Neutropenia	1
CSF2RA	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
CSF2RA	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
CSF2RA	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
CSF2RA	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
CSF3	[MASK] is a promising drug target for the treatment of neutropenia.	D009503	Neutropenia	1
CSF3R	[MASK] is a promising drug target for the treatment of spontaneous abortion.	D000022	Abortion, Spontaneous	0
CSF3R	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	1
CSF3R	[MASK] is a promising drug target for the treatment of aplastic anemia.	D000741	Anemia, Aplastic	1
CSF3R	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
CSF3R	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	1
CSF3R	[MASK] is a promising drug target for the treatment of female infertility.	D007247	Infertility, Female	0
CSF3R	[MASK] is a promising drug target for the treatment of leukopenia.	D007970	Leukopenia	1
CSF3R	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
CSF3R	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
CSF3R	[MASK] is a promising drug target for the treatment of neutropenia.	D009503	Neutropenia	1
CSF3R	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
CSF3R	[MASK] is a promising drug target for the treatment of hematopoietic stem cell mobilization.	D019650	Hematopoietic Stem Cell Mobilization	1
CSF3R	[MASK] is a promising drug target for the treatment of drug-related side effects and adverse reactions.	D064420	Drug-Related Side Effects and Adverse Reactions	0
CSNK1E	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
CSNK2B	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
CSNK2B	[MASK] is a promising drug target for the treatment of papillomavirus infections.	D030361	Papillomavirus Infections	0
CTAG1B	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
CTAG1B	[MASK] is a promising drug target for the treatment of liposarcoma.	D008080	Liposarcoma	0
CTAG1B	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
CTAG1B	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CTAG1B	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
CTAG1B	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
CTAG2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CTLA4	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	1
CTLA4	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
CTNNB1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
CTNNB1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
CTNNB1	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
CTNNB1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
CTNNB1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
CTNNB1	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
CTNNB1	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
CTNNB1	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	0
CTSC	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
CTSK	[MASK] is a promising drug target for the treatment of metabolic bone diseases.	D001851	Bone Diseases, Metabolic	0
CTSK	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	0
CTSS	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
CTSS	[MASK] is a promising drug target for the treatment of sjogren's syndrome.	D012859	Sjogren's Syndrome	0
CUBN	[MASK] is a promising drug target for the treatment of pernicious anemia.	D000752	Anemia, Pernicious	1
CUBN	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	1
CUBN	[MASK] is a promising drug target for the treatment of nervous system diseases.	D009422	Nervous System Diseases	1
CX3CL1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
CX3CL1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
CXCL10	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
CXCL10	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
CXCL10	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
CXCL10	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
CXCL10	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
CXCL10	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
CXCL10	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
CXCL10	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
CXCL12	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
CXCL12	[MASK] is a promising drug target for the treatment of ischemia.	D007511	Ischemia	0
CXCL12	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CXCL12	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CXCL12	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
CXCL8	[MASK] is a promising drug target for the treatment of infections.	D007239	Infections	0
CXCL8	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	0
CXCR1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
CXCR1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CXCR1	[MASK] is a promising drug target for the treatment of bullous pemphigoid.	D010391	Pemphigoid, Bullous	0
CXCR1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
CXCR2	[MASK] is a promising drug target for the treatment of sickle cell anemia.	D000755	Anemia, Sickle Cell	0
CXCR2	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
CXCR2	[MASK] is a promising drug target for the treatment of bronchiectasis.	D001987	Bronchiectasis	0
CXCR2	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
CXCR2	[MASK] is a promising drug target for the treatment of human influenza.	D007251	Influenza, Human	0
CXCR2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
CXCR2	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
CXCR2	[MASK] is a promising drug target for the treatment of bullous pemphigoid.	D010391	Pemphigoid, Bullous	0
CXCR2	[MASK] is a promising drug target for the treatment of familial mediterranean fever.	D010505	Familial Mediterranean Fever	0
CXCR2	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
CXCR2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
CXCR2	[MASK] is a promising drug target for the treatment of hidradenitis suppurativa.	D017497	Hidradenitis Suppurativa	0
CXCR2	[MASK] is a promising drug target for the treatment of respiratory syncytial virus infections.	D018357	Respiratory Syncytial Virus Infections	0
CXCR2	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
CXCR2	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
CXCR4	[MASK] is a promising drug target for the treatment of sickle cell anemia.	D000755	Anemia, Sickle Cell	0
CXCR4	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
CXCR4	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
CXCR4	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
CXCR4	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
CXCR4	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
CXCR4	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
CXCR4	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CXCR4	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
CXCR4	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
CXCR4	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
CXCR4	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
CXCR4	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
CXCR4	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
CYP11A1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CYP11B1	[MASK] is a promising drug target for the treatment of hyperaldosteronism.	D006929	Hyperaldosteronism	0
CYP11B1	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	0
CYP11B1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CYP11B1	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	1
CYP11B2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
CYP11B2	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	1
CYP17A1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
CYP17A1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
CYP19A1	[MASK] is a promising drug target for the treatment of endometriosis.	D004715	Endometriosis	0
CYP3A4	[MASK] is a promising drug target for the treatment of drug synergism.	D004357	Drug Synergism	1
CYP3A4	[MASK] is a promising drug target for the treatment of herpes zoster.	D006562	Herpes Zoster	0
CYP3A4	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
CYP46A1	[MASK] is a promising drug target for the treatment of partial duplication 15q syndrome.	C538036	Partial Duplication 15q Syndrome	0
CYP46A1	[MASK] is a promising drug target for the treatment of tuberous sclerosis.	D014402	Tuberous Sclerosis	0
CYP46A1	[MASK] is a promising drug target for the treatment of complex regional pain syndromes.	D020918	Complex Regional Pain Syndromes	0
CYP46A1	[MASK] is a promising drug target for the treatment of neurodevelopmental disorders.	D065886	Neurodevelopmental Disorders	0
CYP51A1	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	1
CYSLTR1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	1
CYSLTR1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
CYSLTR1	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	1
CYSLTR1	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
CYSLTR1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
CYSLTR1	[MASK] is a promising drug target for the treatment of perennial allergic rhinitis.	D012221	Rhinitis, Allergic, Perennial	1
DAO	[MASK] is a promising drug target for the treatment of hhh syndrome.	C538380	HHH syndrome	0
DAO	[MASK] is a promising drug target for the treatment of lysinuric protein intolerance.	C562687	Lysinuric Protein Intolerance	0
DAO	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
DAO	[MASK] is a promising drug target for the treatment of citrullinemia.	D020159	Citrullinemia	0
DAO	[MASK] is a promising drug target for the treatment of hyperargininemia.	D020162	Hyperargininemia	0
DAO	[MASK] is a promising drug target for the treatment of ornithine carbamoyltransferase deficiency disease.	D020163	Ornithine Carbamoyltransferase Deficiency Disease	0
DAO	[MASK] is a promising drug target for the treatment of argininosuccinic aciduria.	D056807	Argininosuccinic Aciduria	0
DBH	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
DDC	[MASK] is a promising drug target for the treatment of aromatic amino acid decarboxylase deficiency.	C537437	Aromatic amino acid decarboxylase deficiency	1
DDC	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	1
DGAT1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
DGAT1	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
DGAT1	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type i.	D008072	Hyperlipoproteinemia Type I	0
DGAT1	[MASK] is a promising drug target for the treatment of hypertriglyceridemia.	D015228	Hypertriglyceridemia	0
DGAT1	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
DGAT2	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
DHFR	[MASK] is a promising drug target for the treatment of juvenile arthritis.	D001171	Arthritis, Juvenile	1
DHFR	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
DHFR	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
DHFR	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	1
DHFR	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	1
DHFR	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
DHFR	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
DHFR	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
DHFR	[MASK] is a promising drug target for the treatment of ankylosing spondylitis.	D013167	Spondylitis, Ankylosing	0
DHFR	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
DHFR	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	0
DHFR	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
DHFR	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
DHFR	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	1
DHFR	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	1
DHFR	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
DHODH	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
DIABLO	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
DIABLO	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
DIABLO	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
DIABLO	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
DIABLO	[MASK] is a promising drug target for the treatment of polycythemia vera.	D011087	Polycythemia Vera	0
DIABLO	[MASK] is a promising drug target for the treatment of thrombocytosis.	D013922	Thrombocytosis	0
DIABLO	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	0
DIABLO	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
DKK1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
DKK1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
DKK1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
DLL3	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
DLL3	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
DLL3	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
DLL3	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
DLL3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
DLL3	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
DMD	[MASK] is a promising drug target for the treatment of duchenne muscular dystrophy.	D020388	Muscular Dystrophy, Duchenne	1
DMPK	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
DNASE1	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	1
DNASE1	[MASK] is a promising drug target for the treatment of respiratory tract infections.	D012141	Respiratory Tract Infections	0
DNMT1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
DNMT1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
DNMT1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
DNMT1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
DNMT1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
DNMT1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
DNMT1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
DNMT1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
DNMT1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
DNMT1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
DNMT1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
DNMT1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
DNMT1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
DNMT3A	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
DNMT3A	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
DNMT3B	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
DNMT3B	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
DPP4	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
DPP4	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
DPP4	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
DPP4	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
DPP4	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
DPP8	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
DPP9	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
DPYD	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
DRD1	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
DRD1	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
DRD1	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	1
DRD1	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
DRD1	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
DRD2	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
DRD2	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
DRD2	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
DRD2	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
DRD2	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
DRD2	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
DRD2	[MASK] is a promising drug target for the treatment of borderline personality disorder.	D001883	Borderline Personality Disorder	0
DRD2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
DRD2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
DRD2	[MASK] is a promising drug target for the treatment of depression.	D003863	Depression	0
DRD2	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	1
DRD2	[MASK] is a promising drug target for the treatment of fibrosis.	D005355	Fibrosis	0
DRD2	[MASK] is a promising drug target for the treatment of tourette syndrome.	D005879	Tourette Syndrome	0
DRD2	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
DRD2	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
DRD2	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	0
DRD2	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
DRD2	[MASK] is a promising drug target for the treatment of nausea.	D009325	Nausea	1
DRD2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
DRD2	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	1
DRD2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
DRD2	[MASK] is a promising drug target for the treatment of psychomotor agitation.	D011595	Psychomotor Agitation	1
DRD2	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
DRD2	[MASK] is a promising drug target for the treatment of restless legs syndrome.	D012148	Restless Legs Syndrome	0
DRD2	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
DRD2	[MASK] is a promising drug target for the treatment of vomiting.	D014839	Vomiting	1
DRD2	[MASK] is a promising drug target for the treatment of conduct disorder.	D019955	Conduct Disorder	0
DRD2	[MASK] is a promising drug target for the treatment of postoperative nausea and vomiting.	D020250	Postoperative Nausea and Vomiting	1
DRD3	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	0
DRD3	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
DRD3	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
DRD3	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
DRD3	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	0
DRD3	[MASK] is a promising drug target for the treatment of borderline personality disorder.	D001883	Borderline Personality Disorder	0
DRD3	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	1
DRD3	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	1
DRD3	[MASK] is a promising drug target for the treatment of psychomotor agitation.	D011595	Psychomotor Agitation	1
DRD3	[MASK] is a promising drug target for the treatment of restless legs syndrome.	D012148	Restless Legs Syndrome	0
DRD3	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
DRD3	[MASK] is a promising drug target for the treatment of tobacco use disorder.	D014029	Tobacco Use Disorder	0
DRD3	[MASK] is a promising drug target for the treatment of postoperative nausea and vomiting.	D020250	Postoperative Nausea and Vomiting	1
DRD3	[MASK] is a promising drug target for the treatment of binge-eating disorder.	D056912	Binge-Eating Disorder	0
DRD3	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
DRD4	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
DRD4	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
DRD4	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
DRD4	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
DRD4	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
DRD5	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
DRD5	[MASK] is a promising drug target for the treatment of conduct disorder.	D019955	Conduct Disorder	0
DUT	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
E2F1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
EDNRA	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
EDNRA	[MASK] is a promising drug target for the treatment of hepatorenal syndrome.	D006530	Hepatorenal Syndrome	0
EDNRA	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
EDNRA	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
EDNRA	[MASK] is a promising drug target for the treatment of delayed graft function.	D051799	Delayed Graft Function	0
EDNRB	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
EDNRB	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
EDNRB	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	1
EEF1A1	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
EEF2	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
EEF2	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
EEF2	[MASK] is a promising drug target for the treatment of mastocytosis.	D008415	Mastocytosis	0
EEF2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
EEF2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
EEF2	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
EEF2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
EEF2	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
EEF2	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
EEF2	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
EEF2	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
EEF2	[MASK] is a promising drug target for the treatment of hypereosinophilic syndrome.	D017681	Hypereosinophilic Syndrome	0
EEF2	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	1
EEF2	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
EGFL7	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
EGFL7	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
EGFL7	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
EGFL7	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
EGFR	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
EGFR	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
EGFR	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
EGFR	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	1
EGFR	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
EGFR	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
EGFR	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
EGFR	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
EGFR	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
EGFR	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
EGFR	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
EGFR	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
EGFR	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
EGFR	[MASK] is a promising drug target for the treatment of skin neoplasms.	D012878	Skin Neoplasms	0
EGFR	[MASK] is a promising drug target for the treatment of thymus neoplasms.	D013953	Thymus Neoplasms	0
EGFR	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
EGFR	[MASK] is a promising drug target for the treatment of primitive neuroectodermal tumors.	D018242	Neuroectodermal Tumors, Primitive	0
EGFR	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
EGFR	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
EGLN1	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	1
EGLN2	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	1
EGLN2	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
EGLN2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
EGLN2	[MASK] is a promising drug target for the treatment of ischemia.	D007511	Ischemia	0
EGLN2	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
EGLN3	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	1
EGR1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
EIF5A	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
EIF5A	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
EIF5A	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
EIF5A	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
EIF5A	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
ELANE	[MASK] is a promising drug target for the treatment of bronchiectasis.	D001987	Bronchiectasis	0
ELANE	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
ELANE	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
ELANE	[MASK] is a promising drug target for the treatment of netherton syndrome.	D056770	Netherton Syndrome	0
ENG	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
ENG	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
ENG	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
ENG	[MASK] is a promising drug target for the treatment of trophoblastic neoplasms.	D014328	Trophoblastic Neoplasms	0
ENG	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ENPEP	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
ENPEP	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
ENPP2	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
ENPP2	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
ENPP2	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
ENPP2	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
ENPP3	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ENTPD1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
EPAS1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
EPAS1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
EPAS1	[MASK] is a promising drug target for the treatment of von hippel-lindau disease.	D006623	von Hippel-Lindau Disease	1
EPAS1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
EPAS1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
EPAS1	[MASK] is a promising drug target for the treatment of hemangioblastoma.	D018325	Hemangioblastoma	1
EPAS1	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	1
EPCAM	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
EPCAM	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
EPHA1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
EPHA1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
EPHA1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
EPHA1	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
EPHA1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
EPHA1	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
EPHA1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
EPHA1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
EPHA1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
EPHA1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
EPHA1	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
EPHA1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
EPHA1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
EPHA1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
EPHA1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
EPHA1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
EPHA1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
EPHA2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
EPHA2	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
EPHA2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
EPHA2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
EPHA2	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
EPHX2	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	0
EPHX2	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
EPOR	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	1
EPOR	[MASK] is a promising drug target for the treatment of aplastic anemia.	D000741	Anemia, Aplastic	1
EPOR	[MASK] is a promising drug target for the treatment of blood coagulation disorders.	D001778	Blood Coagulation Disorders	1
EPOR	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
ERBB2	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
ERBB2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
ERBB2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
ERBB2	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	1
ERBB2	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ERBB2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
ERBB2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
ERBB2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
ERBB2	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
ERBB2	[MASK] is a promising drug target for the treatment of skin neoplasms.	D012878	Skin Neoplasms	0
ERBB2	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
ERBB2	[MASK] is a promising drug target for the treatment of thymus neoplasms.	D013953	Thymus Neoplasms	0
ERBB2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
ERBB2	[MASK] is a promising drug target for the treatment of primitive neuroectodermal tumors.	D018242	Neuroectodermal Tumors, Primitive	0
ERBB2	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
ERBB3	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
ERBB3	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
ERBB3	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
ERBB3	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
ERBB3	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
ERBB3	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
ERBB3	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
ERBB3	[MASK] is a promising drug target for the treatment of ewing sarcoma.	D012512	Sarcoma, Ewing	0
ERBB3	[MASK] is a promising drug target for the treatment of thymus neoplasms.	D013953	Thymus Neoplasms	0
ERBB3	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
ERBB4	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
ERBB4	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
ERBB4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
ERBB4	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
ERBB4	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ERBB4	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
ERBB4	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
ERBB4	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ERBB4	[MASK] is a promising drug target for the treatment of skin neoplasms.	D012878	Skin Neoplasms	0
ERBB4	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
ERVW-1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
ESR1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
ESR1	[MASK] is a promising drug target for the treatment of contraception.	D003267	Contraception	0
ESR1	[MASK] is a promising drug target for the treatment of dyspareunia.	D004414	Dyspareunia	1
ESR1	[MASK] is a promising drug target for the treatment of endocrine system diseases.	D004700	Endocrine System Diseases	0
ESR1	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	1
ESR1	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	1
ESR1	[MASK] is a promising drug target for the treatment of hormone replacement therapy.	D020249	Hormone Replacement Therapy	1
ESR1	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	0
ESR1	[MASK] is a promising drug target for the treatment of atrophic vaginitis.	D059268	Atrophic Vaginitis	1
ESR2	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	0
EXOG	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
EXOG	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
EXOG	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
EXOG	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
EXOG	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
EZH1	[MASK] is a promising drug target for the treatment of t-cell lymphoma.	D016399	Lymphoma, T-Cell	1
EZH1	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	1
EZH2	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
EZH2	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	1
EZH2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
EZH2	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
EZH2	[MASK] is a promising drug target for the treatment of t-cell lymphoma.	D016399	Lymphoma, T-Cell	1
EZH2	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	1
F10	[MASK] is a promising drug target for the treatment of unstable angina.	D000789	Angina, Unstable	1
F10	[MASK] is a promising drug target for the treatment of arthritis.	D001168	Arthritis	1
F10	[MASK] is a promising drug target for the treatment of hemophilia b.	D002836	Hemophilia B	1
F10	[MASK] is a promising drug target for the treatment of eczema.	D004485	Eczema	1
F10	[MASK] is a promising drug target for the treatment of factor x deficiency.	D005171	Factor X Deficiency	1
F10	[MASK] is a promising drug target for the treatment of hemophilia a.	D006467	Hemophilia A	1
F10	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	1
F10	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	1
F10	[MASK] is a promising drug target for the treatment of prurigo.	D011536	Prurigo	0
F10	[MASK] is a promising drug target for the treatment of pulmonary embolism.	D011655	Pulmonary Embolism	1
F10	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
F10	[MASK] is a promising drug target for the treatment of thrombophlebitis.	D013924	Thrombophlebitis	1
F10	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	1
F10	[MASK] is a promising drug target for the treatment of venous insufficiency.	D014689	Venous Insufficiency	1
F10	[MASK] is a promising drug target for the treatment of venous thrombosis.	D020246	Venous Thrombosis	1
F10	[MASK] is a promising drug target for the treatment of acute coronary syndrome.	D054058	Acute Coronary Syndrome	0
F11	[MASK] is a promising drug target for the treatment of factor xi deficiency.	D005173	Factor XI Deficiency	1
F2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
F2	[MASK] is a promising drug target for the treatment of afibrinogenemia.	D000347	Afibrinogenemia	1
F2	[MASK] is a promising drug target for the treatment of unstable angina.	D000789	Angina, Unstable	1
F2	[MASK] is a promising drug target for the treatment of blood coagulation disorders.	D001778	Blood Coagulation Disorders	0
F2	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	1
F2	[MASK] is a promising drug target for the treatment of hemophilia b.	D002836	Hemophilia B	1
F2	[MASK] is a promising drug target for the treatment of disseminated intravascular coagulation.	D004211	Disseminated Intravascular Coagulation	1
F2	[MASK] is a promising drug target for the treatment of hemophilia a.	D006467	Hemophilia A	1
F2	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	1
F2	[MASK] is a promising drug target for the treatment of hypoprothrombinemias.	D007020	Hypoprothrombinemias	1
F2	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	1
F2	[MASK] is a promising drug target for the treatment of pulmonary embolism.	D011655	Pulmonary Embolism	1
F2	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
F2	[MASK] is a promising drug target for the treatment of thrombocytopenia.	D013921	Thrombocytopenia	1
F2	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	1
F2	[MASK] is a promising drug target for the treatment of venous insufficiency.	D014689	Venous Insufficiency	1
F2	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
F2	[MASK] is a promising drug target for the treatment of antithrombin iii deficiency.	D020152	Antithrombin III Deficiency	1
F2	[MASK] is a promising drug target for the treatment of venous thrombosis.	D020246	Venous Thrombosis	1
F2	[MASK] is a promising drug target for the treatment of acute coronary syndrome.	D054058	Acute Coronary Syndrome	0
F2R	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	1
F2R	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
F2R	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
F2R	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
F2R	[MASK] is a promising drug target for the treatment of intervertebral disc degeneration.	D055959	Intervertebral Disc Degeneration	0
F2R	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
F2RL1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
F2RL3	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
F2RL3	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	0
F3	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	1
F7	[MASK] is a promising drug target for the treatment of hemophilia b.	D002836	Hemophilia B	1
F7	[MASK] is a promising drug target for the treatment of factor vii deficiency.	D005168	Factor VII Deficiency	0
F7	[MASK] is a promising drug target for the treatment of hemophilia a.	D006467	Hemophilia A	1
F7	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	1
F7	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	0
F7	[MASK] is a promising drug target for the treatment of thrombasthenia.	D013915	Thrombasthenia	1
F8	[MASK] is a promising drug target for the treatment of blood coagulation disorders.	D001778	Blood Coagulation Disorders	1
F8	[MASK] is a promising drug target for the treatment of hemophilia a.	D006467	Hemophilia A	1
F8	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
F8	[MASK] is a promising drug target for the treatment of von willebrand diseases.	D014842	von Willebrand Diseases	1
F9	[MASK] is a promising drug target for the treatment of hemophilia b.	D002836	Hemophilia B	1
F9	[MASK] is a promising drug target for the treatment of hemophilia a.	D006467	Hemophilia A	1
F9	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	1
FAAH	[MASK] is a promising drug target for the treatment of social phobia.	D000072861	Phobia, Social	0
FAAH	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
FAAH	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
FAAH	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
FAAH	[MASK] is a promising drug target for the treatment of prostatitis.	D011472	Prostatitis	0
FAAH	[MASK] is a promising drug target for the treatment of urethritis.	D014526	Urethritis	0
FAAH	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
FAAH	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
FAAH	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
FADS1	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
FADS1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
FADS1	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
FAP	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
FAP	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
FAP	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
FAP	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
FAP	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
FCGR2B	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
FCGR2B	[MASK] is a promising drug target for the treatment of iga glomerulonephritis.	D005922	Glomerulonephritis, IGA	0
FCGR2B	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
FCGR2B	[MASK] is a promising drug target for the treatment of idiopathic thrombocytopenic purpura.	D016553	Purpura, Thrombocytopenic, Idiopathic	0
FCGR2B	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
FCGR3A	[MASK] is a promising drug target for the treatment of mastocytosis.	D008415	Mastocytosis	0
FCGRT	[MASK] is a promising drug target for the treatment of myasthenia gravis.	D009157	Myasthenia Gravis	1
FCGRT	[MASK] is a promising drug target for the treatment of thrombocytopenia.	D013921	Thrombocytopenia	0
FDPS	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	1
FFAR1	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
FFAR1	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
FFAR1	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
FFAR1	[MASK] is a promising drug target for the treatment of alstrom syndrome.	D056769	Alstrom Syndrome	0
FFAR2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
FFAR2	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	0
FGA	[MASK] is a promising drug target for the treatment of afibrinogenemia.	D000347	Afibrinogenemia	1
FGA	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	1
FGA	[MASK] is a promising drug target for the treatment of menorrhagia.	D008595	Menorrhagia	0
FGA	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
FGA	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
FGA	[MASK] is a promising drug target for the treatment of hearing loss.	D034381	Hearing Loss	0
FGA	[MASK] is a promising drug target for the treatment of intervertebral disc degeneration.	D055959	Intervertebral Disc Degeneration	0
FGA	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
FGB	[MASK] is a promising drug target for the treatment of afibrinogenemia.	D000347	Afibrinogenemia	1
FGB	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	1
FGB	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
FGB	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
FGB	[MASK] is a promising drug target for the treatment of hearing loss.	D034381	Hearing Loss	0
FGB	[MASK] is a promising drug target for the treatment of intervertebral disc degeneration.	D055959	Intervertebral Disc Degeneration	0
FGB	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
FGF1	[MASK] is a promising drug target for the treatment of spinal cord injuries.	D013119	Spinal Cord Injuries	0
FGF2	[MASK] is a promising drug target for the treatment of burns.	D002056	Burns	1
FGF2	[MASK] is a promising drug target for the treatment of skin diseases.	D012871	Skin diseases	1
FGF2	[MASK] is a promising drug target for the treatment of ulcer.	D014456	Ulcer	1
FGF2	[MASK] is a promising drug target for the treatment of vitiligo.	D014820	Vitiligo	1
FGF2	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
FGF2	[MASK] is a promising drug target for the treatment of tympanic membrane perforation.	D018058	Tympanic Membrane Perforation	1
FGF2	[MASK] is a promising drug target for the treatment of corneal injuries.	D065306	Corneal Injuries	1
FGF21	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
FGF21	[MASK] is a promising drug target for the treatment of fibrosis.	D005355	Fibrosis	0
FGF21	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
FGF23	[MASK] is a promising drug target for the treatment of connective tissue neoplasms.	D009372	Neoplasms, Connective Tissue	1
FGF23	[MASK] is a promising drug target for the treatment of osteomalacia.	D010018	Osteomalacia	1
FGF23	[MASK] is a promising drug target for the treatment of hypophosphatemia.	D017674	Hypophosphatemia	1
FGFR1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	1
FGFR1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
FGFR1	[MASK] is a promising drug target for the treatment of burns.	D002056	Burns	1
FGFR1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
FGFR1	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
FGFR1	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
FGFR1	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
FGFR1	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
FGFR1	[MASK] is a promising drug target for the treatment of myeloproliferative disorders.	D009196	Myeloproliferative Disorders	1
FGFR1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
FGFR1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	1
FGFR1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
FGFR1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
FGFR1	[MASK] is a promising drug target for the treatment of spinal cord injuries.	D013119	Spinal Cord Injuries	0
FGFR1	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
FGFR1	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
FGFR1	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
FGFR1	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
FGFR1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
FGFR1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
FGFR1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
FGFR1	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	1
FGFR1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
FGFR1	[MASK] is a promising drug target for the treatment of hearing loss.	D034381	Hearing Loss	0
FGFR1	[MASK] is a promising drug target for the treatment of diabetes complications.	D048909	Diabetes Complications	1
FGFR1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
FGFR1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
FGFR1	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
FGFR2	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	1
FGFR2	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
FGFR2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
FGFR2	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
FGFR2	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
FGFR2	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
FGFR2	[MASK] is a promising drug target for the treatment of myeloproliferative disorders.	D009196	Myeloproliferative Disorders	1
FGFR2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
FGFR2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
FGFR2	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
FGFR2	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
FGFR2	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
FGFR2	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
FGFR2	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
FGFR2	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
FGFR2	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
FGFR2	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
FGFR2	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
FGFR2	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
FGFR3	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	1
FGFR3	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
FGFR3	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
FGFR3	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	1
FGFR3	[MASK] is a promising drug target for the treatment of tonic-clonic epilepsy.	D004830	Epilepsy, Tonic-Clonic	1
FGFR3	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	1
FGFR3	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
FGFR3	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
FGFR3	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
FGFR3	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
FGFR3	[MASK] is a promising drug target for the treatment of myeloproliferative disorders.	D009196	Myeloproliferative Disorders	1
FGFR3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
FGFR3	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
FGFR3	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
FGFR3	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
FGFR3	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
FGFR3	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
FGFR3	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
FGFR3	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
FGFR3	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
FGFR3	[MASK] is a promising drug target for the treatment of skin aging.	D015595	Skin Aging	1
FGFR3	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
FGFR3	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
FGFR3	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
FGFR4	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	1
FGFR4	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
FGFR4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
FGFR4	[MASK] is a promising drug target for the treatment of constipation.	D003248	Constipation	0
FGFR4	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
FGFR4	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
FGFR4	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
FGFR4	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
FGFR4	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
FGFR4	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
FGFR4	[MASK] is a promising drug target for the treatment of sclerosing cholangitis.	D015209	Cholangitis, Sclerosing	0
FGFR4	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
FGFR4	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
FGFR4	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
FGFR4	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
FGG	[MASK] is a promising drug target for the treatment of afibrinogenemia.	D000347	Afibrinogenemia	1
FGG	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	1
FGG	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
FGG	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
FGG	[MASK] is a promising drug target for the treatment of hearing loss.	D034381	Hearing Loss	0
FGG	[MASK] is a promising drug target for the treatment of intervertebral disc degeneration.	D055959	Intervertebral Disc Degeneration	0
FGG	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
FGR	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
FGR	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
FGR	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
FGR	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
FGR	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
FKBP1A	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
FKBP1A	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	1
FLT1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
FLT1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
FLT1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
FLT1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
FLT1	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	1
FLT1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
FLT1	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
FLT1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
FLT1	[MASK] is a promising drug target for the treatment of myopia.	D009216	Myopia	1
FLT1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
FLT1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	1
FLT1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
FLT1	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	0
FLT1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
FLT1	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
FLT1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
FLT1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
FLT1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
FLT1	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	1
FLT1	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	0
FLT1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
FLT1	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	1
FLT3	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
FLT3	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
FLT3	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
FLT3	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
FLT3	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
FLT3	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
FLT3	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
FLT3	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
FLT3	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
FLT3	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
FLT3	[MASK] is a promising drug target for the treatment of polycythemia vera.	D011087	Polycythemia Vera	1
FLT3	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
FLT3	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	0
FLT3	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
FLT3	[MASK] is a promising drug target for the treatment of thrombocytosis.	D013922	Thrombocytosis	1
FLT3	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
FLT3	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
FLT3	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
FLT3	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
FLT3	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
FLT3	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
FLT3	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	1
FLT4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
FLT4	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
FLT4	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
FLT4	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
FLT4	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
FLT4	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
FLT4	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
FLT4	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
FLT4	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	1
FLT4	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
FLT4	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	0
FLT4	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
FLT4	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
FLT4	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
FLT4	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
FLT4	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
FLT4	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
FLT4	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
FLT4	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	1
FLT4	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
FLT4	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
FOLH1	[MASK] is a promising drug target for the treatment of anus neoplasms.	D001005	Anus Neoplasms	0
FOLH1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
FOLH1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
FOLH1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
FOLH1	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
FOLH1	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	1
FOLH1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
FOLH1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
FOLH1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
FOLH1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
FOLH1	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
FOLR1	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	1
FOLR1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	1
FOLR1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
FOLR1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	1
FOLR1	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	1
FOXP3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
FSHR	[MASK] is a promising drug target for the treatment of female infertility.	D007247	Infertility, Female	1
FSHR	[MASK] is a promising drug target for the treatment of male infertility.	D007248	Infertility, Male	1
GAA	[MASK] is a promising drug target for the treatment of glycogen storage disease type ii.	D006009	Glycogen Storage Disease Type II	1
GABBR1	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	1
GABBR1	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
GABBR1	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	1
GABBR1	[MASK] is a promising drug target for the treatment of muscle spasticity.	D009128	Muscle Spasticity	1
GABBR1	[MASK] is a promising drug target for the treatment of spinal cord injuries.	D013119	Spinal Cord Injuries	1
GABRA1	[MASK] is a promising drug target for the treatment of traumatic brain injuries.	D000070642	Brain Injuries, Traumatic	0
GABRA1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
GABRA1	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
GABRA1	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	0
GABRA1	[MASK] is a promising drug target for the treatment of generalized epilepsy.	D004829	Epilepsy, Generalized	0
GABRA1	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	0
GABRA1	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
GABRA1	[MASK] is a promising drug target for the treatment of status epilepticus.	D013226	Status Epilepticus	1
GABRA1	[MASK] is a promising drug target for the treatment of panic disorder.	D016584	Panic Disorder	0
GABRA1	[MASK] is a promising drug target for the treatment of drug-related side effects and adverse reactions.	D064420	Drug-Related Side Effects and Adverse Reactions	0
GABRA1	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
GABRA2	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
GABRA2	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
GABRA2	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	0
GABRA2	[MASK] is a promising drug target for the treatment of generalized epilepsy.	D004829	Epilepsy, Generalized	0
GABRA2	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	0
GABRA2	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
GABRA2	[MASK] is a promising drug target for the treatment of status epilepticus.	D013226	Status Epilepticus	1
GABRA2	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
GABRA2	[MASK] is a promising drug target for the treatment of drug-related side effects and adverse reactions.	D064420	Drug-Related Side Effects and Adverse Reactions	0
GABRA2	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
GABRA3	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
GABRA3	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
GABRA3	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	0
GABRA3	[MASK] is a promising drug target for the treatment of generalized epilepsy.	D004829	Epilepsy, Generalized	0
GABRA3	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	0
GABRA3	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
GABRA3	[MASK] is a promising drug target for the treatment of status epilepticus.	D013226	Status Epilepticus	1
GABRA3	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
GABRA3	[MASK] is a promising drug target for the treatment of drug-related side effects and adverse reactions.	D064420	Drug-Related Side Effects and Adverse Reactions	0
GABRA3	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
GABRA4	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
GABRA4	[MASK] is a promising drug target for the treatment of status epilepticus.	D013226	Status Epilepticus	1
GABRA4	[MASK] is a promising drug target for the treatment of panic disorder.	D016584	Panic Disorder	0
GABRA5	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
GABRA5	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
GABRA5	[MASK] is a promising drug target for the treatment of down syndrome.	D004314	Down Syndrome	0
GABRA5	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
GABRA5	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	0
GABRA5	[MASK] is a promising drug target for the treatment of generalized epilepsy.	D004829	Epilepsy, Generalized	0
GABRA5	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	0
GABRA5	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
GABRA5	[MASK] is a promising drug target for the treatment of status epilepticus.	D013226	Status Epilepticus	1
GABRA5	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
GABRA5	[MASK] is a promising drug target for the treatment of drug-related side effects and adverse reactions.	D064420	Drug-Related Side Effects and Adverse Reactions	0
GABRA5	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
GALC	[MASK] is a promising drug target for the treatment of globoid cell leukodystrophy.	D007965	Leukodystrophy, Globoid Cell	0
GALR3	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
GALR3	[MASK] is a promising drug target for the treatment of cognition disorders.	D003072	Cognition Disorders	0
GALR3	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
GART	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
GART	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	1
GAS6	[MASK] is a promising drug target for the treatment of iga glomerulonephritis.	D005922	Glomerulonephritis, IGA	0
GAST	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
GAST	[MASK] is a promising drug target for the treatment of peptic ulcer.	D010437	Peptic Ulcer	0
GATA3	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
GATA3	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
GBA1	[MASK] is a promising drug target for the treatment of gaucher disease.	D005776	Gaucher Disease	1
GCG	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	1
GCG	[MASK] is a promising drug target for the treatment of hypoglycemia.	D007003	Hypoglycemia	1
GCG	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
GCGR	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	0
GCGR	[MASK] is a promising drug target for the treatment of hypoglycemia.	D007003	Hypoglycemia	1
GCGR	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
GCGR	[MASK] is a promising drug target for the treatment of renal insufficiency.	D051437	Renal Insufficiency	0
GCGR	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
GCK	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
GCK	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
GDF2	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
GDF2	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
GDF2	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
GDF2	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
GDF2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
GDF2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of neuroblastoma.	D009447	Neuroblastoma	1
GDF2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
GDF2	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
GDF5	[MASK] is a promising drug target for the treatment of bone regeneration.	D001861	Bone Regeneration	0
GDNF	[MASK] is a promising drug target for the treatment of huntington disease.	D006816	Huntington Disease	0
GDNF	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
GDNF	[MASK] is a promising drug target for the treatment of multiple system atrophy.	D019578	Multiple System Atrophy	0
GDNF	[MASK] is a promising drug target for the treatment of hearing loss.	D034381	Hearing Loss	0
GFRA3	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
GHR	[MASK] is a promising drug target for the treatment of blood coagulation disorders.	D001778	Blood Coagulation Disorders	1
GHR	[MASK] is a promising drug target for the treatment of burns.	D002056	Burns	1
GHR	[MASK] is a promising drug target for the treatment of pituitary dwarfism.	D004393	Dwarfism, Pituitary	1
GHR	[MASK] is a promising drug target for the treatment of endocrine system diseases.	D004700	Endocrine System Diseases	1
GHR	[MASK] is a promising drug target for the treatment of growth disorders.	D006130	Growth Disorders	1
GHR	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	1
GHR	[MASK] is a promising drug target for the treatment of metabolic diseases.	D008659	Metabolic Diseases	1
GHR	[MASK] is a promising drug target for the treatment of noonan syndrome.	D009634	Noonan Syndrome	1
GHR	[MASK] is a promising drug target for the treatment of prader-willi syndrome.	D011218	Prader-Willi Syndrome	1
GHR	[MASK] is a promising drug target for the treatment of delayed puberty.	D011628	Puberty, Delayed	1
GHR	[MASK] is a promising drug target for the treatment of turner syndrome.	D014424	Turner Syndrome	1
GHR	[MASK] is a promising drug target for the treatment of hiv wasting syndrome.	D019247	HIV Wasting Syndrome	1
GHSR	[MASK] is a promising drug target for the treatment of anorexia nervosa.	D000856	Anorexia Nervosa	0
GHSR	[MASK] is a promising drug target for the treatment of cachexia.	D002100	Cachexia	0
GHSR	[MASK] is a promising drug target for the treatment of prader-willi syndrome.	D011218	Prader-Willi Syndrome	0
GJA1	[MASK] is a promising drug target for the treatment of varicose ulcer.	D014647	Varicose Ulcer	0
GJA1	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
GJA1	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
GJA1	[MASK] is a promising drug target for the treatment of corneal injuries.	D065306	Corneal Injuries	0
GLA	[MASK] is a promising drug target for the treatment of fabry disease.	D000795	Fabry Disease	1
GLP1R	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	0
GLP1R	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	0
GLP1R	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
GLP1R	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
GLP1R	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	1
GLP1R	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
GLP1R	[MASK] is a promising drug target for the treatment of renal insufficiency.	D051437	Renal Insufficiency	0
GLP2R	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
GLP2R	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
GLP2R	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	0
GLS	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
GLS	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
GLS	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
GLS	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
GLS	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
GLS	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
GLS	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
GNA11	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
GNAQ	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
GNRH1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
GNRH1	[MASK] is a promising drug target for the treatment of endometriosis.	D004715	Endometriosis	1
GNRH1	[MASK] is a promising drug target for the treatment of leiomyoma.	D007889	Leiomyoma	1
GNRH1	[MASK] is a promising drug target for the treatment of menstruation disturbances.	D008599	Menstruation Disturbances	1
GNRH1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
GNRH1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
GNRHR	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
GNRHR	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
GNRHR	[MASK] is a promising drug target for the treatment of endometriosis.	D004715	Endometriosis	1
GNRHR	[MASK] is a promising drug target for the treatment of female infertility.	D007247	Infertility, Female	1
GNRHR	[MASK] is a promising drug target for the treatment of leiomyoma.	D007889	Leiomyoma	1
GNRHR	[MASK] is a promising drug target for the treatment of paraphilic disorders.	D010262	Paraphilic Disorders	1
GNRHR	[MASK] is a promising drug target for the treatment of prostatic hyperplasia.	D011470	Prostatic Hyperplasia	0
GNRHR	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
GNRHR	[MASK] is a promising drug target for the treatment of precocious puberty.	D011629	Puberty, Precocious	1
GPA33	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
GPBAR1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
GPR119	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
GPR119	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
GPR35	[MASK] is a promising drug target for the treatment of cough.	D003371	Cough	0
GPR35	[MASK] is a promising drug target for the treatment of mastocytosis.	D008415	Mastocytosis	0
GPR35	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
GPR35	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
GPR55	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
GPR55	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
GPR55	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
GPR55	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
GPR55	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	0
GPR55	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	0
GPR55	[MASK] is a promising drug target for the treatment of absence epilepsy.	D004832	Epilepsy, absence	0
GPR55	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
GPR55	[MASK] is a promising drug target for the treatment of muscle spasticity.	D009128	Muscle Spasticity	0
GPR55	[MASK] is a promising drug target for the treatment of prader-willi syndrome.	D011218	Prader-Willi Syndrome	0
GPR55	[MASK] is a promising drug target for the treatment of infantile spasms.	D013036	Spasms, Infantile	0
GPR55	[MASK] is a promising drug target for the treatment of angelman syndrome.	D017204	Angelman Syndrome	0
GPR55	[MASK] is a promising drug target for the treatment of cocaine-related disorders.	D019970	Cocaine-Related Disorders	0
GPR55	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	0
GPR84	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
GPR84	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
GPR84	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
GPR84	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
GPR84	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
GPR84	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
GPR84	[MASK] is a promising drug target for the treatment of alstrom syndrome.	D056769	Alstrom Syndrome	0
GPRC5D	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
GRIA1	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
GRIA1	[MASK] is a promising drug target for the treatment of apnea.	D001049	Apnea	0
GRIA1	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
GRIA1	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
GRIA1	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	1
GRIA1	[MASK] is a promising drug target for the treatment of generalized epilepsy.	D004829	Epilepsy, Generalized	1
GRIA1	[MASK] is a promising drug target for the treatment of tonic-clonic epilepsy.	D004830	Epilepsy, Tonic-Clonic	1
GRIA1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
GRIA1	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
GRIA1	[MASK] is a promising drug target for the treatment of muscle spasticity.	D009128	Muscle Spasticity	0
GRIA1	[MASK] is a promising drug target for the treatment of respiratory insufficiency.	D012131	Respiratory Insufficiency	0
GRIA1	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
GRIA1	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
GRIK1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
GRIK1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
GRIK1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
GRIK1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
GRIN1	[MASK] is a promising drug target for the treatment of social phobia.	D000072861	Phobia, Social	0
GRIN1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
GRIN1	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	1
GRIN1	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
GRIN1	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	1
GRIN1	[MASK] is a promising drug target for the treatment of drug-induced dyskinesia.	D004409	Dyskinesia, Drug-Induced	1
GRIN1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
GRIN1	[MASK] is a promising drug target for the treatment of obsessive-compulsive disorder.	D009771	Obsessive-Compulsive Disorder	0
GRIN1	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	1
GRIN1	[MASK] is a promising drug target for the treatment of post-traumatic stress disorders.	D013313	Stress Disorders, Post-Traumatic	0
GRIN1	[MASK] is a promising drug target for the treatment of tinnitus.	D014012	Tinnitus	0
GRIN1	[MASK] is a promising drug target for the treatment of panic disorder.	D016584	Panic Disorder	0
GRIN2B	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
GRIN2B	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
GRIN2B	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
GRIN2B	[MASK] is a promising drug target for the treatment of huntington disease.	D006816	Huntington Disease	0
GRIN2B	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
GRIN2B	[MASK] is a promising drug target for the treatment of infantile spasms.	D013036	Spasms, Infantile	0
GRIN2B	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
GRM2	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
GRM2	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
GRM2	[MASK] is a promising drug target for the treatment of dementia.	D003704	Dementia	0
GRM2	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
GRM2	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
GRM2	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
GRM3	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
GRM3	[MASK] is a promising drug target for the treatment of dementia.	D003704	Dementia	0
GRM3	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
GRM3	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
GRM4	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
GRM5	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
GRM5	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
GRM5	[MASK] is a promising drug target for the treatment of drug-induced dyskinesia.	D004409	Dyskinesia, Drug-Induced	0
GRM5	[MASK] is a promising drug target for the treatment of fragile x syndrome.	D005600	Fragile X Syndrome	0
GRM5	[MASK] is a promising drug target for the treatment of gastroesophageal reflux.	D005764	Gastroesophageal Reflux	0
GRM5	[MASK] is a promising drug target for the treatment of huntington disease.	D006816	Huntington Disease	0
GRM5	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
GRM5	[MASK] is a promising drug target for the treatment of obsessive-compulsive disorder.	D009771	Obsessive-Compulsive Disorder	0
GRM5	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
GRPR	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
GSAP	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
GSAP	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
GSK3A	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
GSK3A	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
GSK3A	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
GSK3B	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
GSK3B	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
GSK3B	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	0
GSK3B	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
GSK3B	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
GSK3B	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
GSN	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
GUCY1A1	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
GUCY1A1	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	1
GUCY1A1	[MASK] is a promising drug target for the treatment of raynaud disease.	D011928	Raynaud Disease	0
GUCY1A1	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
GUCY1A1	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
GUCY1A1	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
GUCY1A1	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
GUCY1B1	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
GUCY1B1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
GUCY1B1	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	1
GUCY1B1	[MASK] is a promising drug target for the treatment of raynaud disease.	D011928	Raynaud Disease	0
GUCY1B1	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
GUCY1B1	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
GUCY1B1	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
GUCY1B1	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
GUCY2C	[MASK] is a promising drug target for the treatment of opioid-induced constipation.	D000079689	Opioid-Induced Constipation	0
GUCY2C	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
GUCY2C	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
GUCY2C	[MASK] is a promising drug target for the treatment of dyspepsia.	D004415	Dyspepsia	0
GUCY2C	[MASK] is a promising drug target for the treatment of esophageal achalasia.	D004931	Esophageal Achalasia	0
GUCY2C	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
GUCY2C	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
GUCY2C	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
GUCY2C	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	0
GUCY2C	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
GUCY2C	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
GUCY2C	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
GUCY2C	[MASK] is a promising drug target for the treatment of gastroparesis.	D018589	Gastroparesis	0
GUCY2C	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
GUSB	[MASK] is a promising drug target for the treatment of mucopolysaccharidosis vii.	D016538	Mucopolysaccharidosis VII	1
HAMP	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	0
HAO1	[MASK] is a promising drug target for the treatment of hyperoxaluria.	D006959	Hyperoxaluria	1
HARS1	[MASK] is a promising drug target for the treatment of dysferlinopathy.	C537995	Dysferlinopathy	0
HARS1	[MASK] is a promising drug target for the treatment of facioscapulohumeral muscular dystrophy.	D020391	Muscular Dystrophy, Facioscapulohumeral	0
HARS1	[MASK] is a promising drug target for the treatment of limb-girdle muscular dystrophies.	D049288	Muscular Dystrophies, Limb-Girdle	0
HARS1	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
HAS2	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	1
HAVCR1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
HAVCR1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
HBB	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
HBB	[MASK] is a promising drug target for the treatment of lymphoproliferative disorders.	D008232	Lymphoproliferative Disorders	0
HBEGF	[MASK] is a promising drug target for the treatment of tympanic membrane perforation.	D018058	Tympanic Membrane Perforation	0
HCAR2	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	0
HCAR2	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
HCAR2	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	0
HCAR2	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
HCAR2	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
HCAR3	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	0
HCAR3	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
HCAR3	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
HCK	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
HCK	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
HCK	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
HCK	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
HCK	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
HCN1	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
HCN1	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
HCN1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
HCN2	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
HCN2	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
HCN2	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
HCN3	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
HCN3	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
HCN3	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
HCN4	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
HCN4	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
HCN4	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
HCRTR1	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
HCRTR1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
HCRTR1	[MASK] is a promising drug target for the treatment of sleep initiation and maintenance disorders.	D007319	Sleep Initiation and Maintenance Disorders	1
HCRTR1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
HCRTR1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
HCRTR1	[MASK] is a promising drug target for the treatment of binge-eating disorder.	D056912	Binge-Eating Disorder	0
HCRTR2	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
HCRTR2	[MASK] is a promising drug target for the treatment of sleep initiation and maintenance disorders.	D007319	Sleep Initiation and Maintenance Disorders	1
HCRTR2	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
HCRTR2	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
HDAC1	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
HDAC1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
HDAC1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
HDAC1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
HDAC1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
HDAC1	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
HDAC1	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
HDAC1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
HDAC1	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
HDAC1	[MASK] is a promising drug target for the treatment of lymphoproliferative disorders.	D008232	Lymphoproliferative Disorders	0
HDAC1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
HDAC1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
HDAC1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
HDAC1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
HDAC1	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
HDAC1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
HDAC1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
HDAC1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
HDAC1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
HDAC1	[MASK] is a promising drug target for the treatment of t-cell lymphoma.	D016399	Lymphoma, T-Cell	0
HDAC1	[MASK] is a promising drug target for the treatment of basal cell neoplasms.	D018295	Neoplasms, Basal Cell	0
HDAC1	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
HDAC1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
HDAC1	[MASK] is a promising drug target for the treatment of actinic keratosis.	D055623	Keratosis, Actinic	0
HDAC1	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	0
HDAC1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
HDAC10	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
HDAC10	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
HDAC10	[MASK] is a promising drug target for the treatment of t-cell lymphoma.	D016399	Lymphoma, T-Cell	1
HDAC10	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
HDAC10	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	1
HDAC2	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
HDAC2	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
HDAC2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
HDAC2	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
HDAC2	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
HDAC2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
HDAC2	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
HDAC2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
HDAC2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
HDAC2	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
HDAC2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
HDAC2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
HDAC2	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
HDAC2	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
HDAC2	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
HDAC2	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
HDAC2	[MASK] is a promising drug target for the treatment of basal cell neoplasms.	D018295	Neoplasms, Basal Cell	0
HDAC2	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
HDAC2	[MASK] is a promising drug target for the treatment of actinic keratosis.	D055623	Keratosis, Actinic	0
HDAC2	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	0
HDAC3	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
HDAC3	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
HDAC3	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
HDAC4	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
HDAC4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
HDAC4	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
HDAC4	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
HDAC4	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
HDAC6	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
HDAC6	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
HDAC6	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
HDAC8	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
HDAC8	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
HDAC8	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
HEXA	[MASK] is a promising drug target for the treatment of sandhoff disease.	D012497	Sandhoff Disease	0
HEXA	[MASK] is a promising drug target for the treatment of tay-sachs disease.	D013661	Tay-Sachs Disease	0
HEXB	[MASK] is a promising drug target for the treatment of sandhoff disease.	D012497	Sandhoff Disease	0
HEXB	[MASK] is a promising drug target for the treatment of tay-sachs disease.	D013661	Tay-Sachs Disease	0
HGF	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
HGF	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
HGF	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
HGF	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
HGF	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
HGF	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
HGF	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
HGF	[MASK] is a promising drug target for the treatment of human viral hepatitis.	D006525	Hepatitis, Viral, Human	1
HGF	[MASK] is a promising drug target for the treatment of ischemia.	D007511	Ischemia	0
HGF	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
HGF	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
HGF	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
HGF	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
HGF	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
HGF	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
HGF	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
HGF	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
HGF	[MASK] is a promising drug target for the treatment of ulcer.	D014456	Ulcer	0
HGF	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
HGF	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
HGF	[MASK] is a promising drug target for the treatment of delayed graft function.	D051799	Delayed Graft Function	0
HGF	[MASK] is a promising drug target for the treatment of acute lung injury.	D055371	Acute Lung Injury	0
HGF	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
HGF	[MASK] is a promising drug target for the treatment of acute kidney injury.	D058186	Acute Kidney Injury	0
HIF1A	[MASK] is a promising drug target for the treatment of tissue adhesions.	D000267	Tissue Adhesions	0
HIF1A	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	0
HLA-A	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
HLA-A	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
HLA-A	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
HLA-A	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
HMGCR	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	1
HMGCR	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	1
HMGCR	[MASK] is a promising drug target for the treatment of ischemia.	D007511	Ischemia	0
HMGCR	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
HPD	[MASK] is a promising drug target for the treatment of tyrosinemias.	D020176	Tyrosinemias	1
HPSE	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
HPSE	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
HRH1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
HRH1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
HRH1	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	1
HRH1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
HRH1	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
HRH1	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	1
HRH1	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
HRH1	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	1
HRH1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
HRH1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
HRH1	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	1
HRH1	[MASK] is a promising drug target for the treatment of respiration disorders.	D012120	Respiration Disorders	0
HRH1	[MASK] is a promising drug target for the treatment of perennial allergic rhinitis.	D012221	Rhinitis, Allergic, Perennial	1
HRH1	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
HRH1	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	0
HRH1	[MASK] is a promising drug target for the treatment of urticaria.	D014581	Urticaria	1
HRH1	[MASK] is a promising drug target for the treatment of weight gain.	D015430	Weight Gain	0
HRH1	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
HRH1	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
HRH1	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	1
HRH2	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
HRH2	[MASK] is a promising drug target for the treatment of peptic ulcer.	D010437	Peptic Ulcer	0
HRH3	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
HRH3	[MASK] is a promising drug target for the treatment of apnea.	D001049	Apnea	1
HRH3	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
HRH3	[MASK] is a promising drug target for the treatment of cataplexy.	D002385	Cataplexy	1
HRH3	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
HRH3	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
HRH3	[MASK] is a promising drug target for the treatment of tourette syndrome.	D005879	Tourette Syndrome	0
HRH3	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
HRH3	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
HRH3	[MASK] is a promising drug target for the treatment of narcolepsy.	D009290	Narcolepsy	1
HRH3	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
HRH3	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
HRH3	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
HRH3	[MASK] is a promising drug target for the treatment of sleep wake disorders.	D012893	Sleep Wake Disorders	0
HRH3	[MASK] is a promising drug target for the treatment of weight gain.	D015430	Weight Gain	0
HRH3	[MASK] is a promising drug target for the treatment of circadian rhythm sleep disorders.	D020178	Sleep Disorders, Circadian Rhythm	0
HRH3	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
HRH3	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
HRH3	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
HRH4	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
HRH4	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
HRH4	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
HRH4	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
HRH4	[MASK] is a promising drug target for the treatment of respiration disorders.	D012120	Respiration Disorders	0
HRH4	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	0
HRH4	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
HRH4	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
HRH4	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
HSD11B1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
HSD11B1	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
HSD11B1	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	0
HSD11B1	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	0
HSD11B1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
HSD11B1	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
HSD11B1	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
HSP90AA1	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
HSP90AA1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
HSP90AA1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
HSP90AA1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
HSP90AA1	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
HSP90AA1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
HSP90AA1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
HSP90AA1	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
HSP90AA1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
HSP90AA1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
HSP90AA1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
HSP90AA1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
HSP90AA1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
HSP90AA1	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
HSP90AA1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
HSP90AA1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
HSP90AA1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
HSP90AA1	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
HSP90AA1	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	1
HSP90AA1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
HTN3	[MASK] is a promising drug target for the treatment of candidiasis.	D002177	Candidiasis	0
HTN3	[MASK] is a promising drug target for the treatment of periodontitis.	D010518	Periodontitis	0
HTR1A	[MASK] is a promising drug target for the treatment of social phobia.	D000072861	Phobia, Social	0
HTR1A	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
HTR1A	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
HTR1A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
HTR1A	[MASK] is a promising drug target for the treatment of borderline personality disorder.	D001883	Borderline Personality Disorder	0
HTR1A	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	1
HTR1A	[MASK] is a promising drug target for the treatment of tourette syndrome.	D005879	Tourette Syndrome	0
HTR1A	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
HTR1A	[MASK] is a promising drug target for the treatment of sleep initiation and maintenance disorders.	D007319	Sleep Initiation and Maintenance Disorders	0
HTR1A	[MASK] is a promising drug target for the treatment of nervous system diseases.	D009422	Nervous System Diseases	0
HTR1A	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
HTR1A	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
HTR1A	[MASK] is a promising drug target for the treatment of psychomotor agitation.	D011595	Psychomotor Agitation	1
HTR1A	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
HTR1A	[MASK] is a promising drug target for the treatment of physiological sexual dysfunction.	D012735	Sexual Dysfunction, Physiological	0
HTR1A	[MASK] is a promising drug target for the treatment of psychological sexual dysfunctions.	D020018	Sexual Dysfunctions, Psychological	0
HTR1A	[MASK] is a promising drug target for the treatment of geographic atrophy.	D057092	Geographic Atrophy	0
HTR1A	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
HTR1B	[MASK] is a promising drug target for the treatment of cluster headache.	D003027	Cluster Headache	0
HTR1B	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
HTR1D	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
HTR1D	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
HTR1D	[MASK] is a promising drug target for the treatment of sleep initiation and maintenance disorders.	D007319	Sleep Initiation and Maintenance Disorders	0
HTR1D	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
HTR2A	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
HTR2A	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
HTR2A	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
HTR2A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
HTR2A	[MASK] is a promising drug target for the treatment of borderline personality disorder.	D001883	Borderline Personality Disorder	0
HTR2A	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
HTR2A	[MASK] is a promising drug target for the treatment of dementia.	D003704	Dementia	0
HTR2A	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	1
HTR2A	[MASK] is a promising drug target for the treatment of fibrosis.	D005355	Fibrosis	0
HTR2A	[MASK] is a promising drug target for the treatment of tourette syndrome.	D005879	Tourette Syndrome	0
HTR2A	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
HTR2A	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
HTR2A	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	0
HTR2A	[MASK] is a promising drug target for the treatment of psychomotor agitation.	D011595	Psychomotor Agitation	1
HTR2A	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
HTR2A	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
HTR2A	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	0
HTR2A	[MASK] is a promising drug target for the treatment of venous insufficiency.	D014689	Venous Insufficiency	0
HTR2B	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
HTR2B	[MASK] is a promising drug target for the treatment of fibrosis.	D005355	Fibrosis	0
HTR2B	[MASK] is a promising drug target for the treatment of fibromyalgia.	D005356	Fibromyalgia	0
HTR2B	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
HTR2B	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
HTR2B	[MASK] is a promising drug target for the treatment of sleep initiation and maintenance disorders.	D007319	Sleep Initiation and Maintenance Disorders	0
HTR2C	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
HTR2C	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
HTR2C	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	0
HTR2C	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	1
HTR2C	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
HTR2C	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
HTR3A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
HTR3A	[MASK] is a promising drug target for the treatment of dyspepsia.	D004415	Dyspepsia	1
HTR3A	[MASK] is a promising drug target for the treatment of nausea.	D009325	Nausea	1
HTR3A	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
HTR3A	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
HTR3A	[MASK] is a promising drug target for the treatment of vomiting.	D014839	Vomiting	1
HTR3A	[MASK] is a promising drug target for the treatment of postoperative nausea and vomiting.	D020250	Postoperative Nausea and Vomiting	1
HTR4	[MASK] is a promising drug target for the treatment of constipation.	D003248	Constipation	0
HTR4	[MASK] is a promising drug target for the treatment of dyspepsia.	D004415	Dyspepsia	1
HTR4	[MASK] is a promising drug target for the treatment of gastroesophageal reflux.	D005764	Gastroesophageal Reflux	0
HTR4	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
HTR6	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
HTR6	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
HTR6	[MASK] is a promising drug target for the treatment of dementia.	D003704	Dementia	0
HTR6	[MASK] is a promising drug target for the treatment of psychotic disorders.	D011618	Psychotic Disorders	0
HTR6	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
HTR7	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
HTR7	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
HTRA1	[MASK] is a promising drug target for the treatment of geographic atrophy.	D057092	Geographic Atrophy	0
HYAL1	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
IAPP	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
ICAM1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
ICAM1	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
ICAM1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
ICAM1	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	1
ICOS	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ICOS	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
ICOS	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
ICOS	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
ICOSLG	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
ICOSLG	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
ICOSLG	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
ICOSLG	[MASK] is a promising drug target for the treatment of sjogren's syndrome.	D012859	Sjogren's Syndrome	0
IDH1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	1
IDH1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
IDH2	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
IDH2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
IDH2	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
IDH2	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
IDH2	[MASK] is a promising drug target for the treatment of t-cell lymphoma.	D016399	Lymphoma, T-Cell	0
IDO1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
IDO1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
IDO1	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
IDO1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
IDS	[MASK] is a promising drug target for the treatment of mucopolysaccharidosis ii.	D016532	Mucopolysaccharidosis II	1
IFNA1	[MASK] is a promising drug target for the treatment of bronchiolitis obliterans.	D001989	Bronchiolitis Obliterans	1
IFNA1	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	1
IFNA1	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	1
IFNA1	[MASK] is a promising drug target for the treatment of hairy cell leukemia.	D007943	Leukemia, Hairy cell	1
IFNA2	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
IFNAR1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
IFNAR1	[MASK] is a promising drug target for the treatment of nervous system diseases.	D009422	Nervous System Diseases	1
IFNAR1	[MASK] is a promising drug target for the treatment of eye infections.	D015817	Eye Infections	1
IFNAR1	[MASK] is a promising drug target for the treatment of ebola hemorrhagic fever.	D019142	Hemorrhagic Fever, Ebola	0
IFNAR1	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	1
IFNAR1	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	1
IFNAR2	[MASK] is a promising drug target for the treatment of recurrent respiratory papillomatosis.	C535297	Recurrent respiratory papillomatosis	1
IFNAR2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
IFNAR2	[MASK] is a promising drug target for the treatment of autoimmune diseases.	D001327	Autoimmune Diseases	1
IFNAR2	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
IFNAR2	[MASK] is a promising drug target for the treatment of bone neoplasms.	D001859	Bone Neoplasms	1
IFNAR2	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	1
IFNAR2	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	1
IFNAR2	[MASK] is a promising drug target for the treatment of hepatitis a.	D006506	Hepatitis A	1
IFNAR2	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	1
IFNAR2	[MASK] is a promising drug target for the treatment of human viral hepatitis.	D006525	Hepatitis, Viral, Human	1
IFNAR2	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	1
IFNAR2	[MASK] is a promising drug target for the treatment of herpes simplex.	D006561	Herpes Simplex	1
IFNAR2	[MASK] is a promising drug target for the treatment of herpes zoster.	D006562	Herpes Zoster	1
IFNAR2	[MASK] is a promising drug target for the treatment of infections.	D007239	Infections	0
IFNAR2	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
IFNAR2	[MASK] is a promising drug target for the treatment of hairy cell leukemia.	D007943	Leukemia, Hairy cell	1
IFNAR2	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	1
IFNAR2	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
IFNAR2	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
IFNAR2	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
IFNAR2	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	1
IFNAR2	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	1
IFNAR2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
IFNAR2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
IFNAR2	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
IFNAR2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
IFNAR2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	1
IFNAR2	[MASK] is a promising drug target for the treatment of polycythemia vera.	D011087	Polycythemia Vera	1
IFNAR2	[MASK] is a promising drug target for the treatment of kaposi sarcoma.	D012514	Sarcoma, Kaposi	1
IFNAR2	[MASK] is a promising drug target for the treatment of urinary tract infections.	D014552	Urinary Tract Infections	0
IFNAR2	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
IFNAR2	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	1
IFNAR2	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	1
IFNAR2	[MASK] is a promising drug target for the treatment of basal cell neoplasms.	D018295	Neoplasms, Basal Cell	1
IFNAR2	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	1
IFNAR2	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	1
IFNAR2	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	1
IFNAR2	[MASK] is a promising drug target for the treatment of papillomavirus infections.	D030361	Papillomavirus Infections	1
IFNAR2	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
IFNAR2	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	0
IFNB1	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
IFNB1	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	1
IFNB1	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	1
IFNB1	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	1
IFNG	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
IFNG	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
IFNG	[MASK] is a promising drug target for the treatment of human influenza.	D007251	Influenza, Human	1
IFNG	[MASK] is a promising drug target for the treatment of severe acute respiratory syndrome.	D045169	Severe Acute Respiratory Syndrome	1
IFNGR1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
IFNGR1	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	1
IFNGR1	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	1
IFNGR1	[MASK] is a promising drug target for the treatment of infections.	D007239	Infections	0
IFNGR1	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	1
IFNGR1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
IFNGR1	[MASK] is a promising drug target for the treatment of tuberculosis.	D014376	Tuberculosis	1
IFNGR1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
IFNGR1	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	1
IFNGR1	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
IFNLR1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
IFNLR1	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
IGF1	[MASK] is a promising drug target for the treatment of burns.	D002056	Burns	0
IGF1	[MASK] is a promising drug target for the treatment of spinal muscular atrophy.	D009134	Muscular Atrophy, Spinal	0
IGF1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
IGF1	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
IGF1R	[MASK] is a promising drug target for the treatment of adrenal gland neoplasms.	D000310	Adrenal Gland Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IGF1R	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
IGF1R	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
IGF1R	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
IGF1R	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
IGF1R	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of rhabdomyosarcoma.	D012208	Rhabdomyosarcoma	0
IGF1R	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
IGF1R	[MASK] is a promising drug target for the treatment of osteosarcoma.	D012516	Osteosarcoma	0
IGF1R	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of thymus neoplasms.	D013953	Thymus Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of urogenital neoplasms.	D014565	Urogenital Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of varicose ulcer.	D014647	Varicose Ulcer	0
IGF1R	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
IGF1R	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
IGF1R	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
IGF1R	[MASK] is a promising drug target for the treatment of graves ophthalmopathy.	D049970	Graves Ophthalmopathy	1
IGF1R	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
IGF2R	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
IGF2R	[MASK] is a promising drug target for the treatment of glycogen storage disease type ii.	D006009	Glycogen Storage Disease Type II	0
IGF2R	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
IGFBP2	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
IGFBP3	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
IGFBP3	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
IGFBP3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
IKBKB	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IKBKB	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
IKBKB	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	0
IKBKB	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
IKBKB	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
IKBKB	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
IKBKB	[MASK] is a promising drug target for the treatment of diabetes complications.	D048909	Diabetes Complications	0
IKBKB	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
IL10	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
IL10	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
IL10	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
IL10RA	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL11RA	[MASK] is a promising drug target for the treatment of thrombocytopenia.	D013921	Thrombocytopenia	1
IL12A	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
IL12A	[MASK] is a promising drug target for the treatment of radiation injuries.	D011832	Radiation Injuries	0
IL12A	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
IL12A	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
IL12A	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
IL12B	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IL12B	[MASK] is a promising drug target for the treatment of autoimmune diseases.	D001327	Autoimmune Diseases	0
IL12B	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
IL12B	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
IL12B	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
IL12B	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
IL12B	[MASK] is a promising drug target for the treatment of radiation injuries.	D011832	Radiation Injuries	0
IL12B	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
IL12B	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
IL13	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	1
IL13	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL13	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
IL13	[MASK] is a promising drug target for the treatment of food hypersensitivity.	D005512	Food Hypersensitivity	0
IL13	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
IL13	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
IL13	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
IL13	[MASK] is a promising drug target for the treatment of nasal polyps.	D009298	Nasal Polyps	1
IL13	[MASK] is a promising drug target for the treatment of prurigo.	D011536	Prurigo	1
IL13	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
IL13	[MASK] is a promising drug target for the treatment of sinusitis.	D012852	Sinusitis	1
IL13	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
IL13	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
IL13	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
IL13	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
IL13	[MASK] is a promising drug target for the treatment of eosinophilic esophagitis.	D057765	Eosinophilic Esophagitis	1
IL15	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
IL15	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
IL15RA	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
IL15RA	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
IL15RA	[MASK] is a promising drug target for the treatment of mastocytosis.	D008415	Mastocytosis	0
IL15RA	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
IL15RA	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
IL15RA	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
IL15RA	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
IL15RA	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
IL15RA	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
IL17A	[MASK] is a promising drug target for the treatment of juvenile arthritis.	D001171	Arthritis, Juvenile	1
IL17A	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IL17A	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
IL17A	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
IL17A	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL17A	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	0
IL17A	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
IL17A	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
IL17A	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
IL17A	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
IL17A	[MASK] is a promising drug target for the treatment of ankylosing spondylitis.	D013167	Spondylitis, Ankylosing	1
IL17A	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
IL17A	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
IL17A	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	1
IL17A	[MASK] is a promising drug target for the treatment of hidradenitis suppurativa.	D017497	Hidradenitis Suppurativa	1
IL17A	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
IL17A	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
IL17A	[MASK] is a promising drug target for the treatment of graves ophthalmopathy.	D049970	Graves Ophthalmopathy	0
IL17C	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
IL17F	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IL17F	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
IL17F	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
IL17RA	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IL17RA	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
IL17RA	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL17RA	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
IL17RA	[MASK] is a promising drug target for the treatment of ankylosing spondylitis.	D013167	Spondylitis, Ankylosing	1
IL17RA	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	1
IL18	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL18	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
IL18	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
IL18	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
IL18	[MASK] is a promising drug target for the treatment of delayed graft function.	D051799	Delayed Graft Function	0
IL1A	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
IL1A	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
IL1A	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
IL1A	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
IL1A	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
IL1A	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
IL1A	[MASK] is a promising drug target for the treatment of postoperative complications.	D011183	Postoperative Complications	0
IL1A	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
IL1A	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
IL1A	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
IL1A	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
IL1A	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
IL1A	[MASK] is a promising drug target for the treatment of pyoderma gangrenosum.	D017511	Pyoderma Gangrenosum	0
IL1A	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	0
IL1A	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
IL1A	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
IL1B	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
IL1B	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
IL1B	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
IL1B	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
IL1R1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
IL1R1	[MASK] is a promising drug target for the treatment of hidradenitis suppurativa.	D017497	Hidradenitis Suppurativa	0
IL1R1	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
IL1R1	[MASK] is a promising drug target for the treatment of cryopyrin-associated periodic syndromes.	D056587	Cryopyrin-Associated Periodic Syndromes	1
IL1R2	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
IL1R2	[MASK] is a promising drug target for the treatment of hidradenitis suppurativa.	D017497	Hidradenitis Suppurativa	0
IL1R2	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
IL1R2	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
IL1RL1	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
IL1RL1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
IL1RL1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
IL1RL1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
IL1RL1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
IL1RL1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
IL1RL1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
IL1RL1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
IL1RL2	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
IL1RL2	[MASK] is a promising drug target for the treatment of ichthyosis.	D007057	Ichthyosis	0
IL1RL2	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
IL1RN	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IL1RN	[MASK] is a promising drug target for the treatment of cachexia.	D002100	Cachexia	0
IL1RN	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
IL1RN	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL1RN	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
IL2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
IL2	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IL2	[MASK] is a promising drug target for the treatment of behcet syndrome.	D001528	Behcet Syndrome	0
IL2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
IL2	[MASK] is a promising drug target for the treatment of cholangitis.	D002761	Cholangitis	0
IL2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
IL2	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL2	[MASK] is a promising drug target for the treatment of hepatitis.	D006505	Hepatitis	0
IL2	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
IL2	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
IL2	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
IL2	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
IL2	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
IL2	[MASK] is a promising drug target for the treatment of skin neoplasms.	D012878	Skin Neoplasms	0
IL2	[MASK] is a promising drug target for the treatment of ankylosing spondylitis.	D013167	Spondylitis, Ankylosing	0
IL2	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
IL2	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
IL2	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
IL2	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
IL21	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IL21	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL21	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	0
IL22RA1	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
IL22RA1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
IL22RA1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IL22RA1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL22RA1	[MASK] is a promising drug target for the treatment of pneumonia.	D011014	Pneumonia	0
IL22RA1	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
IL22RA1	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	0
IL23A	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
IL23A	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
IL23A	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	1
IL23A	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
IL23A	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
IL23A	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
IL23A	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	1
IL23A	[MASK] is a promising drug target for the treatment of hidradenitis suppurativa.	D017497	Hidradenitis Suppurativa	0
IL23R	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL2RA	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
IL2RA	[MASK] is a promising drug target for the treatment of ascites.	D001201	Ascites	1
IL2RA	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
IL2RA	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
IL2RA	[MASK] is a promising drug target for the treatment of candidiasis.	D002177	Candidiasis	1
IL2RA	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
IL2RA	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
IL2RA	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
IL2RA	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	1
IL2RA	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
IL2RA	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	1
IL2RA	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
IL2RA	[MASK] is a promising drug target for the treatment of leprosy.	D007918	Leprosy	1
IL2RA	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
IL2RA	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	1
IL2RA	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	1
IL2RA	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	1
IL2RA	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
IL2RA	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
IL2RA	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
IL2RA	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
IL2RA	[MASK] is a promising drug target for the treatment of sjogren's syndrome.	D012859	Sjogren's Syndrome	1
IL2RA	[MASK] is a promising drug target for the treatment of tuberculosis.	D014376	Tuberculosis	1
IL2RA	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
IL2RA	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
IL2RA	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
IL2RA	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
IL2RB	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
IL2RB	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
IL2RB	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
IL2RB	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
IL2RB	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
IL2RB	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
IL2RB	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
IL2RB	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
IL2RB	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
IL2RB	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
IL2RB	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
IL2RB	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
IL2RG	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
IL2RG	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
IL2RG	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
IL2RG	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
IL2RG	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
IL2RG	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
IL2RG	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
IL2RG	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
IL2RG	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
IL2RG	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
IL2RG	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
IL31	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
IL31	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	1
IL33	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
IL33	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
IL33	[MASK] is a promising drug target for the treatment of food hypersensitivity.	D005512	Food Hypersensitivity	0
IL33	[MASK] is a promising drug target for the treatment of sinusitis.	D012852	Sinusitis	0
IL3RA	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
IL3RA	[MASK] is a promising drug target for the treatment of mastocytosis.	D008415	Mastocytosis	0
IL3RA	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
IL3RA	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
IL3RA	[MASK] is a promising drug target for the treatment of hypereosinophilic syndrome.	D017681	Hypereosinophilic Syndrome	0
IL3RA	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	1
IL4	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
IL4	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
IL4	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
IL4	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
IL4	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
IL4	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
IL4R	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	1
IL4R	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
IL4R	[MASK] is a promising drug target for the treatment of food hypersensitivity.	D005512	Food Hypersensitivity	0
IL4R	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
IL4R	[MASK] is a promising drug target for the treatment of nasal polyps.	D009298	Nasal Polyps	1
IL4R	[MASK] is a promising drug target for the treatment of prurigo.	D011536	Prurigo	1
IL4R	[MASK] is a promising drug target for the treatment of rhinitis.	D012220	Rhinitis	0
IL4R	[MASK] is a promising drug target for the treatment of sinusitis.	D012852	Sinusitis	1
IL4R	[MASK] is a promising drug target for the treatment of eosinophilic esophagitis.	D057765	Eosinophilic Esophagitis	1
IL6	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
IL6	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	0
IL6	[MASK] is a promising drug target for the treatment of juvenile arthritis.	D001171	Arthritis, Juvenile	0
IL6	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
IL6	[MASK] is a promising drug target for the treatment of autoimmune diseases.	D001327	Autoimmune Diseases	0
IL6	[MASK] is a promising drug target for the treatment of cachexia.	D002100	Cachexia	0
IL6	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL6	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
IL6	[MASK] is a promising drug target for the treatment of fatigue.	D005221	Fatigue	0
IL6	[MASK] is a promising drug target for the treatment of infections.	D007239	Infections	0
IL6	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
IL6	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
IL6	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
IL6	[MASK] is a promising drug target for the treatment of polymyalgia rheumatica.	D011111	Polymyalgia Rheumatica	0
IL6	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	1
IL6	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	0
IL6	[MASK] is a promising drug target for the treatment of vasculitis.	D014657	Vasculitis	0
IL6	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	0
IL6R	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	1
IL6R	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
IL6R	[MASK] is a promising drug target for the treatment of juvenile arthritis.	D001171	Arthritis, Juvenile	1
IL6R	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
IL6R	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL6R	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
IL6R	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
IL6R	[MASK] is a promising drug target for the treatment of neuromyelitis optica.	D009471	Neuromyelitis Optica	1
IL6R	[MASK] is a promising drug target for the treatment of pain.	D010146	Pain	0
IL6R	[MASK] is a promising drug target for the treatment of polymyalgia rheumatica.	D011111	Polymyalgia Rheumatica	1
IL6R	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
IL6R	[MASK] is a promising drug target for the treatment of ankylosing spondylitis.	D013167	Spondylitis, Ankylosing	0
IL6R	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
IL7R	[MASK] is a promising drug target for the treatment of autoimmune diseases.	D001327	Autoimmune Diseases	0
IL7R	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
IL7R	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
ILK	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
ILK	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
ILK	[MASK] is a promising drug target for the treatment of rosacea.	D012393	Rosacea	0
IMPDH1	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	1
IMPDH1	[MASK] is a promising drug target for the treatment of immune system diseases.	D007154	Immune System Diseases	1
IMPDH1	[MASK] is a promising drug target for the treatment of lupus nephritis.	D008181	Lupus Nephritis	0
INSR	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
INSR	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	1
INSR	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	1
INSR	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
INSR	[MASK] is a promising drug target for the treatment of mucopolysaccharidosis i.	D008059	Mucopolysaccharidosis I	0
INSR	[MASK] is a promising drug target for the treatment of short bowel syndrome.	D012778	Short Bowel Syndrome	0
IRAK4	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
IRAK4	[MASK] is a promising drug target for the treatment of hidradenitis suppurativa.	D017497	Hidradenitis Suppurativa	0
ITGA2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
ITGA2	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
ITGA2	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ITGA2	[MASK] is a promising drug target for the treatment of retinal diseases.	D012164	Retinal Diseases	0
ITGA2	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
ITGA2	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ITGA2B	[MASK] is a promising drug target for the treatment of unstable angina.	D000789	Angina, Unstable	1
ITGA2B	[MASK] is a promising drug target for the treatment of coronary thrombosis.	D003328	Coronary Thrombosis	1
ITGA2B	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
ITGA2B	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	1
ITGA4	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
ITGA4	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
ITGA4	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
ITGA4	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
ITGA5	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
ITGA5	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ITGA5	[MASK] is a promising drug target for the treatment of retinal diseases.	D012164	Retinal Diseases	0
ITGA5	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ITGAE	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
ITGAE	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
ITGAL	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
ITGAL	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
ITGAL	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	1
ITGAL	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
ITGAM	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
ITGAM	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
ITGAV	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
ITGAV	[MASK] is a promising drug target for the treatment of unstable angina.	D000789	Angina, Unstable	1
ITGAV	[MASK] is a promising drug target for the treatment of coronary thrombosis.	D003328	Coronary Thrombosis	1
ITGAV	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
ITGAV	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ITGAV	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ITGAV	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
ITGAV	[MASK] is a promising drug target for the treatment of retinal diseases.	D012164	Retinal Diseases	0
ITGAV	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
ITGAV	[MASK] is a promising drug target for the treatment of varicose ulcer.	D014647	Varicose Ulcer	0
ITGAV	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
ITGAV	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ITGAV	[MASK] is a promising drug target for the treatment of interstitial lung diseases.	D017563	Lung Diseases, Interstitial	0
ITGAV	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
ITGAV	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	1
ITGAV	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ITGB1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
ITGB1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
ITGB1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
ITGB1	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
ITGB1	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ITGB1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ITGB1	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
ITGB1	[MASK] is a promising drug target for the treatment of retinal diseases.	D012164	Retinal Diseases	0
ITGB1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ITGB1	[MASK] is a promising drug target for the treatment of interstitial lung diseases.	D017563	Lung Diseases, Interstitial	0
ITGB1	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ITGB2	[MASK] is a promising drug target for the treatment of unstable angina.	D000789	Angina, Unstable	1
ITGB2	[MASK] is a promising drug target for the treatment of coronary thrombosis.	D003328	Coronary Thrombosis	1
ITGB2	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
ITGB2	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	1
ITGB3	[MASK] is a promising drug target for the treatment of unstable angina.	D000789	Angina, Unstable	1
ITGB3	[MASK] is a promising drug target for the treatment of coronary thrombosis.	D003328	Coronary Thrombosis	1
ITGB3	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ITGB3	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ITGB3	[MASK] is a promising drug target for the treatment of retinal diseases.	D012164	Retinal Diseases	0
ITGB3	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
ITGB3	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ITGB3	[MASK] is a promising drug target for the treatment of interstitial lung diseases.	D017563	Lung Diseases, Interstitial	0
ITGB3	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	1
ITGB3	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ITGB5	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
ITGB5	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ITGB5	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ITGB5	[MASK] is a promising drug target for the treatment of retinal diseases.	D012164	Retinal Diseases	0
ITGB5	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ITGB5	[MASK] is a promising drug target for the treatment of interstitial lung diseases.	D017563	Lung Diseases, Interstitial	0
ITGB5	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ITGB6	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
ITGB6	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ITGB6	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ITGB6	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
ITGB6	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ITGB6	[MASK] is a promising drug target for the treatment of interstitial lung diseases.	D017563	Lung Diseases, Interstitial	0
ITGB6	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ITGB7	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
ITGB7	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
ITGB8	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ITGB8	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
ITGB8	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ITGB8	[MASK] is a promising drug target for the treatment of interstitial lung diseases.	D017563	Lung Diseases, Interstitial	0
ITGB8	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
ITK	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
ITK	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
JAK1	[MASK] is a promising drug target for the treatment of healthcare-associated pneumonia.	D000077299	Healthcare-Associated Pneumonia	1
JAK1	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	1
JAK1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
JAK1	[MASK] is a promising drug target for the treatment of alopecia.	D000505	Alopecia	0
JAK1	[MASK] is a promising drug target for the treatment of alopecia areata.	D000506	Alopecia Areata	1
JAK1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
JAK1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
JAK1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
JAK1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	1
JAK1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
JAK1	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
JAK1	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
JAK1	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	1
JAK1	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
JAK1	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
JAK1	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
JAK1	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
JAK1	[MASK] is a promising drug target for the treatment of lupus nephritis.	D008181	Lupus Nephritis	0
JAK1	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
JAK1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
JAK1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
JAK1	[MASK] is a promising drug target for the treatment of polycythemia vera.	D011087	Polycythemia Vera	1
JAK1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
JAK1	[MASK] is a promising drug target for the treatment of ankylosing spondylitis.	D013167	Spondylitis, Ankylosing	1
JAK1	[MASK] is a promising drug target for the treatment of thalassemia.	D013789	Thalassemia	0
JAK1	[MASK] is a promising drug target for the treatment of vitiligo.	D014820	Vitiligo	1
JAK1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
JAK1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
JAK1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
JAK1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
JAK1	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	1
JAK1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
JAK1	[MASK] is a promising drug target for the treatment of acute lung injury.	D055371	Acute Lung Injury	0
JAK1	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	1
JAK2	[MASK] is a promising drug target for the treatment of healthcare-associated pneumonia.	D000077299	Healthcare-Associated Pneumonia	1
JAK2	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	1
JAK2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
JAK2	[MASK] is a promising drug target for the treatment of alopecia areata.	D000506	Alopecia Areata	1
JAK2	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
JAK2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
JAK2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
JAK2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
JAK2	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
JAK2	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
JAK2	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
JAK2	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	1
JAK2	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
JAK2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
JAK2	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
JAK2	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
JAK2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
JAK2	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
JAK2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
JAK2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
JAK2	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
JAK2	[MASK] is a promising drug target for the treatment of polycythemia vera.	D011087	Polycythemia Vera	1
JAK2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
JAK2	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
JAK2	[MASK] is a promising drug target for the treatment of thalassemia.	D013789	Thalassemia	0
JAK2	[MASK] is a promising drug target for the treatment of thrombocytosis.	D013922	Thrombocytosis	1
JAK2	[MASK] is a promising drug target for the treatment of vitiligo.	D014820	Vitiligo	1
JAK2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
JAK2	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
JAK2	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
JAK2	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
JAK2	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	0
JAK2	[MASK] is a promising drug target for the treatment of acute lung injury.	D055371	Acute Lung Injury	0
JAK2	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	1
JAK3	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
JAK3	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
JAK3	[MASK] is a promising drug target for the treatment of alopecia.	D000505	Alopecia	0
JAK3	[MASK] is a promising drug target for the treatment of alopecia areata.	D000506	Alopecia Areata	1
JAK3	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
JAK3	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
JAK3	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
JAK3	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
JAK3	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
JAK3	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
JAK3	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
JAK3	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
JAK3	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
JAK3	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	1
JAK3	[MASK] is a promising drug target for the treatment of acute lung injury.	D055371	Acute Lung Injury	0
JUN	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
JUN	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
JUN	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
JUN	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
JUN	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
KCNA5	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
KCNH2	[MASK] is a promising drug target for the treatment of cardiac arrhythmias.	D001145	Arrhythmias, Cardiac	1
KCNH2	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	1
KCNH2	[MASK] is a promising drug target for the treatment of ventricular fibrillation.	D014693	Ventricular Fibrillation	1
KCNJ11	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	1
KCNJ11	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
KCNJ3	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
KCNJ5	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
KCNK2	[MASK] is a promising drug target for the treatment of apnea.	D001049	Apnea	0
KCNQ2	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	0
KCNQ2	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	0
KCNQ2	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
KCNQ3	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	0
KCNQ3	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	0
KCNQ3	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
KCNQ5	[MASK] is a promising drug target for the treatment of apnea.	D001049	Apnea	0
KDM1A	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
KDM1A	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
KDM1A	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
KDM1A	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
KDR	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
KDR	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
KDR	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
KDR	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
KDR	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
KDR	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	1
KDR	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
KDR	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
KDR	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
KDR	[MASK] is a promising drug target for the treatment of myopia.	D009216	Myopia	1
KDR	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	1
KDR	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	0
KDR	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
KDR	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
KDR	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
KDR	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
KDR	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
KDR	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
KDR	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
KDR	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
KDR	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	1
KDR	[MASK] is a promising drug target for the treatment of papillomavirus infections.	D030361	Papillomavirus Infections	0
KDR	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
KDR	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
KDR	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	1
KHK	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
KIF11	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
KIF11	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
KIF11	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
KIF11	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
KIF11	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
KIF11	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
KIF11	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
KIF11	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
KIF11	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
KIF11	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
KIF11	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
KIR2DL1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
KIR2DL1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
KIR2DL1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
KIR2DL3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
KIR2DL3	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
KIR2DL3	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
KIT	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
KIT	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
KIT	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
KIT	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
KIT	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
KIT	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
KIT	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
KIT	[MASK] is a promising drug target for the treatment of mastocytosis.	D008415	Mastocytosis	1
KIT	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
KIT	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
KIT	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
KIT	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
KIT	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
KIT	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	0
KIT	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
KIT	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
KIT	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
KIT	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
KIT	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
KIT	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	1
KLB	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
KLK1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
KLK3	[MASK] is a promising drug target for the treatment of prostatic hyperplasia.	D011470	Prostatic Hyperplasia	1
KLK3	[MASK] is a promising drug target for the treatment of prostatitis.	D011472	Prostatitis	1
KLK7	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
KLK7	[MASK] is a promising drug target for the treatment of netherton syndrome.	D056770	Netherton Syndrome	0
KLKB1	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	0
KLKB1	[MASK] is a promising drug target for the treatment of hereditary angioedemas.	D054179	Angioedemas, Hereditary	1
KLRC1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
KLRC1	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
KLRC1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
KLRC1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
KLRC1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
KLRC1	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
KLRK1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
KLRK1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
KLRK1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
KLRK1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
KLRK1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
KLRK1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
KMT2A	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
KPNB1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
KPNB1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
KPNB1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
KPNB1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
KPNB1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
KPNB1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
KPNB1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
KPNB1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
KPNB1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
KPNB1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
KPNB1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
KPNB1	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
KPNB1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
KRAS	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
LAG3	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
LAG3	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
LAG3	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
LAG3	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
LAG3	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
LAG3	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
LANCL2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
LANCL2	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
LCAT	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	0
LCAT	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
LCAT	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
LCAT	[MASK] is a promising drug target for the treatment of acute coronary syndrome.	D054058	Acute Coronary Syndrome	0
LCK	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
LGALS1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
LGALS1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
LGALS3	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
LHCGR	[MASK] is a promising drug target for the treatment of cryptorchidism.	D003456	Cryptorchidism	1
LHCGR	[MASK] is a promising drug target for the treatment of hypogonadism.	D007006	Hypogonadism	1
LHCGR	[MASK] is a promising drug target for the treatment of female infertility.	D007247	Infertility, Female	1
LHCGR	[MASK] is a promising drug target for the treatment of male infertility.	D007248	Infertility, Male	1
LHCGR	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
LHCGR	[MASK] is a promising drug target for the treatment of polycystic ovary syndrome.	D011085	Polycystic Ovary Syndrome	1
LHCGR	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
LINGO1	[MASK] is a promising drug target for the treatment of optic neuritis.	D009902	Optic Neuritis	0
LINGO1	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
LINGO1	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
LIPA	[MASK] is a promising drug target for the treatment of lysosomal acid lipase deficiency.	C531854	Lysosomal acid lipase deficiency	1
LOXL2	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
LOXL2	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
LOXL2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
LOXL2	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
LOXL2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
LOXL2	[MASK] is a promising drug target for the treatment of sclerosing cholangitis.	D015209	Cholangitis, Sclerosing	0
LOXL2	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
LOXL2	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
LOXL2	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
LPA	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
LPAR1	[MASK] is a promising drug target for the treatment of nephrosclerosis.	D009400	Nephrosclerosis	0
LPL	[MASK] is a promising drug target for the treatment of pancreatic diseases.	D010182	Pancreatic Diseases	0
LTA	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
LTA	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
LTA4H	[MASK] is a promising drug target for the treatment of bronchiectasis.	D001987	Bronchiectasis	0
LTA4H	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
LTA4H	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
LTA4H	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
LTA4H	[MASK] is a promising drug target for the treatment of vesiculobullous skin diseases.	D012872	Skin Diseases, Vesiculobullous	0
LTA4H	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
LTB4R	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
LTB4R	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
LTB4R	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
LTB4R	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
LTB4R	[MASK] is a promising drug target for the treatment of hemolytic-uremic syndrome.	D006463	Hemolytic-Uremic Syndrome	0
LTB4R	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
LTBR	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
LTBR	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
LTBR	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
LTBR	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
LTBR	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	0
LTBR	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
LTF	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
LTF	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
MADCAM1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
MADCAM1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
MAG	[MASK] is a promising drug target for the treatment of traumatic brain injuries.	D000070642	Brain Injuries, Traumatic	0
MAG	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
MAG	[MASK] is a promising drug target for the treatment of spinal cord injuries.	D013119	Spinal Cord Injuries	0
MAGEA3	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
MAGEA4	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
MAGEA4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
MAGEA4	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
MAGEA4	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
MAGEA4	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
MAOA	[MASK] is a promising drug target for the treatment of depression.	D003863	Depression	0
MAOA	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
MAOA	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
MAOB	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
MAOB	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
MAP2K1	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
MAP2K1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
MAP2K1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	1
MAP2K1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
MAP2K1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
MAP2K1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
MAP2K1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	1
MAP2K1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
MAP2K1	[MASK] is a promising drug target for the treatment of langerhans-cell histiocytosis.	D006646	Histiocytosis, Langerhans-Cell	1
MAP2K1	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
MAP2K1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
MAP2K1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	1
MAP2K1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
MAP2K1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
MAP2K1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
MAP2K1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
MAP2K1	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
MAP2K1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
MAP2K1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
MAP2K1	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
MAP2K1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
MAP2K1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
MAP2K1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
MAP2K1	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
MAP2K1	[MASK] is a promising drug target for the treatment of erdheim-chester disease.	D031249	Erdheim-Chester Disease	0
MAP2K2	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
MAP2K2	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
MAP2K2	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	1
MAP2K2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
MAP2K2	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of gastrointestinal neoplasms.	D005770	Gastrointestinal Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	1
MAP2K2	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of langerhans-cell histiocytosis.	D006646	Histiocytosis, Langerhans-Cell	1
MAP2K2	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
MAP2K2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	1
MAP2K2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
MAP2K2	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
MAP2K2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
MAP2K2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
MAP2K2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
MAP2K2	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
MAP2K2	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
MAP2K2	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
MAP2K2	[MASK] is a promising drug target for the treatment of erdheim-chester disease.	D031249	Erdheim-Chester Disease	0
MAP2K3	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
MAP2K3	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
MAP2K3	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
MAP3K1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
MAP3K1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
MAP3K1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
MAP3K1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
MAP3K1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
MAP3K1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
MAP3K1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
MAP3K1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
MAP3K1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
MAP3K11	[MASK] is a promising drug target for the treatment of postoperative cognitive complications.	D000079690	Postoperative Cognitive Complications	0
MAP3K11	[MASK] is a promising drug target for the treatment of cognition disorders.	D003072	Cognition Disorders	0
MAP3K11	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
MAP3K11	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
MAP3K5	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
MAP3K5	[MASK] is a promising drug target for the treatment of alcoholic hepatitis.	D006519	Hepatitis, Alcoholic	0
MAP3K5	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
MAP3K5	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
MAP3K5	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
MAP3K8	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
MAPK1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
MAPK1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
MAPK1	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
MAPK1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
MAPK1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
MAPK1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
MAPK1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
MAPK1	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
MAPK1	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
MAPK14	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
MAPK14	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
MAPK14	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
MAPK14	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
MAPK14	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
MAPK14	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
MAPK14	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
MAPK14	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	1
MAPK14	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
MAPK14	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
MAPK14	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
MAPK14	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
MAPK14	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
MAPK14	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
MAPK14	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
MAPK14	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
MAPK14	[MASK] is a promising drug target for the treatment of acute coronary syndrome.	D054058	Acute Coronary Syndrome	0
MAPK14	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	1
MAPK14	[MASK] is a promising drug target for the treatment of cryopyrin-associated periodic syndromes.	D056587	Cryopyrin-Associated Periodic Syndromes	0
MAPK14	[MASK] is a promising drug target for the treatment of acute kidney injury.	D058186	Acute Kidney Injury	0
MAPK14	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
MAPK3	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
MAPK3	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
MAPK3	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
MAPK3	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
MAPK3	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
MAPK3	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
MAPK3	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
MAPK3	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
MAPK3	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
MAPK8	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
MAPK8	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
MAPK8	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
MAPKAPK2	[MASK] is a promising drug target for the treatment of ankylosing spondylitis.	D013167	Spondylitis, Ankylosing	0
MAPKAPK5	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
MAPT	[MASK] is a promising drug target for the treatment of neurological diagnostic techniques.	D003943	Diagnostic Techniques, Neurological	1
MAS1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
MAS1	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	1
MAS1	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
MAS1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
MAS1	[MASK] is a promising drug target for the treatment of osteosarcoma.	D012516	Osteosarcoma	0
MAS1	[MASK] is a promising drug target for the treatment of thrombocytopenia.	D013921	Thrombocytopenia	0
MAS1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
MASP2	[MASK] is a promising drug target for the treatment of thrombotic thrombocytopenic purpura.	D011697	Purpura, Thrombotic Thrombocytopenic	0
MASP2	[MASK] is a promising drug target for the treatment of membranoproliferative glomerulonephritis.	D015432	Glomerulonephritis, Membranoproliferative	0
MBOAT4	[MASK] is a promising drug target for the treatment of prader-willi syndrome.	D011218	Prader-Willi Syndrome	0
MBP	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
MC1R	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
MC4R	[MASK] is a promising drug target for the treatment of inborn errors metabolism.	D008661	Metabolism, Inborn Errors	1
MC4R	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	1
MC4R	[MASK] is a promising drug target for the treatment of prader-willi syndrome.	D011218	Prader-Willi Syndrome	0
MC4R	[MASK] is a promising drug target for the treatment of physiological sexual dysfunction.	D012735	Sexual Dysfunction, Physiological	0
MC4R	[MASK] is a promising drug target for the treatment of psychological sexual dysfunctions.	D020018	Sexual Dysfunctions, Psychological	0
MC4R	[MASK] is a promising drug target for the treatment of bardet-biedl syndrome.	D020788	Bardet-Biedl Syndrome	1
MC5R	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
MC5R	[MASK] is a promising drug target for the treatment of seborrheic dermatitis.	D012628	Dermatitis, Seborrheic	0
MCHR1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
MCL1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
MCL1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
MCL1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
MCL1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
MCL1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
MCL1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
MDM2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
MDM2	[MASK] is a promising drug target for the treatment of liposarcoma.	D008080	Liposarcoma	0
MDM2	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
MDM2	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
MDM2	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
MDM2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
MDM2	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	0
MDM2	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
MDM4	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
MDM4	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
MDM4	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
MDM4	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
MDM4	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	0
MDM4	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
MELK	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
MELK	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
MEN1	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
MERTK	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
MET	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
MET	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
MET	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
MET	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
MET	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
MET	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
MET	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
MET	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
MET	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
MET	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
MET	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
MET	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
MET	[MASK] is a promising drug target for the treatment of anaplastic large-cell lymphoma.	D017728	Lymphoma, Large-Cell, Anaplastic	1
MET	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
METAP2	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
METAP2	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
MGLL	[MASK] is a promising drug target for the treatment of tourette syndrome.	D005879	Tourette Syndrome	0
MKNK1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
MKNK2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
MLANA	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
MLNR	[MASK] is a promising drug target for the treatment of gastroparesis.	D018589	Gastroparesis	0
MME	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
MME	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	0
MME	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
MME	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
MMP1	[MASK] is a promising drug target for the treatment of pterygium.	D011625	Pterygium	0
MMP1	[MASK] is a promising drug target for the treatment of rosacea.	D012393	Rosacea	1
MMP1	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
MMP1	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
MMP1	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
MMP12	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
MMP12	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
MMP12	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
MMP12	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
MMP13	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
MMP14	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
MMP2	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
MMP3	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
MMP8	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
MMP9	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
MMP9	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
MMP9	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
MMP9	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
MMP9	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
MMP9	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
MMP9	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
MMP9	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
MMP9	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
MMP9	[MASK] is a promising drug target for the treatment of pterygium.	D011625	Pterygium	0
MMP9	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
MMP9	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
MMP9	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
MPL	[MASK] is a promising drug target for the treatment of aplastic anemia.	D000741	Anemia, Aplastic	1
MPL	[MASK] is a promising drug target for the treatment of thrombocytopenia.	D013921	Thrombocytopenia	1
MPL	[MASK] is a promising drug target for the treatment of idiopathic thrombocytopenic purpura.	D016553	Purpura, Thrombocytopenic, Idiopathic	1
MPO	[MASK] is a promising drug target for the treatment of healthcare-associated pneumonia.	D000077299	Healthcare-Associated Pneumonia	0
MPO	[MASK] is a promising drug target for the treatment of infections.	D007239	Infections	0
MPO	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
MPO	[MASK] is a promising drug target for the treatment of urinary tract infections.	D014552	Urinary Tract Infections	0
MPO	[MASK] is a promising drug target for the treatment of multiple system atrophy.	D019578	Multiple System Atrophy	0
MS4A1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
MS4A1	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	1
MS4A1	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	1
MS4A1	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
MS4A1	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
MS4A1	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	1
MS4A1	[MASK] is a promising drug target for the treatment of lymphoproliferative disorders.	D008232	Lymphoproliferative Disorders	1
MS4A1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
MS4A1	[MASK] is a promising drug target for the treatment of pemphigus.	D010392	Pemphigus	1
MS4A1	[MASK] is a promising drug target for the treatment of vasculitis.	D014657	Vasculitis	1
MS4A1	[MASK] is a promising drug target for the treatment of granulomatosis with polyangiitis.	D014890	Granulomatosis with Polyangiitis	1
MS4A1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	1
MS4A1	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	1
MS4A1	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	1
MS4A1	[MASK] is a promising drug target for the treatment of idiopathic thrombocytopenic purpura.	D016553	Purpura, Thrombocytopenic, Idiopathic	1
MS4A1	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	1
MS4A1	[MASK] is a promising drug target for the treatment of microscopic polyangiitis.	D055953	Microscopic Polyangiitis	1
MST1R	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
MST1R	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
MST1R	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
MST1R	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
MST1R	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
MST1R	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
MSTN	[MASK] is a promising drug target for the treatment of cachexia.	D002100	Cachexia	0
MSTN	[MASK] is a promising drug target for the treatment of myositis.	D009220	Myositis	0
MSTN	[MASK] is a promising drug target for the treatment of duchenne muscular dystrophy.	D020388	Muscular Dystrophy, Duchenne	0
MSTN	[MASK] is a promising drug target for the treatment of sarcopenia.	D055948	Sarcopenia	0
MTM1	[MASK] is a promising drug target for the treatment of congenital structural myopathies.	D020914	Myopathies, Structural, Congenital	0
MTNR1A	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
MTNR1A	[MASK] is a promising drug target for the treatment of sleep initiation and maintenance disorders.	D007319	Sleep Initiation and Maintenance Disorders	1
MTNR1A	[MASK] is a promising drug target for the treatment of sleep wake disorders.	D012893	Sleep Wake Disorders	1
MTNR1A	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
MTNR1B	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
MTNR1B	[MASK] is a promising drug target for the treatment of sleep initiation and maintenance disorders.	D007319	Sleep Initiation and Maintenance Disorders	1
MTNR1B	[MASK] is a promising drug target for the treatment of sleep wake disorders.	D012893	Sleep Wake Disorders	1
MTNR1B	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
MTOR	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
MTOR	[MASK] is a promising drug target for the treatment of anus neoplasms.	D001005	Anus Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of gout.	D006073	Gout	0
MTOR	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
MTOR	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of leigh disease.	D007888	Leigh Disease	0
MTOR	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
MTOR	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	0
MTOR	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
MTOR	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
MTOR	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
MTOR	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
MTOR	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
MTOR	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of respiratory tract infections.	D012141	Respiratory Tract Infections	0
MTOR	[MASK] is a promising drug target for the treatment of skin diseases.	D012871	Skin diseases	0
MTOR	[MASK] is a promising drug target for the treatment of skin neoplasms.	D012878	Skin Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of tuberous sclerosis.	D014402	Tuberous Sclerosis	1
MTOR	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	1
MTOR	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
MTOR	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
MTOR	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
MTOR	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
MTOR	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
MTOR	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
MTOR	[MASK] is a promising drug target for the treatment of lymphangioleiomyomatosis.	D018192	Lymphangioleiomyomatosis	1
MTOR	[MASK] is a promising drug target for the treatment of basal cell neoplasms.	D018295	Neoplasms, Basal Cell	0
MTOR	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
MTOR	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
MTOR	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	1
MTOR	[MASK] is a promising drug target for the treatment of lymphatic abnormalities.	D044148	Lymphatic Abnormalities	1
MTOR	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
MTOR	[MASK] is a promising drug target for the treatment of perivascular epithelioid cell neoplasms.	D054973	Perivascular Epithelioid Cell Neoplasms	1
MTOR	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
MTTP	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
MTTP	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
MTTP	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
MUC1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
MUC1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
MUC1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
MUC1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
MUC1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
MYC	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
MYC	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
MYC	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
MYC	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
MYC	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
MYC	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
MYC	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
MYC	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
MYC	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
MYC	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
MYC	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	0
MYD88	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
MYO7A	[MASK] is a promising drug target for the treatment of usher syndromes.	D052245	Usher Syndromes	0
NAGLU	[MASK] is a promising drug target for the treatment of mucopolysaccharidosis iii.	D009084	Mucopolysaccharidosis III	0
NCL	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
NCL	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
NCL	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	0
NCL	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
NFE2L2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
NFE2L2	[MASK] is a promising drug target for the treatment of friedreich ataxia.	D005621	Friedreich Ataxia	1
NFE2L2	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
NFE2L2	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
NFE2L2	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
NFE2L2	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
NFE2L2	[MASK] is a promising drug target for the treatment of subarachnoid hemorrhage.	D013345	Subarachnoid Hemorrhage	0
NFE2L2	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	1
NFKB1	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
NFKB1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
NFKB1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
NFKB1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
NFKB1	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
NFKB1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
NFKB1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
NFKB1	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
NFKB1	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
NFKB1	[MASK] is a promising drug target for the treatment of human influenza.	D007251	Influenza, Human	0
NFKB1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
NFKB1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
NFKB1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
NFKB1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
NFKB1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
NFKB1	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
NFKB1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
NFKB1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
NFKB1	[MASK] is a promising drug target for the treatment of rhinitis.	D012220	Rhinitis	0
NFKB1	[MASK] is a promising drug target for the treatment of rosacea.	D012393	Rosacea	0
NFKB1	[MASK] is a promising drug target for the treatment of skin diseases.	D012871	Skin diseases	0
NFKB1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
NFKBIA	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
NGFR	[MASK] is a promising drug target for the treatment of keratitis.	D007634	Keratitis	1
NGFR	[MASK] is a promising drug target for the treatment of retinitis pigmentosa.	D012174	Retinitis Pigmentosa	0
NGFR	[MASK] is a promising drug target for the treatment of nervous system trauma.	D020196	Trauma, Nervous System	1
NISCH	[MASK] is a promising drug target for the treatment of headache.	D006261	Headache	0
NLRP3	[MASK] is a promising drug target for the treatment of cytokine release syndrome.	D000080424	Cytokine Release Syndrome	0
NLRP3	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
NLRP3	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
NLRP3	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
NLRP3	[MASK] is a promising drug target for the treatment of gout.	D006073	Gout	0
NLRP3	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
NLRP3	[MASK] is a promising drug target for the treatment of joint diseases.	D007592	Joint Diseases	0
NOD2	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
NOS1	[MASK] is a promising drug target for the treatment of healthcare-associated pneumonia.	D000077299	Healthcare-Associated Pneumonia	0
NOS1	[MASK] is a promising drug target for the treatment of headache.	D006261	Headache	0
NOS1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
NOS1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
NOS1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
NOS1	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
NOS1	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
NOS1	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
NOS1	[MASK] is a promising drug target for the treatment of dyskinesias.	D020820	Dyskinesias	0
NOS1	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
NOS1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
NOS2	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
NOS2	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
NOS2	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
NOTCH1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
NOTCH2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
NOTCH2	[MASK] is a promising drug target for the treatment of liposarcoma.	D008080	Liposarcoma	0
NOTCH2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
NOTCH2	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
NOTCH2	[MASK] is a promising drug target for the treatment of kaposi sarcoma.	D012514	Sarcoma, Kaposi	0
NOTCH2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
NOTCH2	[MASK] is a promising drug target for the treatment of t-cell lymphoma.	D016399	Lymphoma, T-Cell	0
NOTCH2	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
NOTCH2	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
NOTCH3	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
NOTCH3	[MASK] is a promising drug target for the treatment of liposarcoma.	D008080	Liposarcoma	0
NOTCH3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
NOTCH3	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
NOTCH3	[MASK] is a promising drug target for the treatment of kaposi sarcoma.	D012514	Sarcoma, Kaposi	0
NOTCH3	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
NOTCH3	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
NOTCH4	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
NPC1L1	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	1
NPC1L1	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
NPM1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
NPR2	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
NPY4R	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
NPY4R	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
NPY4R	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
NPY4R	[MASK] is a promising drug target for the treatment of short bowel syndrome.	D012778	Short Bowel Syndrome	0
NPY4R	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
NPY5R	[MASK] is a promising drug target for the treatment of cognition disorders.	D003072	Cognition Disorders	0
NPY5R	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
NQO1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
NR1H2	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
NR1H4	[MASK] is a promising drug target for the treatment of intrahepatic cholestasis.	D002780	Cholestasis, Intrahepatic	0
NR1H4	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
NR1H4	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	0
NR1H4	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
NR1H4	[MASK] is a promising drug target for the treatment of liver diseases.	D008107	Liver Diseases	0
NR3C1	[MASK] is a promising drug target for the treatment of familial hypoadrenocorticism.	D000075262	Hypoadrenocorticism, Familial	1
NR3C1	[MASK] is a promising drug target for the treatment of addison disease.	D000224	Addison Disease	1
NR3C1	[MASK] is a promising drug target for the treatment of arthritis.	D001168	Arthritis	0
NR3C1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
NR3C1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	1
NR3C1	[MASK] is a promising drug target for the treatment of blepharitis.	D001762	Blepharitis	0
NR3C1	[MASK] is a promising drug target for the treatment of cataract.	D002386	Cataract	1
NR3C1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
NR3C1	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
NR3C1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	1
NR3C1	[MASK] is a promising drug target for the treatment of depression.	D003863	Depression	0
NR3C1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
NR3C1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
NR3C1	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
NR3C1	[MASK] is a promising drug target for the treatment of eczema.	D004485	Eczema	0
NR3C1	[MASK] is a promising drug target for the treatment of eye diseases.	D005128	Eye Diseases	1
NR3C1	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	1
NR3C1	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
NR3C1	[MASK] is a promising drug target for the treatment of leiomyoma.	D007889	Leiomyoma	0
NR3C1	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	1
NR3C1	[MASK] is a promising drug target for the treatment of meniere disease.	D008575	Meniere Disease	0
NR3C1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
NR3C1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
NR3C1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
NR3C1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
NR3C1	[MASK] is a promising drug target for the treatment of respiration disorders.	D012120	Respiration Disorders	1
NR3C1	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	1
NR3C1	[MASK] is a promising drug target for the treatment of perennial allergic rhinitis.	D012221	Rhinitis, Allergic, Perennial	1
NR3C1	[MASK] is a promising drug target for the treatment of sinusitis.	D012852	Sinusitis	1
NR3C1	[MASK] is a promising drug target for the treatment of skin diseases.	D012871	Skin diseases	0
NR3C1	[MASK] is a promising drug target for the treatment of infectious skin diseases.	D012874	Skin Diseases, Infectious	1
NR3C1	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	1
NR3C1	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
NR3C1	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
NR3C1	[MASK] is a promising drug target for the treatment of duchenne muscular dystrophy.	D020388	Muscular Dystrophy, Duchenne	1
NR3C1	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
NR3C1	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
NR3C1	[MASK] is a promising drug target for the treatment of hearing loss.	D034381	Hearing Loss	0
NR3C1	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	1
NR3C1	[MASK] is a promising drug target for the treatment of limb-girdle muscular dystrophies.	D049288	Muscular Dystrophies, Limb-Girdle	0
NR3C1	[MASK] is a promising drug target for the treatment of graves ophthalmopathy.	D049970	Graves Ophthalmopathy	0
NR3C1	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
NR3C1	[MASK] is a promising drug target for the treatment of eosinophilic esophagitis.	D057765	Eosinophilic Esophagitis	1
NR3C1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
NR3C1	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
NR3C2	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	1
NR3C2	[MASK] is a promising drug target for the treatment of edema.	D004487	Edema	1
NR3C2	[MASK] is a promising drug target for the treatment of cardiac edema.	D004489	Edema, Cardiac	1
NR3C2	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
NR3C2	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
NR3C2	[MASK] is a promising drug target for the treatment of kidney diseases.	D007674	Kidney Diseases	0
NR3C2	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	0
NT5E	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
NTRK1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
NTRK1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
NTRK1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
NTRK1	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
NTRK1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
NTRK1	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
NTRK1	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	0
NTRK1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
NTRK1	[MASK] is a promising drug target for the treatment of leiomyosarcoma.	D007890	Leiomyosarcoma	0
NTRK1	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
NTRK1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
NTRK1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
NTRK1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
NTRK1	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
NTRK1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
NTRK1	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
NTRK1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
NTRK1	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
NTRK1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
NTRK1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
NTRK1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
NTRK2	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
NTRK2	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
NTRK2	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
NTRK2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
NTRK2	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
NTRK2	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
NTRK2	[MASK] is a promising drug target for the treatment of leiomyosarcoma.	D007890	Leiomyosarcoma	0
NTRK2	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
NTRK2	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
NTRK2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
NTRK2	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
NTRK2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
NTRK3	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
NTRK3	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
NTRK3	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
NTRK3	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
NTRK3	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
NTRK3	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
NTRK3	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
NTRK3	[MASK] is a promising drug target for the treatment of leiomyosarcoma.	D007890	Leiomyosarcoma	0
NTRK3	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
NTRK3	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
NTRK3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
NTRK3	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
NTRK3	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
NTRK3	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
NTRK3	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
NTSR1	[MASK] is a promising drug target for the treatment of bone neoplasms.	D001859	Bone Neoplasms	0
NTSR1	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	0
NTSR1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
NTSR1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
NTSR1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
NTSR1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
NTSR1	[MASK] is a promising drug target for the treatment of ewing sarcoma.	D012512	Sarcoma, Ewing	0
NTSR1	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
NTSR1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
OPRD1	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	1
OPRD1	[MASK] is a promising drug target for the treatment of opioid-induced constipation.	D000079689	Opioid-Induced Constipation	1
OPRD1	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	0
OPRD1	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
OPRD1	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
OPRD1	[MASK] is a promising drug target for the treatment of opioid-related disorders.	D009293	Opioid-Related Disorders	1
OPRD1	[MASK] is a promising drug target for the treatment of nausea.	D009325	Nausea	1
OPRD1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	1
OPRD1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
OPRD1	[MASK] is a promising drug target for the treatment of vomiting.	D014839	Vomiting	1
OPRD1	[MASK] is a promising drug target for the treatment of cocaine-related disorders.	D019970	Cocaine-Related Disorders	0
OPRD1	[MASK] is a promising drug target for the treatment of complex regional pain syndromes.	D020918	Complex Regional Pain Syndromes	0
OPRD1	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	1
OPRD1	[MASK] is a promising drug target for the treatment of ileus.	D045823	Ileus	0
OPRD1	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
OPRD1	[MASK] is a promising drug target for the treatment of binge-eating disorder.	D056912	Binge-Eating Disorder	0
OPRD1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
OPRD1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	1
OPRK1	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	1
OPRK1	[MASK] is a promising drug target for the treatment of opioid-induced constipation.	D000079689	Opioid-Induced Constipation	1
OPRK1	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	1
OPRK1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
OPRK1	[MASK] is a promising drug target for the treatment of opioid-related disorders.	D009293	Opioid-Related Disorders	1
OPRK1	[MASK] is a promising drug target for the treatment of nausea.	D009325	Nausea	1
OPRK1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	1
OPRK1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	1
OPRK1	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	1
OPRK1	[MASK] is a promising drug target for the treatment of tobacco use disorder.	D014029	Tobacco Use Disorder	0
OPRK1	[MASK] is a promising drug target for the treatment of vomiting.	D014839	Vomiting	1
OPRK1	[MASK] is a promising drug target for the treatment of cocaine-related disorders.	D019970	Cocaine-Related Disorders	0
OPRK1	[MASK] is a promising drug target for the treatment of complex regional pain syndromes.	D020918	Complex Regional Pain Syndromes	0
OPRK1	[MASK] is a promising drug target for the treatment of ileus.	D045823	Ileus	0
OPRK1	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
OPRK1	[MASK] is a promising drug target for the treatment of binge-eating disorder.	D056912	Binge-Eating Disorder	0
OPRK1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
OPRK1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	1
OPRK1	[MASK] is a promising drug target for the treatment of drug-related side effects and adverse reactions.	D064420	Drug-Related Side Effects and Adverse Reactions	1
OPRL1	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	0
OPRL1	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	0
OPRL1	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
OPRL1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
OPRL1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
OPRL1	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
OPRL1	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
OPRL1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
OPRL1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
OPRM1	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	1
OPRM1	[MASK] is a promising drug target for the treatment of opioid-induced constipation.	D000079689	Opioid-Induced Constipation	1
OPRM1	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	1
OPRM1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
OPRM1	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
OPRM1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
OPRM1	[MASK] is a promising drug target for the treatment of gastrointestinal diseases.	D005767	Gastrointestinal Diseases	0
OPRM1	[MASK] is a promising drug target for the treatment of gastrointestinal motility.	D005769	Gastrointestinal Motility	0
OPRM1	[MASK] is a promising drug target for the treatment of opioid-related disorders.	D009293	Opioid-Related Disorders	1
OPRM1	[MASK] is a promising drug target for the treatment of nausea.	D009325	Nausea	1
OPRM1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	1
OPRM1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
OPRM1	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
OPRM1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	1
OPRM1	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
OPRM1	[MASK] is a promising drug target for the treatment of vomiting.	D014839	Vomiting	1
OPRM1	[MASK] is a promising drug target for the treatment of cocaine-related disorders.	D019970	Cocaine-Related Disorders	0
OPRM1	[MASK] is a promising drug target for the treatment of complex regional pain syndromes.	D020918	Complex Regional Pain Syndromes	0
OPRM1	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	1
OPRM1	[MASK] is a promising drug target for the treatment of ileus.	D045823	Ileus	0
OPRM1	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
OPRM1	[MASK] is a promising drug target for the treatment of binge-eating disorder.	D056912	Binge-Eating Disorder	0
OPRM1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
OPRM1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	1
OPRM1	[MASK] is a promising drug target for the treatment of drug-related side effects and adverse reactions.	D064420	Drug-Related Side Effects and Adverse Reactions	1
OSM	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
OSM	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
OSM	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
OSM	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
OXTR	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
OXTR	[MASK] is a promising drug target for the treatment of postpartum hemorrhage.	D006473	Postpartum Hemorrhage	1
OXTR	[MASK] is a promising drug target for the treatment of premature obstetric labor.	D007752	Obstetric Labor, Premature	0
OXTR	[MASK] is a promising drug target for the treatment of lactation disorders.	D007775	Lactation Disorders	0
OXTR	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	0
OXTR	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
OXTR	[MASK] is a promising drug target for the treatment of atrophic vaginitis.	D059268	Atrophic Vaginitis	0
OXTR	[MASK] is a promising drug target for the treatment of premature ejaculation.	D061686	Premature Ejaculation	0
OXTR	[MASK] is a promising drug target for the treatment of adenomyosis.	D062788	Adenomyosis	0
P2RX3	[MASK] is a promising drug target for the treatment of apnea.	D001049	Apnea	0
P2RX3	[MASK] is a promising drug target for the treatment of cough.	D003371	Cough	1
P2RX3	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
P2RX3	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
P2RX3	[MASK] is a promising drug target for the treatment of urethritis.	D014526	Urethritis	0
P2RX3	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
P2RX3	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
P2RX7	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
P2RX7	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
P2RX7	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
P2RX7	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
P2RX7	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
P2RY12	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	1
P2RY12	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	1
P2RY12	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	1
P2RY12	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	1
P2RY12	[MASK] is a promising drug target for the treatment of acute coronary syndrome.	D054058	Acute Coronary Syndrome	1
PARP1	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
PARP1	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
PARP1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
PARP1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
PARP1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
PARP1	[MASK] is a promising drug target for the treatment of cognition disorders.	D003072	Cognition Disorders	0
PARP1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	1
PARP1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
PARP1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
PARP1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
PARP1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
PARP1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
PARP1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	1
PARP1	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	1
PARP1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
PARP1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
PARP1	[MASK] is a promising drug target for the treatment of ewing sarcoma.	D012512	Sarcoma, Ewing	0
PARP1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
PARP1	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
PARP2	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
PARP2	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
PARP2	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	1
PARP2	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
PARP2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
PARP2	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
PARP2	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	1
PARP2	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	1
PARP2	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
PARP2	[MASK] is a promising drug target for the treatment of ewing sarcoma.	D012512	Sarcoma, Ewing	0
PARP2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
PARP2	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
PCK1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
PCK1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
PCSK9	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	0
PCSK9	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
PCSK9	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	1
PCSK9	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type ii.	D006938	Hyperlipoproteinemia Type II	1
PCSK9	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	1
PCSK9	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	0
PCSK9	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	1
PCSK9	[MASK] is a promising drug target for the treatment of acute coronary syndrome.	D054058	Acute Coronary Syndrome	0
PDCD1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
PDCD1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
PDCD1	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
PDCD1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	1
PDCD1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
PDCD1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
PDCD1	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	1
PDCD1	[MASK] is a promising drug target for the treatment of nasopharyngeal neoplasms.	D009303	Nasopharyngeal Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	1
PDCD1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
PDCD1	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	1
PDCD1	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	1
PDCD1	[MASK] is a promising drug target for the treatment of basal cell neoplasms.	D018295	Neoplasms, Basal Cell	1
PDCD1	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	1
PDCD1	[MASK] is a promising drug target for the treatment of sepsis.	D018805	Sepsis	0
PDCD1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
PDE10A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	0
PDE10A	[MASK] is a promising drug target for the treatment of huntington disease.	D006816	Huntington Disease	0
PDE3A	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
PDE3A	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
PDE3A	[MASK] is a promising drug target for the treatment of intermittent claudication.	D007383	Intermittent Claudication	0
PDE3A	[MASK] is a promising drug target for the treatment of thrombocytosis.	D013922	Thrombocytosis	1
PDE3A	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
PDE3A	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
PDE4A	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
PDE4A	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PDE4A	[MASK] is a promising drug target for the treatment of behcet syndrome.	D001528	Behcet Syndrome	0
PDE4A	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
PDE4A	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
PDE4A	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
PDE4A	[MASK] is a promising drug target for the treatment of eczema.	D004485	Eczema	0
PDE4A	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
PDE4A	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
PDE4A	[MASK] is a promising drug target for the treatment of respiration disorders.	D012120	Respiration Disorders	0
PDE4A	[MASK] is a promising drug target for the treatment of rosacea.	D012393	Rosacea	0
PDE4A	[MASK] is a promising drug target for the treatment of staphylococcal infections.	D013203	Staphylococcal Infections	0
PDE4A	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	0
PDE4A	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
PDE4A	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
PDE4A	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
PDE4A	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
PDE4B	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
PDE4B	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PDE4B	[MASK] is a promising drug target for the treatment of behcet syndrome.	D001528	Behcet Syndrome	0
PDE4B	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
PDE4B	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
PDE4B	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
PDE4B	[MASK] is a promising drug target for the treatment of eczema.	D004485	Eczema	0
PDE4B	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
PDE4B	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
PDE4B	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
PDE4C	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
PDE4C	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PDE4C	[MASK] is a promising drug target for the treatment of behcet syndrome.	D001528	Behcet Syndrome	0
PDE4C	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
PDE4C	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
PDE4C	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
PDE4C	[MASK] is a promising drug target for the treatment of eczema.	D004485	Eczema	0
PDE4C	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
PDE4C	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
PDE4C	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
PDE4D	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PDE4D	[MASK] is a promising drug target for the treatment of behcet syndrome.	D001528	Behcet Syndrome	0
PDE4D	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
PDE4D	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
PDE4D	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
PDE4D	[MASK] is a promising drug target for the treatment of eczema.	D004485	Eczema	0
PDE4D	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
PDE4D	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
PDE4D	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
PDE5A	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
PDE5A	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
PDE5A	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
PDE5A	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
PDE5A	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	0
PDE5A	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	1
PDE5A	[MASK] is a promising drug target for the treatment of erectile dysfunction.	D007172	Erectile Dysfunction	1
PDE5A	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
PDE5A	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
PDE5A	[MASK] is a promising drug target for the treatment of raynaud disease.	D011928	Raynaud Disease	0
PDE5A	[MASK] is a promising drug target for the treatment of vascular diseases.	D014652	Vascular Diseases	0
PDE5A	[MASK] is a promising drug target for the treatment of nervous system trauma.	D020196	Trauma, Nervous System	0
PDE5A	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
PDE5A	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
PDE9A	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
PDE9A	[MASK] is a promising drug target for the treatment of sickle cell anemia.	D000755	Anemia, Sickle Cell	0
PDE9A	[MASK] is a promising drug target for the treatment of prostatic hyperplasia.	D011470	Prostatic Hyperplasia	0
PDE9A	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
PDE9A	[MASK] is a promising drug target for the treatment of thalassemia.	D013789	Thalassemia	0
PDGFA	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
PDGFB	[MASK] is a promising drug target for the treatment of pressure ulcer.	D003668	Pressure Ulcer	0
PDGFB	[MASK] is a promising drug target for the treatment of varicose ulcer.	D014647	Varicose Ulcer	0
PDGFB	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
PDGFB	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
PDGFRA	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
PDGFRA	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
PDGFRA	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
PDGFRA	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
PDGFRA	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
PDGFRA	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
PDGFRA	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
PDGFRA	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
PDGFRA	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
PDGFRA	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
PDGFRA	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
PDGFRA	[MASK] is a promising drug target for the treatment of mastocytosis.	D008415	Mastocytosis	1
PDGFRA	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
PDGFRA	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
PDGFRA	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
PDGFRA	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
PDGFRA	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PDGFRA	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
PDGFRA	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
PDGFRA	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	0
PDGFRA	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
PDGFRA	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
PDGFRA	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
PDGFRA	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
PDGFRA	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
PDGFRA	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	1
PDGFRB	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
PDGFRB	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
PDGFRB	[MASK] is a promising drug target for the treatment of pressure ulcer.	D003668	Pressure Ulcer	0
PDGFRB	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
PDGFRB	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
PDGFRB	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
PDGFRB	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
PDGFRB	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
PDGFRB	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PDGFRB	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
PDGFRB	[MASK] is a promising drug target for the treatment of tendon injuries.	D013708	Tendon Injuries	0
PDGFRB	[MASK] is a promising drug target for the treatment of tennis elbow.	D013716	Tennis Elbow	0
PDGFRB	[MASK] is a promising drug target for the treatment of testicular neoplasms.	D013736	Testicular Neoplasms	0
PDGFRB	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
PDGFRB	[MASK] is a promising drug target for the treatment of varicose ulcer.	D014647	Varicose Ulcer	0
PDGFRB	[MASK] is a promising drug target for the treatment of wounds and injuries.	D014947	Wounds and Injuries	0
PDGFRB	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
PDGFRB	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	1
PDK1	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
PDYN	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	0
PDYN	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
PGF	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	1
PGF	[MASK] is a promising drug target for the treatment of retinal telangiectasis.	D058456	Retinal Telangiectasis	0
PGR	[MASK] is a promising drug target for the treatment of spontaneous abortion.	D000022	Abortion, Spontaneous	1
PGR	[MASK] is a promising drug target for the treatment of traumatic brain injuries.	D000070642	Brain Injuries, Traumatic	1
PGR	[MASK] is a promising drug target for the treatment of amenorrhea.	D000568	Amenorrhea	0
PGR	[MASK] is a promising drug target for the treatment of cachexia.	D002100	Cachexia	1
PGR	[MASK] is a promising drug target for the treatment of contraception.	D003267	Contraception	1
PGR	[MASK] is a promising drug target for the treatment of endometriosis.	D004715	Endometriosis	1
PGR	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	1
PGR	[MASK] is a promising drug target for the treatment of female infertility.	D007247	Infertility, Female	1
PGR	[MASK] is a promising drug target for the treatment of premature obstetric labor.	D007752	Obstetric Labor, Premature	1
PGR	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	1
PGR	[MASK] is a promising drug target for the treatment of menorrhagia.	D008595	Menorrhagia	1
PGR	[MASK] is a promising drug target for the treatment of menstruation disturbances.	D008599	Menstruation Disturbances	1
PGR	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	1
PGR	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
PGR	[MASK] is a promising drug target for the treatment of hormone replacement therapy.	D020249	Hormone Replacement Therapy	1
PGR	[MASK] is a promising drug target for the treatment of papillomavirus infections.	D030361	Papillomavirus Infections	1
PI4KA	[MASK] is a promising drug target for the treatment of malaria.	D008288	Malaria	0
PIK3CA	[MASK] is a promising drug target for the treatment of and epidermal nevi vascular malformations congenital lipomatous overgrowth.	C567863	Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi	1
PIK3CA	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
PIK3CA	[MASK] is a promising drug target for the treatment of arteriovenous malformations.	D001165	Arteriovenous Malformations	0
PIK3CA	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
PIK3CA	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
PIK3CA	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
PIK3CA	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
PIK3CA	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	0
PIK3CA	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
PIK3CA	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
PIK3CA	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
PIK3CA	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
PIK3CA	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PIK3CA	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
PIK3CA	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
PIK3CA	[MASK] is a promising drug target for the treatment of respiratory tract infections.	D012141	Respiratory Tract Infections	0
PIK3CA	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
PIK3CA	[MASK] is a promising drug target for the treatment of skin diseases.	D012871	Skin diseases	0
PIK3CA	[MASK] is a promising drug target for the treatment of skin neoplasms.	D012878	Skin Neoplasms	0
PIK3CA	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
PIK3CA	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
PIK3CA	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
PIK3CA	[MASK] is a promising drug target for the treatment of basal cell neoplasms.	D018295	Neoplasms, Basal Cell	0
PIK3CA	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
PIK3CA	[MASK] is a promising drug target for the treatment of lymphatic abnormalities.	D044148	Lymphatic Abnormalities	0
PIK3CA	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
PIK3CB	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
PIK3CB	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
PIK3CB	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
PIK3CB	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
PIK3CB	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
PIK3CB	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
PIK3CB	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
PIK3CB	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of t-cell lymphoma.	D016399	Lymphoma, T-Cell	0
PIK3CB	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
PIK3CB	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of activated pi3k-delta syndrome.	C585640	Activated PI3K-delta Syndrome	1
PIK3CD	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PIK3CD	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
PIK3CD	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
PIK3CD	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
PIK3CD	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
PIK3CD	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
PIK3CD	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
PIK3CD	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
PIK3CD	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of sjogren's syndrome.	D012859	Sjogren's Syndrome	0
PIK3CD	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	1
PIK3CD	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
PIK3CD	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
PIK3CD	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
PIK3CD	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
PIK3CG	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PIK3CG	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
PIK3CG	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
PIK3CG	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
PIK3CG	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	1
PIK3CG	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
PIK3CG	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
PIK3CG	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
PIK3CG	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	1
PIK3CG	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
PIK3CG	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
PIK3CG	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
PIK3CG	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
PKLR	[MASK] is a promising drug target for the treatment of pyruvate kinase deficiency of red cells.	C564858	Pyruvate Kinase Deficiency of Red Cells	1
PLA2G4A	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PLA2G4A	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
PLA2G4A	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
PLA2G4A	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
PLAT	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	1
PLAT	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	1
PLAT	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	1
PLAT	[MASK] is a promising drug target for the treatment of pulmonary embolism.	D011655	Pulmonary Embolism	1
PLAU	[MASK] is a promising drug target for the treatment of arthritis.	D001168	Arthritis	1
PLAU	[MASK] is a promising drug target for the treatment of blood coagulation disorders.	D001778	Blood Coagulation Disorders	1
PLAU	[MASK] is a promising drug target for the treatment of eczema.	D004485	Eczema	1
PLAU	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	1
PLAU	[MASK] is a promising drug target for the treatment of prurigo.	D011536	Prurigo	0
PLAU	[MASK] is a promising drug target for the treatment of pulmonary embolism.	D011655	Pulmonary Embolism	1
PLAU	[MASK] is a promising drug target for the treatment of thrombophlebitis.	D013924	Thrombophlebitis	1
PLAU	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	1
PLAU	[MASK] is a promising drug target for the treatment of venous insufficiency.	D014689	Venous Insufficiency	1
PLAU	[MASK] is a promising drug target for the treatment of venous thrombosis.	D020246	Venous Thrombosis	1
PLG	[MASK] is a promising drug target for the treatment of congenital plasminogen deficiency.	C580017	Congenital Plasminogen Deficiency	1
PLG	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
PLG	[MASK] is a promising drug target for the treatment of hemorrhage.	D006470	Hemorrhage	0
PLG	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	1
PLG	[MASK] is a promising drug target for the treatment of pulmonary embolism.	D011655	Pulmonary Embolism	1
PLG	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	1
PLG	[MASK] is a promising drug target for the treatment of venous thrombosis.	D020246	Venous Thrombosis	1
PLK1	[MASK] is a promising drug target for the treatment of adrenal gland neoplasms.	D000310	Adrenal Gland Neoplasms	0
PLK1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
PLK1	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
PLK1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
PLK1	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
PLK1	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
PLK1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
PLK1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
PLK1	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
PLK1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PLK1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
PLK1	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
PLK1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
PMEL	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	1
PNLIP	[MASK] is a promising drug target for the treatment of exocrine pancreatic insufficiency.	D010188	Exocrine Pancreatic Insufficiency	1
POLA1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
POLA1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
PON1	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type ii.	D006938	Hyperlipoproteinemia Type II	0
PPARA	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
PPARA	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
PPARA	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	1
PPARA	[MASK] is a promising drug target for the treatment of lipodystrophy.	D008060	Lipodystrophy	0
PPARA	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PPARA	[MASK] is a promising drug target for the treatment of hypertriglyceridemia.	D015228	Hypertriglyceridemia	1
PPARA	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
PPARA	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
PPARA	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	1
PPARD	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
PPARD	[MASK] is a promising drug target for the treatment of hyperlipoproteinemia type ii.	D006938	Hyperlipoproteinemia Type II	0
PPARD	[MASK] is a promising drug target for the treatment of hypertriglyceridemia.	D015228	Hypertriglyceridemia	0
PPARD	[MASK] is a promising drug target for the treatment of dyslipidemias.	D050171	Dyslipidemias	0
PPARD	[MASK] is a promising drug target for the treatment of acute kidney injury.	D058186	Acute Kidney Injury	0
PPARD	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
PPARG	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	0
PPARG	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
PPARG	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	1
PPARG	[MASK] is a promising drug target for the treatment of lipodystrophy.	D008060	Lipodystrophy	0
PPARG	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PPARG	[MASK] is a promising drug target for the treatment of hypertriglyceridemia.	D015228	Hypertriglyceridemia	1
PPARG	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
PPARG	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
PPARG	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
PPARG	[MASK] is a promising drug target for the treatment of hearing loss.	D034381	Hearing Loss	0
PPARG	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	1
PPIA	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
PPIA	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	1
PPIA	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
PPIA	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	1
PPIA	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	1
PPIB	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
PPIB	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
PPIB	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	0
PPP2CA	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
PPP2CA	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
PRAME	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
PRAME	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
PRAME	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
PRAME	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
PRCP	[MASK] is a promising drug target for the treatment of rhinitis.	D012220	Rhinitis	0
PRG2	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
PRG2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
PRKCA	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
PRKCA	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
PRKCA	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
PRKCA	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
PRKCA	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
PRKCA	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
PRKCA	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
PRKCB	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
PRKCB	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
PRKCB	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
PRKCB	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
PRKCB	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
PRKCD	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
PRKCD	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
PRKCD	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
PRKCD	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
PRKCD	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
PRKCD	[MASK] is a promising drug target for the treatment of diabetic foot.	D017719	Diabetic Foot	0
PRKCE	[MASK] is a promising drug target for the treatment of coronary artery bypass.	D001026	Coronary Artery Bypass	0
PRKCE	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
PRKCE	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
PRKCE	[MASK] is a promising drug target for the treatment of secondary hyperparathyroidism.	D006962	Hyperparathyroidism, Secondary	0
PRKCE	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
PRKCE	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
PRKCE	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
PRKCE	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
PRKCE	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
PRKCE	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
PRKCH	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
PRKCH	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
PRKCH	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
PRKCH	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
PRKCH	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
PRKCQ	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
PRKCQ	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
PRKCQ	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
PRKCQ	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
PRKCQ	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
PRKDC	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
PRKDC	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
PRKDC	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
PRKDC	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PRKDC	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
PRKDC	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
PRLR	[MASK] is a promising drug target for the treatment of hyperprolactinemia.	D006966	Hyperprolactinemia	0
PRMT5	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
PRMT5	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
PROC	[MASK] is a promising drug target for the treatment of burns.	D002056	Burns	0
PROC	[MASK] is a promising drug target for the treatment of ulcer.	D014456	Ulcer	0
PROC	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	0
PSCA	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
PTGDR	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
PTGDR	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
PTGDR	[MASK] is a promising drug target for the treatment of perennial allergic rhinitis.	D012221	Rhinitis, Allergic, Perennial	0
PTGDR2	[MASK] is a promising drug target for the treatment of alopecia.	D000505	Alopecia	0
PTGDR2	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
PTGDR2	[MASK] is a promising drug target for the treatment of allergic conjunctivitis.	D003233	Conjunctivitis, Allergic	0
PTGDR2	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
PTGDR2	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
PTGDR2	[MASK] is a promising drug target for the treatment of nasal polyps.	D009298	Nasal Polyps	0
PTGDR2	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
PTGDR2	[MASK] is a promising drug target for the treatment of eosinophilic esophagitis.	D057765	Eosinophilic Esophagitis	0
PTGDS	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
PTGER1	[MASK] is a promising drug target for the treatment of gastroesophageal reflux.	D005764	Gastroesophageal Reflux	0
PTGER1	[MASK] is a promising drug target for the treatment of induced labor.	D007751	Labor, Induced	1
PTGER1	[MASK] is a promising drug target for the treatment of spinal stenosis.	D013130	Spinal Stenosis	1
PTGER1	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
PTGER1	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
PTGER2	[MASK] is a promising drug target for the treatment of arthritis.	D001168	Arthritis	1
PTGER2	[MASK] is a promising drug target for the treatment of eczema.	D004485	Eczema	1
PTGER2	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
PTGER2	[MASK] is a promising drug target for the treatment of prurigo.	D011536	Prurigo	0
PTGER2	[MASK] is a promising drug target for the treatment of thrombophlebitis.	D013924	Thrombophlebitis	1
PTGER2	[MASK] is a promising drug target for the treatment of venous insufficiency.	D014689	Venous Insufficiency	1
PTGER3	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
PTGER3	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
PTGER3	[MASK] is a promising drug target for the treatment of induced labor.	D007751	Labor, Induced	1
PTGER3	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
PTGER4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
PTGER4	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
PTGER4	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
PTGES	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
PTGES	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
PTGES	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	0
PTGES	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
PTGES	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
PTGFR	[MASK] is a promising drug target for the treatment of eye diseases.	D005128	Eye Diseases	1
PTGFR	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
PTGIR	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	0
PTGIR	[MASK] is a promising drug target for the treatment of endocrine system diseases.	D004700	Endocrine System Diseases	0
PTGIR	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	1
PTGIR	[MASK] is a promising drug target for the treatment of ischemia.	D007511	Ischemia	0
PTGIR	[MASK] is a promising drug target for the treatment of liver diseases.	D008107	Liver Diseases	0
PTGIR	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PTGIR	[MASK] is a promising drug target for the treatment of nervous system diseases.	D009422	Nervous System Diseases	0
PTGIR	[MASK] is a promising drug target for the treatment of peptic ulcer.	D010437	Peptic Ulcer	0
PTGIR	[MASK] is a promising drug target for the treatment of raynaud disease.	D011928	Raynaud Disease	0
PTGIR	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
PTGIR	[MASK] is a promising drug target for the treatment of spinal stenosis.	D013130	Spinal Stenosis	0
PTGIR	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	0
PTGIR	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
PTGIR	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
PTGIR	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
PTGIR	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
PTGS1	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	1
PTGS1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PTGS1	[MASK] is a promising drug target for the treatment of bursitis.	D002062	Bursitis	0
PTGS1	[MASK] is a promising drug target for the treatment of cataract.	D002386	Cataract	1
PTGS1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
PTGS1	[MASK] is a promising drug target for the treatment of contraception.	D003267	Contraception	0
PTGS1	[MASK] is a promising drug target for the treatment of patent ductus arteriosus.	D004374	Ductus Arteriosus, Patent	0
PTGS1	[MASK] is a promising drug target for the treatment of dysmenorrhea.	D004412	Dysmenorrhea	0
PTGS1	[MASK] is a promising drug target for the treatment of eye diseases.	D005128	Eye Diseases	1
PTGS1	[MASK] is a promising drug target for the treatment of fever.	D005334	Fever	1
PTGS1	[MASK] is a promising drug target for the treatment of fibromyalgia.	D005356	Fibromyalgia	0
PTGS1	[MASK] is a promising drug target for the treatment of gout.	D006073	Gout	0
PTGS1	[MASK] is a promising drug target for the treatment of headache.	D006261	Headache	0
PTGS1	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	1
PTGS1	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	1
PTGS1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
PTGS1	[MASK] is a promising drug target for the treatment of myositis.	D009220	Myositis	0
PTGS1	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	1
PTGS1	[MASK] is a promising drug target for the treatment of tennis elbow.	D013716	Tennis Elbow	1
PTGS1	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
PTGS1	[MASK] is a promising drug target for the treatment of duchenne muscular dystrophy.	D020388	Muscular Dystrophy, Duchenne	0
PTGS1	[MASK] is a promising drug target for the treatment of tendinopathy.	D052256	Tendinopathy	0
PTGS1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
PTGS1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	1
PTGS2	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	1
PTGS2	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
PTGS2	[MASK] is a promising drug target for the treatment of bursitis.	D002062	Bursitis	0
PTGS2	[MASK] is a promising drug target for the treatment of cataract.	D002386	Cataract	1
PTGS2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
PTGS2	[MASK] is a promising drug target for the treatment of patent ductus arteriosus.	D004374	Ductus Arteriosus, Patent	0
PTGS2	[MASK] is a promising drug target for the treatment of dysmenorrhea.	D004412	Dysmenorrhea	0
PTGS2	[MASK] is a promising drug target for the treatment of eye diseases.	D005128	Eye Diseases	1
PTGS2	[MASK] is a promising drug target for the treatment of fever.	D005334	Fever	1
PTGS2	[MASK] is a promising drug target for the treatment of fibromyalgia.	D005356	Fibromyalgia	0
PTGS2	[MASK] is a promising drug target for the treatment of gout.	D006073	Gout	0
PTGS2	[MASK] is a promising drug target for the treatment of headache.	D006261	Headache	0
PTGS2	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	1
PTGS2	[MASK] is a promising drug target for the treatment of joint diseases.	D007592	Joint Diseases	0
PTGS2	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	1
PTGS2	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
PTGS2	[MASK] is a promising drug target for the treatment of myositis.	D009220	Myositis	0
PTGS2	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	1
PTGS2	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	1
PTGS2	[MASK] is a promising drug target for the treatment of tennis elbow.	D013716	Tennis Elbow	1
PTGS2	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
PTGS2	[MASK] is a promising drug target for the treatment of duchenne muscular dystrophy.	D020388	Muscular Dystrophy, Duchenne	0
PTGS2	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
PTGS2	[MASK] is a promising drug target for the treatment of tendinopathy.	D052256	Tendinopathy	0
PTGS2	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
PTGS2	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	1
PTH1R	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	1
PTMA	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
PTP4A3	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
PTPN1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
PYGL	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
RAD51	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
RAD51	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
RAF1	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
RAF1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
RAF1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
RAF1	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
RAF1	[MASK] is a promising drug target for the treatment of nasopharyngeal neoplasms.	D009303	Nasopharyngeal Neoplasms	0
RAF1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
RAF1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
RAF1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
RAF1	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	1
RAMP1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
RARA	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	1
RARA	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
RARA	[MASK] is a promising drug target for the treatment of neutropenia.	D009503	Neutropenia	0
RARA	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
RARB	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	1
RARB	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	1
RARB	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
RARG	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	1
RARG	[MASK] is a promising drug target for the treatment of ichthyosis.	D007057	Ichthyosis	0
RARG	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
REG3A	[MASK] is a promising drug target for the treatment of alcoholic hepatitis.	D006519	Hepatitis, Alcoholic	0
REG3A	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
REG3A	[MASK] is a promising drug target for the treatment of liver diseases.	D008107	Liver Diseases	0
REG3A	[MASK] is a promising drug target for the treatment of nervous system diseases.	D009422	Nervous System Diseases	0
REG3A	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	0
REN	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
REN	[MASK] is a promising drug target for the treatment of proteinuria.	D011507	Proteinuria	0
RET	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
RET	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
RET	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
RET	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
RET	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
RET	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
RET	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
RET	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
RET	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
RET	[MASK] is a promising drug target for the treatment of polycythemia vera.	D011087	Polycythemia Vera	1
RET	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	0
RET	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
RET	[MASK] is a promising drug target for the treatment of thrombocytosis.	D013922	Thrombocytosis	1
RET	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
RET	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
RET	[MASK] is a promising drug target for the treatment of anaplastic large-cell lymphoma.	D017728	Lymphoma, Large-Cell, Anaplastic	1
RET	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
RET	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	1
RET	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	1
RET	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
RET	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
RGMA	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
RGMA	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
RHD	[MASK] is a promising drug target for the treatment of fetal erythroblastosis.	D004899	Erythroblastosis, Fetal	1
RIGI	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
RIGI	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
RIGI	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
RIPK1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
RIPK1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
RIPK1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
ROCK1	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
ROCK1	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
ROCK1	[MASK] is a promising drug target for the treatment of erectile dysfunction.	D007172	Erectile Dysfunction	0
ROCK1	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
ROCK1	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	0
ROCK1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
ROCK1	[MASK] is a promising drug target for the treatment of retinitis pigmentosa.	D012174	Retinitis Pigmentosa	0
ROCK2	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
ROCK2	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
ROCK2	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	1
ROCK2	[MASK] is a promising drug target for the treatment of erectile dysfunction.	D007172	Erectile Dysfunction	0
ROCK2	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
ROCK2	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
ROCK2	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
ROCK2	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
RORC	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
RORC	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
ROS1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
ROS1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
ROS1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
ROS1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
ROS1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
ROS1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
ROS1	[MASK] is a promising drug target for the treatment of anaplastic large-cell lymphoma.	D017728	Lymphoma, Large-Cell, Anaplastic	1
ROS1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
RPE65	[MASK] is a promising drug target for the treatment of retinitis pigmentosa.	D012174	Retinitis Pigmentosa	1
RPE65	[MASK] is a promising drug target for the treatment of geographic atrophy.	D057092	Geographic Atrophy	0
RPE65	[MASK] is a promising drug target for the treatment of leber congenital amaurosis.	D057130	Leber Congenital Amaurosis	1
RPGR	[MASK] is a promising drug target for the treatment of retinitis pigmentosa.	D012174	Retinitis Pigmentosa	0
RPS6KB1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
RPS6KB1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
RPS6KB1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
RPS6KB1	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
RPS6KB1	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
RPS6KB1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
RPS6KB1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
RPS6KB1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
RPS6KB1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
RPS6KB1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
RPS6KB1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
RPS6KB1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
RPS6KB1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
RPS6KB1	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
RPS6KB1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
RRM1	[MASK] is a promising drug target for the treatment of sickle cell anemia.	D000755	Anemia, Sickle Cell	0
RRM1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
RRM1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
RRM1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
RRM2	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
RS1	[MASK] is a promising drug target for the treatment of retinoschisis.	D041441	Retinoschisis	0
RTN4	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
RTN4	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
RTN4	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	0
RTN4	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
RXFP1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
RXFP1	[MASK] is a promising drug target for the treatment of portal hypertension.	D006975	Hypertension, Portal	0
RXFP1	[MASK] is a promising drug target for the treatment of induced labor.	D007751	Labor, Induced	0
RXFP1	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	0
RXFP1	[MASK] is a promising drug target for the treatment of pre-eclampsia.	D011225	Pre-Eclampsia	0
RXFP1	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
RYR2	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
RYR2	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
RYR2	[MASK] is a promising drug target for the treatment of ventricular tachycardia.	D017180	Tachycardia, Ventricular	0
S1PR1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
S1PR1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
S1PR1	[MASK] is a promising drug target for the treatment of dermatomyositis.	D003882	Dermatomyositis	0
S1PR1	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
S1PR1	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
S1PR1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
S1PR1	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
S1PR1	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
S1PR1	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
S1PR1	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
S1PR1	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	0
S1PR1	[MASK] is a promising drug target for the treatment of polymyositis.	D017285	Polymyositis	0
S1PR1	[MASK] is a promising drug target for the treatment of pyoderma gangrenosum.	D017511	Pyoderma Gangrenosum	0
S1PR1	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	1
S1PR1	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	1
S1PR1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
S1PR2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
S1PR2	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
S1PR2	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
S1PR2	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
S1PR2	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
S1PR3	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
S1PR3	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
S1PR3	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
S1PR3	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
S1PR3	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
S1PR4	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
S1PR4	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
S1PR4	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
S1PR4	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
S1PR4	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
S1PR4	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	0
S1PR4	[MASK] is a promising drug target for the treatment of pyoderma gangrenosum.	D017511	Pyoderma Gangrenosum	0
S1PR5	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
S1PR5	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
S1PR5	[MASK] is a promising drug target for the treatment of dermatomyositis.	D003882	Dermatomyositis	0
S1PR5	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
S1PR5	[MASK] is a promising drug target for the treatment of biliary liver cirrhosis.	D008105	Liver Cirrhosis, Biliary	0
S1PR5	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
S1PR5	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
S1PR5	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
S1PR5	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
S1PR5	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	0
S1PR5	[MASK] is a promising drug target for the treatment of polymyositis.	D017285	Polymyositis	0
S1PR5	[MASK] is a promising drug target for the treatment of pyoderma gangrenosum.	D017511	Pyoderma Gangrenosum	0
S1PR5	[MASK] is a promising drug target for the treatment of chronic progressive multiple sclerosis.	D020528	Multiple Sclerosis, Chronic Progressive	1
S1PR5	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	1
SCD	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
SCD	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
SCD	[MASK] is a promising drug target for the treatment of seborrheic dermatitis.	D012628	Dermatitis, Seborrheic	0
SCD	[MASK] is a promising drug target for the treatment of gallstones.	D042882	Gallstones	0
SCN10A	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
SCN1A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
SCN1A	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
SCN1A	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	1
SCN1A	[MASK] is a promising drug target for the treatment of tonic-clonic epilepsy.	D004830	Epilepsy, Tonic-Clonic	1
SCN1A	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
SCN1A	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
SCN2A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
SCN2A	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
SCN2A	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	1
SCN2A	[MASK] is a promising drug target for the treatment of tonic-clonic epilepsy.	D004830	Epilepsy, Tonic-Clonic	1
SCN2A	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
SCN2A	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
SCN3A	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
SCN3A	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
SCN3A	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	1
SCN3A	[MASK] is a promising drug target for the treatment of tonic-clonic epilepsy.	D004830	Epilepsy, Tonic-Clonic	1
SCN3A	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
SCN3A	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
SCN5A	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
SCN5A	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	1
SCN5A	[MASK] is a promising drug target for the treatment of anesthesia.	D000758	Anesthesia	1
SCN5A	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
SCN5A	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
SCN5A	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	1
SCN5A	[MASK] is a promising drug target for the treatment of generalized epilepsy.	D004829	Epilepsy, Generalized	1
SCN5A	[MASK] is a promising drug target for the treatment of tonic-clonic epilepsy.	D004830	Epilepsy, Tonic-Clonic	1
SCN5A	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	1
SCN5A	[MASK] is a promising drug target for the treatment of myotonia.	D009222	Myotonia	1
SCN5A	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
SCN5A	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
SCN9A	[MASK] is a promising drug target for the treatment of anesthesia.	D000758	Anesthesia	1
SCN9A	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
SCN9A	[MASK] is a promising drug target for the treatment of dysmenorrhea.	D004412	Dysmenorrhea	0
SCN9A	[MASK] is a promising drug target for the treatment of endometriosis.	D004715	Endometriosis	0
SCN9A	[MASK] is a promising drug target for the treatment of erythromelalgia.	D004916	Erythromelalgia	0
SCN9A	[MASK] is a promising drug target for the treatment of female infertility.	D007247	Infertility, Female	0
SCN9A	[MASK] is a promising drug target for the treatment of intervertebral disc displacement.	D007405	Intervertebral Disc Displacement	0
SCN9A	[MASK] is a promising drug target for the treatment of nervous system diseases.	D009422	Nervous System Diseases	0
SCN9A	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	1
SCN9A	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
SCN9A	[MASK] is a promising drug target for the treatment of otitis media.	D010033	Otitis Media	0
SCN9A	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	1
SCN9A	[MASK] is a promising drug target for the treatment of aphthous stomatitis.	D013281	Stomatitis, Aphthous	1
SCN9A	[MASK] is a promising drug target for the treatment of trigeminal neuralgia.	D014277	Trigeminal Neuralgia	0
SCN9A	[MASK] is a promising drug target for the treatment of urethritis.	D014526	Urethritis	0
SCN9A	[MASK] is a promising drug target for the treatment of papillomavirus infections.	D030361	Papillomavirus Infections	1
SCN9A	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	1
SCN9A	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
SCNN1A	[MASK] is a promising drug target for the treatment of bronchiectasis.	D001987	Bronchiectasis	0
SCNN1A	[MASK] is a promising drug target for the treatment of edema.	D004487	Edema	1
SCNN1A	[MASK] is a promising drug target for the treatment of cardiac edema.	D004489	Edema, Cardiac	1
SCNN1A	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
SCNN1A	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
SCNN1A	[MASK] is a promising drug target for the treatment of sjogren's syndrome.	D012859	Sjogren's Syndrome	0
SCNN1A	[MASK] is a promising drug target for the treatment of xerostomia.	D014987	Xerostomia	0
SCNN1A	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
SCNN1A	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
SDC1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
SDC1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
SELE	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
SELP	[MASK] is a promising drug target for the treatment of sickle cell anemia.	D000755	Anemia, Sickle Cell	1
SELP	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
SELP	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
SELP	[MASK] is a promising drug target for the treatment of venous thrombosis.	D020246	Venous Thrombosis	0
SELP	[MASK] is a promising drug target for the treatment of delayed graft function.	D051799	Delayed Graft Function	0
SELP	[MASK] is a promising drug target for the treatment of acute coronary syndrome.	D054058	Acute Coronary Syndrome	0
SELPLG	[MASK] is a promising drug target for the treatment of venous thrombosis.	D020246	Venous Thrombosis	0
SERPINA1	[MASK] is a promising drug target for the treatment of anthrax.	D000881	Anthrax	0
SERPINA1	[MASK] is a promising drug target for the treatment of bronchiectasis.	D001987	Bronchiectasis	0
SERPINA1	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
SERPINA1	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	0
SERPINA1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
SERPINA1	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
SERPINA1	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
SERPINA1	[MASK] is a promising drug target for the treatment of human influenza.	D007251	Influenza, Human	0
SERPINA1	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
SERPINA1	[MASK] is a promising drug target for the treatment of tuberculosis.	D014376	Tuberculosis	0
SERPINA1	[MASK] is a promising drug target for the treatment of hiv infections.	D015658	HIV Infections	0
SERPINA1	[MASK] is a promising drug target for the treatment of alpha 1-antitrypsin deficiency.	D019896	alpha 1-Antitrypsin Deficiency	1
SERPINC1	[MASK] is a promising drug target for the treatment of unstable angina.	D000789	Angina, Unstable	1
SERPINC1	[MASK] is a promising drug target for the treatment of blood coagulation disorders.	D001778	Blood Coagulation Disorders	0
SERPINC1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
SERPINC1	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	1
SERPINC1	[MASK] is a promising drug target for the treatment of pulmonary embolism.	D011655	Pulmonary Embolism	1
SERPINC1	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
SERPINC1	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	1
SERPINC1	[MASK] is a promising drug target for the treatment of venous insufficiency.	D014689	Venous Insufficiency	1
SERPINC1	[MASK] is a promising drug target for the treatment of antithrombin iii deficiency.	D020152	Antithrombin III Deficiency	1
SERPINC1	[MASK] is a promising drug target for the treatment of venous thrombosis.	D020246	Venous Thrombosis	1
SERPINC1	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
SERPINE1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
SERPINE1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
SERPINE1	[MASK] is a promising drug target for the treatment of diabetes mellitus.	D003920	Diabetes Mellitus	0
SERPINE1	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
SERPINE1	[MASK] is a promising drug target for the treatment of diabetes complications.	D048909	Diabetes Complications	0
SGMS1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
SGMS1	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
SGMS1	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
SGPL1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
SGPL1	[MASK] is a promising drug target for the treatment of darier disease.	D007644	Darier Disease	0
SGPL1	[MASK] is a promising drug target for the treatment of pemphigus.	D010392	Pemphigus	0
SIGLEC8	[MASK] is a promising drug target for the treatment of hypersensitivity.	D006967	Hypersensitivity	0
SIGLEC8	[MASK] is a promising drug target for the treatment of nasal polyps.	D009298	Nasal Polyps	0
SIGMAR1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
SIK2	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
SIK2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
SIK2	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
SIK2	[MASK] is a promising drug target for the treatment of sjogren's syndrome.	D012859	Sjogren's Syndrome	0
SIK3	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
SIK3	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
SIK3	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
SIK3	[MASK] is a promising drug target for the treatment of sjogren's syndrome.	D012859	Sjogren's Syndrome	0
SIRPA	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
SIRPA	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
SIRT1	[MASK] is a promising drug target for the treatment of atrial fibrillation.	D001281	Atrial Fibrillation	0
SIRT1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
SIRT1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
SIRT1	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
SIRT1	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
SIRT1	[MASK] is a promising drug target for the treatment of muscular atrophy.	D009133	Muscular Atrophy	0
SIRT1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
SIRT1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
SIRT1	[MASK] is a promising drug target for the treatment of metabolic syndrome.	D024821	Metabolic Syndrome	0
SIRT1	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
SIRT1	[MASK] is a promising drug target for the treatment of sarcopenia.	D055948	Sarcopenia	0
SIRT1	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
SLAMF7	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
SLC10A1	[MASK] is a promising drug target for the treatment of hepatitis d.	D003699	Hepatitis D	1
SLC10A2	[MASK] is a promising drug target for the treatment of progressive familial intrahepatic 1 cholestasis.	C535933	Cholestasis, progressive familial intrahepatic 1	1
SLC10A2	[MASK] is a promising drug target for the treatment of constipation.	D003248	Constipation	1
SLC10A2	[MASK] is a promising drug target for the treatment of hypercholesterolemia.	D006937	Hypercholesterolemia	0
SLC10A2	[MASK] is a promising drug target for the treatment of hyperlipidemias.	D006949	Hyperlipidemias	0
SLC10A2	[MASK] is a promising drug target for the treatment of alagille syndrome.	D016738	Alagille Syndrome	1
SLC10A2	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
SLC12A1	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
SLC12A1	[MASK] is a promising drug target for the treatment of cardiac edema.	D004489	Edema, Cardiac	0
SLC12A1	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	0
SLC12A1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
SLC12A1	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
SLC12A1	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	1
SLC12A1	[MASK] is a promising drug target for the treatment of papillomavirus infections.	D030361	Papillomavirus Infections	0
SLC12A2	[MASK] is a promising drug target for the treatment of autistic disorder.	D001321	Autistic Disorder	0
SLC12A2	[MASK] is a promising drug target for the treatment of cardiac edema.	D004489	Edema, Cardiac	0
SLC12A2	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	0
SLC12A2	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
SLC12A2	[MASK] is a promising drug target for the treatment of hypertension.	D006973	Hypertension	1
SLC12A2	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	1
SLC12A2	[MASK] is a promising drug target for the treatment of papillomavirus infections.	D030361	Papillomavirus Infections	0
SLC18A2	[MASK] is a promising drug target for the treatment of tardive dyskinesia.	D000071057	Tardive Dyskinesia	1
SLC18A2	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	1
SLC18A2	[MASK] is a promising drug target for the treatment of cognition disorders.	D003072	Cognition Disorders	0
SLC18A2	[MASK] is a promising drug target for the treatment of endocrine diagnostic techniques.	D003940	Diagnostic Techniques, Endocrine	0
SLC18A2	[MASK] is a promising drug target for the treatment of neurological diagnostic techniques.	D003943	Diagnostic Techniques, Neurological	0
SLC18A2	[MASK] is a promising drug target for the treatment of tourette syndrome.	D005879	Tourette Syndrome	0
SLC18A2	[MASK] is a promising drug target for the treatment of huntington disease.	D006816	Huntington Disease	1
SLC18A2	[MASK] is a promising drug target for the treatment of dyskinesias.	D020820	Dyskinesias	1
SLC18A2	[MASK] is a promising drug target for the treatment of binge-eating disorder.	D056912	Binge-Eating Disorder	0
SLC19A1	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	1
SLC1A5	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	1
SLC22A12	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	0
SLC22A12	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
SLC22A12	[MASK] is a promising drug target for the treatment of gout.	D006073	Gout	1
SLC22A12	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
SLC22A12	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	1
SLC22A12	[MASK] is a promising drug target for the treatment of joint diseases.	D007592	Joint Diseases	0
SLC22A12	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
SLC22A12	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
SLC22A12	[MASK] is a promising drug target for the treatment of proteinuria.	D011507	Proteinuria	0
SLC34A2	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
SLC34A2	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
SLC40A1	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	0
SLC40A1	[MASK] is a promising drug target for the treatment of hemochromatosis.	D006432	Hemochromatosis	0
SLC5A1	[MASK] is a promising drug target for the treatment of constipation.	D003248	Constipation	0
SLC5A1	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	1
SLC5A1	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
SLC5A1	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
SLC5A1	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
SLC5A1	[MASK] is a promising drug target for the treatment of renal insufficiency.	D051437	Renal Insufficiency	0
SLC5A2	[MASK] is a promising drug target for the treatment of type 1 diabetes mellitus.	D003922	Diabetes Mellitus, Type 1	1
SLC5A2	[MASK] is a promising drug target for the treatment of type 2 diabetes mellitus.	D003924	Diabetes Mellitus, Type 2	1
SLC5A2	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	1
SLC5A2	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	1
SLC5A2	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	0
SLC5A2	[MASK] is a promising drug target for the treatment of renal insufficiency.	D051437	Renal Insufficiency	0
SLC6A2	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	1
SLC6A2	[MASK] is a promising drug target for the treatment of social phobia.	D000072861	Phobia, Social	1
SLC6A2	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	1
SLC6A2	[MASK] is a promising drug target for the treatment of apnea.	D001049	Apnea	1
SLC6A2	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	1
SLC6A2	[MASK] is a promising drug target for the treatment of depression.	D003863	Depression	1
SLC6A2	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	1
SLC6A2	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
SLC6A2	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
SLC6A2	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
SLC6A2	[MASK] is a promising drug target for the treatment of glaucoma.	D005901	Glaucoma	1
SLC6A2	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
SLC6A2	[MASK] is a promising drug target for the treatment of narcolepsy.	D009290	Narcolepsy	1
SLC6A2	[MASK] is a promising drug target for the treatment of nervous system diseases.	D009422	Nervous System Diseases	0
SLC6A2	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	1
SLC6A2	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	1
SLC6A2	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	1
SLC6A2	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	0
SLC6A2	[MASK] is a promising drug target for the treatment of urticaria.	D014581	Urticaria	0
SLC6A2	[MASK] is a promising drug target for the treatment of rett syndrome.	D015518	Rett Syndrome	0
SLC6A2	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
SLC6A2	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
SLC6A2	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
SLC6A2	[MASK] is a promising drug target for the treatment of premature ejaculation.	D061686	Premature Ejaculation	0
SLC6A2	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
SLC6A3	[MASK] is a promising drug target for the treatment of apnea.	D001049	Apnea	1
SLC6A3	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	1
SLC6A3	[MASK] is a promising drug target for the treatment of depression.	D003863	Depression	1
SLC6A3	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	1
SLC6A3	[MASK] is a promising drug target for the treatment of narcolepsy.	D009290	Narcolepsy	1
SLC6A3	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	1
SLC6A3	[MASK] is a promising drug target for the treatment of cocaine-related disorders.	D019970	Cocaine-Related Disorders	1
SLC6A4	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	1
SLC6A4	[MASK] is a promising drug target for the treatment of social phobia.	D000072861	Phobia, Social	1
SLC6A4	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
SLC6A4	[MASK] is a promising drug target for the treatment of amblyopia.	D000550	Amblyopia	0
SLC6A4	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	1
SLC6A4	[MASK] is a promising drug target for the treatment of attention deficit disorder with hyperactivity.	D001289	Attention Deficit Disorder with Hyperactivity	0
SLC6A4	[MASK] is a promising drug target for the treatment of bipolar disorder.	D001714	Bipolar Disorder	1
SLC6A4	[MASK] is a promising drug target for the treatment of bulimia.	D002032	Bulimia	1
SLC6A4	[MASK] is a promising drug target for the treatment of depression.	D003863	Depression	1
SLC6A4	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	1
SLC6A4	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
SLC6A4	[MASK] is a promising drug target for the treatment of contact dermatitis.	D003877	Dermatitis, Contact	0
SLC6A4	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
SLC6A4	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	1
SLC6A4	[MASK] is a promising drug target for the treatment of fibromyalgia.	D005356	Fibromyalgia	0
SLC6A4	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	1
SLC6A4	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
SLC6A4	[MASK] is a promising drug target for the treatment of obesity.	D009765	Obesity	1
SLC6A4	[MASK] is a promising drug target for the treatment of obsessive-compulsive disorder.	D009771	Obsessive-Compulsive Disorder	1
SLC6A4	[MASK] is a promising drug target for the treatment of postoperative pain.	D010149	Pain, Postoperative	1
SLC6A4	[MASK] is a promising drug target for the treatment of respiratory insufficiency.	D012131	Respiratory Insufficiency	0
SLC6A4	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	1
SLC6A4	[MASK] is a promising drug target for the treatment of urticaria.	D014581	Urticaria	0
SLC6A4	[MASK] is a promising drug target for the treatment of panic disorder.	D016584	Panic Disorder	1
SLC6A4	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
SLC6A4	[MASK] is a promising drug target for the treatment of bulimia nervosa.	D052018	Bulimia Nervosa	1
SLC6A4	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	1
SLC6A4	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
SLC6A4	[MASK] is a promising drug target for the treatment of premature ejaculation.	D061686	Premature Ejaculation	0
SLC6A4	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
SLC6A4	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	1
SLC6A9	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
SLC6A9	[MASK] is a promising drug target for the treatment of obsessive-compulsive disorder.	D009771	Obsessive-Compulsive Disorder	0
SLC6A9	[MASK] is a promising drug target for the treatment of thalassemia.	D013789	Thalassemia	0
SLC7A11	[MASK] is a promising drug target for the treatment of alzheimer disease.	D000544	Alzheimer Disease	0
SLC7A11	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	1
SLC7A11	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
SLC7A11	[MASK] is a promising drug target for the treatment of tobacco use disorder.	D014029	Tobacco Use Disorder	0
SLC7A11	[MASK] is a promising drug target for the treatment of trichotillomania.	D014256	Trichotillomania	0
SLC7A5	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	1
SLC9A1	[MASK] is a promising drug target for the treatment of myocardial infarction.	D009203	Myocardial Infarction	0
SLC9A3	[MASK] is a promising drug target for the treatment of apnea.	D001049	Apnea	0
SLC9A3	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
SLC9A3	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	1
SMAD7	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
SMAD7	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
SMN1	[MASK] is a promising drug target for the treatment of spinal muscular atrophy.	D009134	Muscular Atrophy, Spinal	1
SMN2	[MASK] is a promising drug target for the treatment of spinal muscular atrophy.	D009134	Muscular Atrophy, Spinal	1
SMO	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
SMO	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
SMO	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
SMO	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
SMO	[MASK] is a promising drug target for the treatment of neuroblastoma.	D009447	Neuroblastoma	0
SMO	[MASK] is a promising drug target for the treatment of rhabdomyosarcoma.	D012208	Rhabdomyosarcoma	0
SMO	[MASK] is a promising drug target for the treatment of osteosarcoma.	D012516	Osteosarcoma	0
SMO	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
SMO	[MASK] is a promising drug target for the treatment of basal cell neoplasms.	D018295	Neoplasms, Basal Cell	1
SMO	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
SMO	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	0
SMO	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
SNCA	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
SNCA	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
SOAT1	[MASK] is a promising drug target for the treatment of familial hypoadrenocorticism.	D000075262	Hypoadrenocorticism, Familial	0
SOAT1	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
SOAT1	[MASK] is a promising drug target for the treatment of seborrheic dermatitis.	D012628	Dermatitis, Seborrheic	0
SOAT1	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	0
SOAT1	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
SOST	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	0
SOST	[MASK] is a promising drug target for the treatment of metabolic bone diseases.	D001851	Bone Diseases, Metabolic	0
SOST	[MASK] is a promising drug target for the treatment of hypophosphatasia.	D007014	Hypophosphatasia	0
SPHK2	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
SPHK2	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
SPINK1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
SPINT2	[MASK] is a promising drug target for the treatment of cystic fibrosis.	D003550	Cystic Fibrosis	0
SPINT2	[MASK] is a promising drug target for the treatment of chronic obstructive pulmonary disease.	D029424	Pulmonary Disease, Chronic Obstructive	0
SRC	[MASK] is a promising drug target for the treatment of bone neoplasms.	D001859	Bone Neoplasms	0
SRC	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
SRC	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
SRC	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
SRC	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
SRC	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
SRC	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
SRC	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
SRC	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
SRC	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
SRC	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
SRC	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
SRC	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
SRC	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
SRC	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
SRC	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
SRC	[MASK] is a promising drug target for the treatment of actinic keratosis.	D055623	Keratosis, Actinic	1
SRD5A2	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
SRD5A2	[MASK] is a promising drug target for the treatment of alopecia.	D000505	Alopecia	1
SSTR1	[MASK] is a promising drug target for the treatment of acromegaly.	D000172	Acromegaly	1
SSTR1	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
SSTR1	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	0
SSTR1	[MASK] is a promising drug target for the treatment of malignant carcinoid syndrome.	D008303	Malignant Carcinoid Syndrome	0
SSTR1	[MASK] is a promising drug target for the treatment of pituitary neoplasms.	D010911	Pituitary Neoplasms	0
SSTR1	[MASK] is a promising drug target for the treatment of thymus neoplasms.	D013953	Thymus Neoplasms	0
SSTR1	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
SSTR1	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	1
SSTR1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
SSTR2	[MASK] is a promising drug target for the treatment of acromegaly.	D000172	Acromegaly	1
SSTR2	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
SSTR2	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
SSTR2	[MASK] is a promising drug target for the treatment of malignant carcinoid syndrome.	D008303	Malignant Carcinoid Syndrome	0
SSTR2	[MASK] is a promising drug target for the treatment of pituitary neoplasms.	D010911	Pituitary Neoplasms	0
SSTR2	[MASK] is a promising drug target for the treatment of thymus neoplasms.	D013953	Thymus Neoplasms	0
SSTR2	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	1
SSTR3	[MASK] is a promising drug target for the treatment of acromegaly.	D000172	Acromegaly	1
SSTR3	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
SSTR3	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	0
SSTR3	[MASK] is a promising drug target for the treatment of malignant carcinoid syndrome.	D008303	Malignant Carcinoid Syndrome	0
SSTR3	[MASK] is a promising drug target for the treatment of pituitary neoplasms.	D010911	Pituitary Neoplasms	0
SSTR3	[MASK] is a promising drug target for the treatment of thymus neoplasms.	D013953	Thymus Neoplasms	0
SSTR3	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
SSTR3	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	1
SSTR3	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
SSTR4	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
SSTR4	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
SSTR5	[MASK] is a promising drug target for the treatment of acromegaly.	D000172	Acromegaly	1
SSTR5	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
SSTR5	[MASK] is a promising drug target for the treatment of diagnosis.	D003933	Diagnosis	0
SSTR5	[MASK] is a promising drug target for the treatment of malignant carcinoid syndrome.	D008303	Malignant Carcinoid Syndrome	0
SSTR5	[MASK] is a promising drug target for the treatment of pituitary neoplasms.	D010911	Pituitary Neoplasms	0
SSTR5	[MASK] is a promising drug target for the treatment of thymus neoplasms.	D013953	Thymus Neoplasms	0
SSTR5	[MASK] is a promising drug target for the treatment of neuroendocrine tumors.	D018358	Neuroendocrine Tumors	0
SSTR5	[MASK] is a promising drug target for the treatment of pituitary acth hypersecretion.	D047748	Pituitary ACTH Hypersecretion	1
SSTR5	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
STAB1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
STAB1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
STAT3	[MASK] is a promising drug target for the treatment of anus neoplasms.	D001005	Anus Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
STAT3	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
STAT3	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
STAT3	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
STAT3	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
STAT3	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
STAT3	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
STAT3	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
STAT3	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
STAT3	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
STAT3	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
STAT3	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of subarachnoid hemorrhage.	D013345	Subarachnoid Hemorrhage	0
STAT3	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
STAT3	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
STAT3	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
STEAP1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
SV2A	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	1
SV2A	[MASK] is a promising drug target for the treatment of tonic-clonic epilepsy.	D004830	Epilepsy, Tonic-Clonic	1
SV2A	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	1
SYK	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
SYK	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	0
SYK	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
SYK	[MASK] is a promising drug target for the treatment of graft vs host disease.	D006086	Graft vs Host Disease	0
SYK	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
SYK	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
SYK	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
SYK	[MASK] is a promising drug target for the treatment of lupus nephritis.	D008181	Lupus Nephritis	0
SYK	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	0
SYK	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
SYK	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
SYK	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
SYK	[MASK] is a promising drug target for the treatment of sjogren's syndrome.	D012859	Sjogren's Syndrome	0
SYK	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	0
SYK	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
SYK	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
SYK	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
SYK	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	0
SYK	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
SYK	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
SYK	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
SYK	[MASK] is a promising drug target for the treatment of primary myelofibrosis.	D055728	Primary Myelofibrosis	0
TACR1	[MASK] is a promising drug target for the treatment of social phobia.	D000072861	Phobia, Social	0
TACR1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
TACR1	[MASK] is a promising drug target for the treatment of alcoholism.	D000437	Alcoholism	0
TACR1	[MASK] is a promising drug target for the treatment of cough.	D003371	Cough	0
TACR1	[MASK] is a promising drug target for the treatment of major depressive disorder.	D003865	Depressive Disorder, Major	0
TACR1	[MASK] is a promising drug target for the treatment of opioid-related disorders.	D009293	Opioid-Related Disorders	0
TACR1	[MASK] is a promising drug target for the treatment of nausea.	D009325	Nausea	1
TACR1	[MASK] is a promising drug target for the treatment of vomiting.	D014839	Vomiting	1
TACR1	[MASK] is a promising drug target for the treatment of postoperative nausea and vomiting.	D020250	Postoperative Nausea and Vomiting	1
TACR1	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
TACR1	[MASK] is a promising drug target for the treatment of acute lung injury.	D055371	Acute Lung Injury	0
TACR2	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
TACR3	[MASK] is a promising drug target for the treatment of leiomyoma.	D007889	Leiomyoma	0
TACR3	[MASK] is a promising drug target for the treatment of menopause.	D008593	Menopause	1
TACR3	[MASK] is a promising drug target for the treatment of opioid-related disorders.	D009293	Opioid-Related Disorders	0
TACR3	[MASK] is a promising drug target for the treatment of polycystic ovary syndrome.	D011085	Polycystic Ovary Syndrome	0
TACR3	[MASK] is a promising drug target for the treatment of schizophrenia.	D012559	Schizophrenia	0
TAP1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
TBK1	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
TBXA2R	[MASK] is a promising drug target for the treatment of brain ischemia.	D002545	Brain Ischemia	0
TBXA2R	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
TBXA2R	[MASK] is a promising drug target for the treatment of thrombosis.	D013927	Thrombosis	0
TBXAS1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
TBXAS1	[MASK] is a promising drug target for the treatment of cardiovascular diseases.	D002318	Cardiovascular diseases	0
TBXAS1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
TBXAS1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
TBXAS1	[MASK] is a promising drug target for the treatment of pulmonary edema.	D011654	Pulmonary Edema	0
TBXAS1	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
TEK	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
TEK	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	0
TEK	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
TEK	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	1
TEK	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
TEK	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
TEK	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	0
TEK	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
TERT	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
TERT	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
TFF1	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
TFPI	[MASK] is a promising drug target for the treatment of hemophilia b.	D002836	Hemophilia B	1
TFRC	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TFRC	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
TFRC	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
TFRC	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TFRC	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
TFRC	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
TGFA	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
TGFA	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
TGFA	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
TGFA	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
TGFB1	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
TGFB1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
TGFB1	[MASK] is a promising drug target for the treatment of burns.	D002056	Burns	0
TGFB1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TGFB1	[MASK] is a promising drug target for the treatment of corneal ulcer.	D003320	Corneal Ulcer	0
TGFB1	[MASK] is a promising drug target for the treatment of endomyocardial fibrosis.	D004719	Endomyocardial Fibrosis	0
TGFB1	[MASK] is a promising drug target for the treatment of fever.	D005334	Fever	1
TGFB1	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	1
TGFB1	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	1
TGFB1	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
TGFB1	[MASK] is a promising drug target for the treatment of regeneration.	D012038	Regeneration	1
TGFB1	[MASK] is a promising drug target for the treatment of spinal fusion.	D013123	Spinal Fusion	1
TGFB1	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
TGFB1	[MASK] is a promising drug target for the treatment of dry eye syndromes.	D015352	Dry Eye Syndromes	0
TGFB1	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	1
TGFB1	[MASK] is a promising drug target for the treatment of actinic keratosis.	D055623	Keratosis, Actinic	0
TGFB1	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	0
TGFBR1	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
TGFBR1	[MASK] is a promising drug target for the treatment of myeloproliferative disorders.	D009196	Myeloproliferative Disorders	0
TGFBR1	[MASK] is a promising drug target for the treatment of aggressive fibromatosis.	D018222	Fibromatosis, Aggressive	0
TGM2	[MASK] is a promising drug target for the treatment of graft rejection.	D006084	Graft Rejection	0
TH	[MASK] is a promising drug target for the treatment of adrenal gland neoplasms.	D000310	Adrenal Gland Neoplasms	1
THPO	[MASK] is a promising drug target for the treatment of anemia.	D000740	Anemia	0
THPO	[MASK] is a promising drug target for the treatment of thrombocytopenia.	D013921	Thrombocytopenia	0
TLR1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
TLR2	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
TLR2	[MASK] is a promising drug target for the treatment of bone marrow diseases.	D001855	Bone Marrow Diseases	0
TLR2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
TLR2	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
TLR2	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
TLR2	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
TLR2	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
TLR3	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
TLR3	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
TLR3	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	1
TLR3	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
TLR3	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
TLR4	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
TLR4	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TLR4	[MASK] is a promising drug target for the treatment of uterine cervical dysplasia.	D002578	Uterine Cervical Dysplasia	0
TLR4	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
TLR4	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
TLR4	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
TLR4	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
TLR4	[MASK] is a promising drug target for the treatment of herpes simplex.	D006561	Herpes Simplex	1
TLR4	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
TLR4	[MASK] is a promising drug target for the treatment of liposarcoma.	D008080	Liposarcoma	0
TLR4	[MASK] is a promising drug target for the treatment of liver diseases.	D008107	Liver Diseases	0
TLR4	[MASK] is a promising drug target for the treatment of follicular lymphoma.	D008224	Lymphoma, Follicular	0
TLR4	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
TLR4	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
TLR4	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TLR4	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
TLR4	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
TLR4	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
TLR4	[MASK] is a promising drug target for the treatment of infectious skin diseases.	D012874	Skin Diseases, Infectious	1
TLR4	[MASK] is a promising drug target for the treatment of synovial sarcoma.	D013584	Sarcoma, Synovial	0
TLR4	[MASK] is a promising drug target for the treatment of atherosclerosis.	D050197	Atherosclerosis	0
TLR4	[MASK] is a promising drug target for the treatment of reproductive tract infections.	D060737	Reproductive Tract Infections	0
TLR4	[MASK] is a promising drug target for the treatment of non-alcoholic fatty liver disease.	D065626	Non-alcoholic Fatty Liver Disease	0
TLR5	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
TLR5	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TLR5	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
TLR5	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
TLR6	[MASK] is a promising drug target for the treatment of bone marrow diseases.	D001855	Bone Marrow Diseases	0
TLR7	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
TLR7	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TLR7	[MASK] is a promising drug target for the treatment of seasonal allergic rhinitis.	D006255	Rhinitis, Allergic, Seasonal	0
TLR7	[MASK] is a promising drug target for the treatment of hepatitis c.	D006526	Hepatitis C	0
TLR7	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
TLR7	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
TLR7	[MASK] is a promising drug target for the treatment of waldenstrom macroglobulinemia.	D008258	Waldenstrom Macroglobulinemia	0
TLR7	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
TLR7	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
TLR7	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
TLR7	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
TLR7	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
TLR7	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
TLR7	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
TLR7	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
TLR7	[MASK] is a promising drug target for the treatment of basal cell neoplasms.	D018295	Neoplasms, Basal Cell	0
TLR7	[MASK] is a promising drug target for the treatment of papillomavirus infections.	D030361	Papillomavirus Infections	0
TLR7	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
TLR8	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
TLR8	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
TLR8	[MASK] is a promising drug target for the treatment of waldenstrom macroglobulinemia.	D008258	Waldenstrom Macroglobulinemia	0
TLR8	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
TLR8	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
TLR8	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
TLR8	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
TLR8	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
TLR8	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
TLR8	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
TLR8	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
TLR8	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
TLR9	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	1
TLR9	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
TLR9	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TLR9	[MASK] is a promising drug target for the treatment of dermatomyositis.	D003882	Dermatomyositis	0
TLR9	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
TLR9	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	0
TLR9	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
TLR9	[MASK] is a promising drug target for the treatment of waldenstrom macroglobulinemia.	D008258	Waldenstrom Macroglobulinemia	0
TLR9	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
TLR9	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
TLR9	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
TLR9	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
TLR9	[MASK] is a promising drug target for the treatment of skin neoplasms.	D012878	Skin Neoplasms	0
TLR9	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
TLR9	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
TLR9	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	0
TLR9	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
TLR9	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
TMPRSS6	[MASK] is a promising drug target for the treatment of thalassemia.	D013789	Thalassemia	0
TMSB4X	[MASK] is a promising drug target for the treatment of pterygium.	D011625	Pterygium	0
TNC	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
TNC	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TNC	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	0
TNC	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
TNC	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TNC	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
TNC	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
TNC	[MASK] is a promising drug target for the treatment of merkel cell carcinoma.	D015266	Carcinoma, Merkel Cell	0
TNF	[MASK] is a promising drug target for the treatment of arthritis.	D001168	Arthritis	0
TNF	[MASK] is a promising drug target for the treatment of juvenile arthritis.	D001171	Arthritis, Juvenile	1
TNF	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
TNF	[MASK] is a promising drug target for the treatment of behcet syndrome.	D001528	Behcet Syndrome	1
TNF	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	1
TNF	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	1
TNF	[MASK] is a promising drug target for the treatment of ichthyosis.	D007057	Ichthyosis	1
TNF	[MASK] is a promising drug target for the treatment of inflammation.	D007249	Inflammation	1
TNF	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TNF	[MASK] is a promising drug target for the treatment of polymyalgia rheumatica.	D011111	Polymyalgia Rheumatica	0
TNF	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
TNF	[MASK] is a promising drug target for the treatment of rectal fistula.	D012003	Rectal Fistula	1
TNF	[MASK] is a promising drug target for the treatment of seborrheic dermatitis.	D012628	Dermatitis, Seborrheic	1
TNF	[MASK] is a promising drug target for the treatment of ankylosing spondylitis.	D013167	Spondylitis, Ankylosing	1
TNF	[MASK] is a promising drug target for the treatment of uveitis.	D014605	Uveitis	1
TNF	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	1
TNF	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	1
TNF	[MASK] is a promising drug target for the treatment of hidradenitis suppurativa.	D017497	Hidradenitis Suppurativa	1
TNFRSF10A	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TNFRSF10A	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
TNFRSF10A	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
TNFRSF10B	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
TNFRSF12A	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
TNFRSF12A	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	0
TNFRSF12A	[MASK] is a promising drug target for the treatment of lupus nephritis.	D008181	Lupus Nephritis	0
TNFRSF13B	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
TNFRSF13C	[MASK] is a promising drug target for the treatment of pemphigus.	D010392	Pemphigus	0
TNFRSF13C	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
TNFRSF13C	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	0
TNFRSF17	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
TNFRSF18	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
TNFRSF18	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
TNFRSF18	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
TNFRSF18	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
TNFRSF18	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TNFRSF1A	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
TNFRSF1A	[MASK] is a promising drug target for the treatment of liver cirrhosis.	D008103	Liver Cirrhosis	1
TNFRSF1A	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
TNFRSF1A	[MASK] is a promising drug target for the treatment of wound healing.	D014945	Wound Healing	1
TNFRSF1A	[MASK] is a promising drug target for the treatment of mucositis.	D052016	Mucositis	0
TNFRSF1A	[MASK] is a promising drug target for the treatment of idiopathic pulmonary fibrosis.	D054990	Idiopathic Pulmonary Fibrosis	1
TNFRSF4	[MASK] is a promising drug target for the treatment of autoimmune diseases.	D001327	Autoimmune Diseases	0
TNFRSF4	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
TNFRSF4	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
TNFRSF4	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
TNFRSF4	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
TNFRSF4	[MASK] is a promising drug target for the treatment of urethral neoplasms.	D014523	Urethral Neoplasms	0
TNFRSF4	[MASK] is a promising drug target for the treatment of b-cell lymphoma.	D016393	Lymphoma, B-Cell	0
TNFRSF8	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
TNFRSF8	[MASK] is a promising drug target for the treatment of anaplastic large-cell lymphoma.	D017728	Lymphoma, Large-Cell, Anaplastic	0
TNFRSF9	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
TNFRSF9	[MASK] is a promising drug target for the treatment of leukemia.	D007938	Leukemia	0
TNFRSF9	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
TNFSF10	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TNFSF10	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
TNFSF10	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
TNFSF10	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
TNFSF10	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
TNFSF11	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
TNFSF11	[MASK] is a promising drug target for the treatment of metabolic bone diseases.	D001851	Bone Diseases, Metabolic	1
TNFSF11	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
TNFSF11	[MASK] is a promising drug target for the treatment of osteopetrosis.	D010022	Osteopetrosis	1
TNFSF11	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	1
TNFSF13	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	1
TNFSF13	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
TNFSF13B	[MASK] is a promising drug target for the treatment of chronic kidney failure.	D007676	Kidney Failure, Chronic	0
TNFSF13B	[MASK] is a promising drug target for the treatment of systemic lupus erythematosus.	D008180	Lupus Erythematosus, Systemic	1
TNFSF13B	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
TNFSF13B	[MASK] is a promising drug target for the treatment of relapsing-remitting multiple sclerosis.	D020529	Multiple Sclerosis, Relapsing-Remitting	0
TNFSF15	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
TNFSF4	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
TNFSF4	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TNFSF4	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
TNFSF4	[MASK] is a promising drug target for the treatment of allergic rhinitis.	D065631	Rhinitis, Allergic	0
TNFSF9	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TNPO1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
TNPO1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
TNPO1	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
TNPO1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
TNPO1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TNPO1	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	0
TNPO1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
TNPO1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
TNPO1	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
TNPO1	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
TNPO1	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
TNPO1	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
TNPO1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
TOP1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
TOP1	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
TOP1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
TOP1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
TOP1	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
TOP1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
TOP1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
TOP1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	1
TOP1	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
TOP2A	[MASK] is a promising drug target for the treatment of bacterial infections.	D001424	Bacterial Infections	1
TOP2A	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
TOP2A	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
TOP2A	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	1
TOP2A	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	1
TOP2A	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
TOP2A	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	1
TOP2A	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
TOP2A	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	1
TOP2A	[MASK] is a promising drug target for the treatment of wilms tumor.	D009396	Wilms Tumor	1
TOP2A	[MASK] is a promising drug target for the treatment of neuroblastoma.	D009447	Neuroblastoma	1
TOP2A	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	1
TOP2A	[MASK] is a promising drug target for the treatment of pneumonia.	D011014	Pneumonia	1
TOP2A	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
TOP2A	[MASK] is a promising drug target for the treatment of rhabdomyosarcoma.	D012208	Rhabdomyosarcoma	1
TOP2A	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	1
TOP2A	[MASK] is a promising drug target for the treatment of ewing sarcoma.	D012512	Sarcoma, Ewing	1
TOP2A	[MASK] is a promising drug target for the treatment of kaposi sarcoma.	D012514	Sarcoma, Kaposi	1
TOP2A	[MASK] is a promising drug target for the treatment of osteosarcoma.	D012516	Osteosarcoma	1
TOP2A	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
TOP2A	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	1
TOP2A	[MASK] is a promising drug target for the treatment of urinary tract infections.	D014552	Urinary Tract Infections	1
TOP2A	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	1
TOP2A	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	1
TOP2A	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
TOP2A	[MASK] is a promising drug target for the treatment of peripheral t-cell lymphoma.	D016411	Lymphoma, T-Cell, Peripheral	1
TOP2A	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	1
TOP2A	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
TP53	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
TP53	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of leukoplakia.	D007971	Leukoplakia	0
TP53	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of non-hodgkin lymphoma.	D008228	Lymphoma, Non-Hodgkin	0
TP53	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
TP53	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
TP53	[MASK] is a promising drug target for the treatment of mouth neoplasms.	D009062	Mouth Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of urogenital neoplasms.	D014565	Urogenital Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	0
TP53	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
TP53	[MASK] is a promising drug target for the treatment of mantle-cell lymphoma.	D020522	Lymphoma, Mantle-Cell	0
TP53	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
TPH1	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
TPH1	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
TPH1	[MASK] is a promising drug target for the treatment of dyspepsia.	D004415	Dyspepsia	0
TPH1	[MASK] is a promising drug target for the treatment of malignant carcinoid syndrome.	D008303	Malignant Carcinoid Syndrome	1
TPH1	[MASK] is a promising drug target for the treatment of inflammatory bowel diseases.	D015212	Inflammatory Bowel Diseases	0
TPH1	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
TPH1	[MASK] is a promising drug target for the treatment of ileus.	D045823	Ileus	0
TPP1	[MASK] is a promising drug target for the treatment of neuronal ceroid-lipofuscinoses.	D009472	Neuronal Ceroid-Lipofuscinoses	1
TRHR	[MASK] is a promising drug target for the treatment of spinocerebellar ataxias.	D020754	Spinocerebellar Ataxias	1
TRPA1	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
TRPA1	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	0
TRPA1	[MASK] is a promising drug target for the treatment of charcot-marie-tooth disease.	D002607	Charcot-Marie-Tooth Disease	0
TRPA1	[MASK] is a promising drug target for the treatment of constipation.	D003248	Constipation	1
TRPA1	[MASK] is a promising drug target for the treatment of cough.	D003371	Cough	0
TRPA1	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	0
TRPA1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
TRPA1	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
TRPA1	[MASK] is a promising drug target for the treatment of muscle spasticity.	D009128	Muscle Spasticity	0
TRPA1	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
TRPA1	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
TRPA1	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	1
TRPA1	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
TRPA1	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	1
TRPA1	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	1
TRPA1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
TRPA1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
TRPC5	[MASK] is a promising drug target for the treatment of diabetic nephropathies.	D003928	Diabetic Nephropathies	0
TRPC5	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
TRPV1	[MASK] is a promising drug target for the treatment of morton neuroma.	D000070607	Morton Neuroma	0
TRPV1	[MASK] is a promising drug target for the treatment of cancer pain.	D000072716	Cancer Pain	0
TRPV1	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
TRPV1	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
TRPV1	[MASK] is a promising drug target for the treatment of anxiety disorders.	D001008	Anxiety Disorders	0
TRPV1	[MASK] is a promising drug target for the treatment of charcot-marie-tooth disease.	D002607	Charcot-Marie-Tooth Disease	0
TRPV1	[MASK] is a promising drug target for the treatment of cluster headache.	D003027	Cluster Headache	0
TRPV1	[MASK] is a promising drug target for the treatment of cough.	D003371	Cough	0
TRPV1	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
TRPV1	[MASK] is a promising drug target for the treatment of epilepsy.	D004827	Epilepsy	1
TRPV1	[MASK] is a promising drug target for the treatment of partial epilepsies.	D004828	Epilepsies, Partial	0
TRPV1	[MASK] is a promising drug target for the treatment of myoclonic epilepsies.	D004831	Epilepsies, Myoclonic	0
TRPV1	[MASK] is a promising drug target for the treatment of absence epilepsy.	D004832	Epilepsy, absence	0
TRPV1	[MASK] is a promising drug target for the treatment of gastroesophageal reflux.	D005764	Gastroesophageal Reflux	0
TRPV1	[MASK] is a promising drug target for the treatment of migraine disorders.	D008881	Migraine Disorders	0
TRPV1	[MASK] is a promising drug target for the treatment of multiple sclerosis.	D009103	Multiple Sclerosis	0
TRPV1	[MASK] is a promising drug target for the treatment of muscle spasticity.	D009128	Muscle Spasticity	0
TRPV1	[MASK] is a promising drug target for the treatment of osteoarthritis.	D010003	Osteoarthritis	0
TRPV1	[MASK] is a promising drug target for the treatment of prader-willi syndrome.	D011218	Prader-Willi Syndrome	0
TRPV1	[MASK] is a promising drug target for the treatment of pruritus.	D011537	Pruritus	0
TRPV1	[MASK] is a promising drug target for the treatment of rosacea.	D012393	Rosacea	0
TRPV1	[MASK] is a promising drug target for the treatment of seborrheic dermatitis.	D012628	Dermatitis, Seborrheic	0
TRPV1	[MASK] is a promising drug target for the treatment of infantile spasms.	D013036	Spasms, Infantile	0
TRPV1	[MASK] is a promising drug target for the treatment of urinary incontinence.	D014549	Urinary Incontinence	0
TRPV1	[MASK] is a promising drug target for the treatment of angelman syndrome.	D017204	Angelman Syndrome	0
TRPV1	[MASK] is a promising drug target for the treatment of cocaine-related disorders.	D019970	Cocaine-Related Disorders	0
TRPV1	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
TRPV1	[MASK] is a promising drug target for the treatment of overactive urinary bladder.	D053201	Urinary Bladder, Overactive	0
TRPV1	[MASK] is a promising drug target for the treatment of nociceptive pain.	D059226	Nociceptive Pain	0
TRPV1	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	1
TRPV1	[MASK] is a promising drug target for the treatment of lennox gastaut syndrome.	D065768	Lennox Gastaut Syndrome	0
TRPV3	[MASK] is a promising drug target for the treatment of diabetic neuropathies.	D003929	Diabetic Neuropathies	0
TRPV3	[MASK] is a promising drug target for the treatment of neuralgia.	D009437	Neuralgia	0
TRPV3	[MASK] is a promising drug target for the treatment of skin diseases.	D012871	Skin diseases	0
TRPV3	[MASK] is a promising drug target for the treatment of postherpetic neuralgia.	D051474	Neuralgia, Postherpetic	0
TRPV3	[MASK] is a promising drug target for the treatment of musculoskeletal pain.	D059352	Musculoskeletal Pain	0
TRPV4	[MASK] is a promising drug target for the treatment of cough.	D003371	Cough	0
TRPV4	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
TSHR	[MASK] is a promising drug target for the treatment of hypothyroidism.	D007037	Hypothyroidism	1
TSLP	[MASK] is a promising drug target for the treatment of asthma.	D001249	Asthma	1
TSPO	[MASK] is a promising drug target for the treatment of irritable bowel syndrome.	D043183	Irritable Bowel Syndrome	0
TTR	[MASK] is a promising drug target for the treatment of amyloidosis.	D000686	Amyloidosis	1
TTR	[MASK] is a promising drug target for the treatment of familial amyloid neuropathies.	D028227	Amyloid Neuropathies, Familial	1
TUBB	[MASK] is a promising drug target for the treatment of anus neoplasms.	D001005	Anus Neoplasms	0
TUBB	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
TUBB	[MASK] is a promising drug target for the treatment of uterine cervical dysplasia.	D002578	Uterine Cervical Dysplasia	0
TUBB	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
TUBB	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	0
TUBB	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of lymphoma.	D008223	Lymphoma	0
TUBB	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
TUBB	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of skin neoplasms.	D012878	Skin Neoplasms	0
TUBB	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
TUBB	[MASK] is a promising drug target for the treatment of thyroid neoplasms.	D013964	Thyroid Neoplasms	0
TUBB	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
TUBB	[MASK] is a promising drug target for the treatment of bcr-abl positive chronic myelogenous leukemia.	D015464	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	0
TUBB	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
TUBB	[MASK] is a promising drug target for the treatment of endometrial neoplasms.	D016889	Endometrial Neoplasms	0
TUBB	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
TUBB	[MASK] is a promising drug target for the treatment of hematologic neoplasms.	D019337	Hematologic Neoplasms	0
TUBB	[MASK] is a promising drug target for the treatment of coronary restenosis.	D023903	Coronary Restenosis	1
TUBB	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
TUBB	[MASK] is a promising drug target for the treatment of actinic keratosis.	D055623	Keratosis, Actinic	0
TUBB	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	1
TYK2	[MASK] is a promising drug target for the treatment of ulcerative colitis.	D003093	Colitis, Ulcerative	0
TYK2	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	1
TYK2	[MASK] is a promising drug target for the treatment of cutaneous lupus erythematosus.	D008178	Lupus Erythematosus, Cutaneous	0
TYK2	[MASK] is a promising drug target for the treatment of lupus nephritis.	D008181	Lupus Nephritis	0
TYK2	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
TYK2	[MASK] is a promising drug target for the treatment of vitiligo.	D014820	Vitiligo	0
TYK2	[MASK] is a promising drug target for the treatment of hidradenitis suppurativa.	D017497	Hidradenitis Suppurativa	0
TYMS	[MASK] is a promising drug target for the treatment of juvenile arthritis.	D001171	Arthritis, Juvenile	1
TYMS	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	1
TYMS	[MASK] is a promising drug target for the treatment of bile duct neoplasms.	D001650	Bile Duct Neoplasms	0
TYMS	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	1
TYMS	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
TYMS	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
TYMS	[MASK] is a promising drug target for the treatment of crohn disease.	D003424	Crohn Disease	1
TYMS	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	1
TYMS	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	1
TYMS	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	0
TYMS	[MASK] is a promising drug target for the treatment of mesothelioma.	D008654	Mesothelioma	1
TYMS	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
TYMS	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
TYMS	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	1
TYMS	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
TYMS	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	1
TYMS	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
TYMS	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
TYMS	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
TYMS	[MASK] is a promising drug target for the treatment of psoriatic arthritis.	D015535	Arthritis, Psoriatic	1
TYMS	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	1
TYMS	[MASK] is a promising drug target for the treatment of actinic keratosis.	D055623	Keratosis, Actinic	1
UCHL5	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
UCN3	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
UGCG	[MASK] is a promising drug target for the treatment of polycystic kidney diseases.	D007690	Polycystic Kidney Diseases	0
UGCG	[MASK] is a promising drug target for the treatment of parkinson disease.	D010300	Parkinson Disease	0
USH2A	[MASK] is a promising drug target for the treatment of usher syndromes.	D052245	Usher Syndromes	0
USP14	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
UTRN	[MASK] is a promising drug target for the treatment of duchenne muscular dystrophy.	D020388	Muscular Dystrophy, Duchenne	0
VDR	[MASK] is a promising drug target for the treatment of acne vulgaris.	D000152	Acne Vulgaris	0
VDR	[MASK] is a promising drug target for the treatment of atopic dermatitis.	D003876	Dermatitis, Atopic	0
VDR	[MASK] is a promising drug target for the treatment of secondary hyperparathyroidism.	D006962	Hyperparathyroidism, Secondary	0
VDR	[MASK] is a promising drug target for the treatment of osteoporosis.	D010024	Osteoporosis	0
VDR	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	1
VEGFA	[MASK] is a promising drug target for the treatment of amyotrophic lateral sclerosis.	D000690	Amyotrophic lateral sclerosis	0
VEGFA	[MASK] is a promising drug target for the treatment of anus neoplasms.	D001005	Anus Neoplasms	0
VEGFA	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of carcinoid tumor.	D002276	Carcinoid Tumor	0
VEGFA	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	1
VEGFA	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of diabetic retinopathy.	D003930	Diabetic Retinopathy	1
VEGFA	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	1
VEGFA	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
VEGFA	[MASK] is a promising drug target for the treatment of intermittent claudication.	D007383	Intermittent Claudication	0
VEGFA	[MASK] is a promising drug target for the treatment of ischemia.	D007511	Ischemia	1
VEGFA	[MASK] is a promising drug target for the treatment of kidney neoplasms.	D007680	Kidney Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of liver neoplasms.	D008113	Liver Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of macular edema.	D008269	Macular Edema	1
VEGFA	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	1
VEGFA	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
VEGFA	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	0
VEGFA	[MASK] is a promising drug target for the treatment of myopia.	D009216	Myopia	1
VEGFA	[MASK] is a promising drug target for the treatment of ovarian neoplasms.	D010051	Ovarian Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
VEGFA	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of psoriasis.	D011565	Psoriasis	0
VEGFA	[MASK] is a promising drug target for the treatment of retinal vein occlusion.	D012170	Retinal Vein Occlusion	1
VEGFA	[MASK] is a promising drug target for the treatment of retinopathy of prematurity.	D012178	Retinopathy of Prematurity	1
VEGFA	[MASK] is a promising drug target for the treatment of rhabdomyosarcoma.	D012208	Rhabdomyosarcoma	0
VEGFA	[MASK] is a promising drug target for the treatment of rosacea.	D012393	Rosacea	0
VEGFA	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
VEGFA	[MASK] is a promising drug target for the treatment of colorectal neoplasms.	D015179	Colorectal Neoplasms	1
VEGFA	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
VEGFA	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	1
VEGFA	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
VEGFA	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	1
VEGFB	[MASK] is a promising drug target for the treatment of wet macular degeneration.	D057135	Wet Macular Degeneration	1
VEGFD	[MASK] is a promising drug target for the treatment of angina pectoris.	D000787	Angina Pectoris	0
VEGFD	[MASK] is a promising drug target for the treatment of ischemia.	D007511	Ischemia	0
VEGFD	[MASK] is a promising drug target for the treatment of peripheral vascular diseases.	D016491	Peripheral Vascular Diseases	0
VIPR2	[MASK] is a promising drug target for the treatment of covid-19.	D000086382	COVID-19	0
VIPR2	[MASK] is a promising drug target for the treatment of heart failure.	D006333	Heart Failure	0
VIPR2	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
VIPR2	[MASK] is a promising drug target for the treatment of respiratory distress syndrome.	D012128	Respiratory Distress Syndrome	0
VSIR	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
VSIR	[MASK] is a promising drug target for the treatment of hodgkin disease.	D006689	Hodgkin Disease	0
VSIR	[MASK] is a promising drug target for the treatment of mouth neoplasms.	D009062	Mouth Neoplasms	0
VWF	[MASK] is a promising drug target for the treatment of hemophilia a.	D006467	Hemophilia A	1
VWF	[MASK] is a promising drug target for the treatment of systemic scleroderma.	D012595	Scleroderma, Systemic	0
VWF	[MASK] is a promising drug target for the treatment of operative surgical procedures.	D013514	Surgical Procedures, Operative	1
VWF	[MASK] is a promising drug target for the treatment of von willebrand diseases.	D014842	von Willebrand Diseases	1
VWF	[MASK] is a promising drug target for the treatment of diffuse scleroderma.	D045743	Scleroderma, Diffuse	0
VWF	[MASK] is a promising drug target for the treatment of limited scleroderma.	D045745	Scleroderma, Limited	0
WEE1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
WEE1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
WEE1	[MASK] is a promising drug target for the treatment of uterine cervical neoplasms.	D002583	Uterine Cervical Neoplasms	0
WEE1	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
WEE1	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
WEE1	[MASK] is a promising drug target for the treatment of small cell lung carcinoma.	D055752	Small Cell Lung Carcinoma	0
WT1	[MASK] is a promising drug target for the treatment of urinary bladder neoplasms.	D001749	Urinary Bladder Neoplasms	0
WT1	[MASK] is a promising drug target for the treatment of brain neoplasms.	D001932	Brain Neoplasms	0
WT1	[MASK] is a promising drug target for the treatment of non-small-cell lung carcinoma.	D002289	Carcinoma, Non-Small-Cell Lung	0
WT1	[MASK] is a promising drug target for the treatment of glioblastoma.	D005909	Glioblastoma	0
WT1	[MASK] is a promising drug target for the treatment of medulloblastoma.	D008527	Medulloblastoma	0
WT1	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
WT1	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
WT1	[MASK] is a promising drug target for the treatment of pancreatic neoplasms.	D010190	Pancreatic Neoplasms	0
WT1	[MASK] is a promising drug target for the treatment of prostatic neoplasms.	D011471	Prostatic Neoplasms	0
WT1	[MASK] is a promising drug target for the treatment of sarcoma.	D012509	Sarcoma	0
WT1	[MASK] is a promising drug target for the treatment of stomach neoplasms.	D013274	Stomach Neoplasms	0
WT1	[MASK] is a promising drug target for the treatment of gastrointestinal stromal tumors.	D046152	Gastrointestinal Stromal Tumors	0
WT1	[MASK] is a promising drug target for the treatment of precursor cell lymphoblastic leukemia-lymphoma.	D054198	Precursor Cell Lymphoblastic Leukemia-Lymphoma	0
XDH	[MASK] is a promising drug target for the treatment of focal segmental glomerulosclerosis.	D005923	Glomerulosclerosis, Focal Segmental	0
XDH	[MASK] is a promising drug target for the treatment of gout.	D006073	Gout	1
XDH	[MASK] is a promising drug target for the treatment of pulmonary hypertension.	D006976	Hypertension, Pulmonary	0
XIAP	[MASK] is a promising drug target for the treatment of fallopian tube neoplasms.	D005185	Fallopian Tube Neoplasms	0
XIAP	[MASK] is a promising drug target for the treatment of hepatitis b.	D006509	Hepatitis B	0
XIAP	[MASK] is a promising drug target for the treatment of melanoma.	D008545	Melanoma	0
XIAP	[MASK] is a promising drug target for the treatment of myelodysplastic syndromes.	D009190	Myelodysplastic Syndromes	0
XIAP	[MASK] is a promising drug target for the treatment of peritoneal neoplasms.	D010534	Peritoneal Neoplasms	0
XIAP	[MASK] is a promising drug target for the treatment of acute myeloid leukemia.	D015470	Leukemia, Myeloid, Acute	0
XIAP	[MASK] is a promising drug target for the treatment of chronic myelomonocytic leukemia.	D015477	Leukemia, Myelomonocytic, Chronic	0
XPO1	[MASK] is a promising drug target for the treatment of breast neoplasms.	D001943	Breast Neoplasms	0
XPO1	[MASK] is a promising drug target for the treatment of esophageal neoplasms.	D004938	Esophageal Neoplasms	0
XPO1	[MASK] is a promising drug target for the treatment of head and neck neoplasms.	D006258	Head and Neck Neoplasms	0
XPO1	[MASK] is a promising drug target for the treatment of lung neoplasms.	D008175	Lung Neoplasms	0
XPO1	[MASK] is a promising drug target for the treatment of multiple myeloma.	D009101	Multiple Myeloma	1
XPO1	[MASK] is a promising drug target for the treatment of neoplasms.	D009369	Neoplasms	0
XPO1	[MASK] is a promising drug target for the treatment of b-cell chronic lymphocytic leukemia.	D015451	Leukemia, Lymphocytic, Chronic, B-Cell	0
XPO1	[MASK] is a promising drug target for the treatment of diffuse large b-cell lymphoma.	D016403	Lymphoma, Large B-Cell, Diffuse	1
XPO1	[MASK] is a promising drug target for the treatment of cutaneous t-cell lymphoma.	D016410	Lymphoma, T-Cell, Cutaneous	0
XPO1	[MASK] is a promising drug target for the treatment of squamous cell neoplasms.	D018307	Neoplasms, Squamous cell	0
YES1	[MASK] is a promising drug target for the treatment of macular degeneration.	D008268	Macular Degeneration	0
ZAP70	[MASK] is a promising drug target for the treatment of rheumatoid arthritis.	D001172	Arthritis, Rheumatoid	0
